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THE ROLE OF CUGBP1 IN THE DEVELOPMENT OF ZEBRAFISH 
LENS 
 
 
Abstract                   
 
The lens is a transparent tissue in the anterior of the eye and its main role is to refract light on the retina. 
The lens consists of two types of cells: epithelial cells and fibers. Epithelial cells surround the anterior and lateral 
limits of the lens, remain proliferative and at the equator of the lens they differentiate into lens fibers. In this 
process newly generated lens fibers elongate and gradually lose their organelles, enabling transparency. Cataracts 
are any opacification of the lens that compromises its ability to refract light onto the retina, and can be genetic or 
environmentally induced.  
Since it has been demonstrated that the zebrafish (Danio rerio) is an ideal organism to study human 
ocular disorders, this model system was utilized to study gene products that regulate normal lens development 
and that in pathological states contribute to cataracts. CUGBP1 is an mRNA binding protein that has been 
implicated in the multisystemic disease Myotonic Dystrophy 1 (DM1). DM1 is caused by a (CTG)n repeat 
expansion within the 3'UTR region of the DMPK gene. Its mechanism implies a toxic gain of function where 
expanded CUG mRNA repeats increase steady state levels of CUGBP1 protein among other effects. Patients with 
DM1 develop cataracts. So, it can be hypothesized that CUGBP1 disrupted expression in lenses from DM1 
patients can be, at least, one of the causes that leads to cataracts in this disease. 
In situ hybridization results show that cugbp1 is expressed in the zebrafish lens at early embryonic 
development in newly formed lens fibers. Transgenic embryos expressing nuclear or membrane localized-EGFP 
under the control of a 1.2kb cugbp1 promoter further demonstrate its expression in the lens. Knocking down 
expression of cugbp1 with a splice-altering morpholino results in cataracts as early as 3dpf. Hence, the latter 
reveals that cugbp1 expression is a requirement for normal lens early development. In morphant embryos, lens 
fiber compaction is disturbed. In addition, these cells retain nuclei. Lens overall shape and size is also affected. 
Furthermore, the defective phenotype includes a general developmental delay, little mobility and dilated 
cardiomyopathy, symptoms that are also observed in DM1 patients. 
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EL ROL DE CUGBP1 EN EL DESARROLLO DEL CRISTALINO DEL 
PEZ CEBRA 
 
 
Resumen 
 
El cristalino (lente del ojo) es un tejido transparente en la región anterior del ojo y su rol principal es 
refractar la luz sobre la retina. El cristalino está constituido por dos tipos de células: células epiteliales y fibras. 
Las células epiteliales rodean la parte anterior y los límites laterales de la lente del ojo, mantienen su capacidad 
de proliferación y en el ecuador del cristalino se diferencian para generar fibras. En este proceso, las fibras recién 
generadas se elongan y gradualmente pierden sus organelas, permitiendo así la transparencia. Las cataratas se 
refieren a cualquier opacificación  del cristalino que comprometa su habilidad de refractar la luz hacia la retina y 
pueden ser inducidas por la genética o el ambiente. 
Debido a que se ha demostrado que el pez cebra (Danio rerio) es un organismo ideal para estudiar 
desordenes oculares humanos, este sistema modelo se utilizó para estudiar productos génicos que regulan el 
desarrollo normal de la lente y que en estados patológicos contribuyen a la aparición de cataratas. CUGBP1 es 
una proteína de unión a ARNm que ha sido implicada en la enfermedad multisistémica Distrofia Miotónica 1 
(DM1). La DM1 es causada por la expansión de la repetición (CTG)n localizada en la región 3'UTR del gen 
DMPK. Su mecanismo implica una ganancia de función que es tóxica donde la expansión de las repeticiones 
CUG del ARNm estabilizan la proteína CUGBP1 provocando un aumento de sus niveles, entre otros efectos. 
Pacientes con DM1 desarrollan cataratas. Entonces, se puede plantear la hipótesis de que una expresión 
defectuosa de CUGBP1 en el cristalino de pacientes con DM1 puede ser, por lo menos, una de las causas que 
conllevan a la formación de cataratas en esta enfermedad. 
Resultados de ensayos de hibridación in situ muestran que cugbp1 se expresa en la lente del ojo del pez 
cebra durante el desarrollo embrionario temprano en fibras recién formadas. Embriones transgénicos que 
expresan la proteína verde fluorescente co-localizada en el núcleo o la membrana celular bajo el control de una 
región promotora de 1.2kb del gen cugbp1 evidencian aún más su expresión en el cristalino. El disminuir la 
expresión (knock down) de cugbp1 con un morfolino que altera el proceso de corte y empalme (splicing) resulta 
en la formación de cataratas a partir de los 3 días después de la fertilización. Por lo tanto, lo anterior revela que la 
expresión de cugbp1 es un requerimiento para el desarrollo temprano normal de la lente del ojo. En embriones 
inyectados con el morfolino, la compactación de las fibras del cristalino se ve perturbada. Además, estas células 
retienen el núcleo. La forma y el tamaño generales de la lente del ojo también se ven afectados. Asimismo, el 
fenotipo defectuoso incluye un retraso general en el desarrollo, poca movilidad y miocardiopatía dilatada, 
síntomas que también se observan en pacientes con DM1. 
 
Palabras clave: Cugbp1, Desarrollo del cristalino, Diferenciación de las fibras del cristalino, Pez cebra.  
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Chapter 1. Introduction 
 
 
The lens is a transparent and avascular tissue in the anterior of the eye and its main role 
is to refract light onto the retina where light is transduced into neural signals. Afterwards, 
these signals are transmitted to the brain. The vertebrate lens consists of two types of cells: 
epithelial cells and fibers. Epithelial cells surround the anterior and lateral limits of the lens, 
remain proliferative and at the equator of the lens, or near to it, they differentiate into lens 
fibers (Chow and Lang 2001; Tsang and Gouras 2006; Greiling and Clark 2009). In this 
process newly formed lens fibers elongate and gradually lose their organelles, enabling 
transparency (Bassnett 2009). 
Cataracts are defined as any opacification of the lens that compromises its ability to 
refract light onto the retina (Graw 1999). According to the World Health Organization, the 
latest estimates (Oct., 2011) say there are 285 million people visually impaired worldwide and 
about 90% of them live in developing countries. Cataracts account for 33% of global visual 
impairment (VI = VA ˂ 0.3) and are still the main cause of blindness in third world nations 
(WHO 2011). Visual acuity (VA) is the ability to distinguish details and shapes of objects. 
Any visual deprivation, such as lens opacities, will result in a decrease of VA. In humans, VA 
develops from birth to adolescence and a VA of 1.0 is reached by 5-6 years of age (Ekström 
2009). Cataracts can be genetic and/or environmentally induced and can happen via many 
different cellular and molecular mechanisms. Therefore, it is necessary to investigate the 
cellular and molecular basis of lens development and physiology to be able to understand the 
reasons that cause cataracts. This will lead to aim for new and better therapeutic treatments 
(Gross and Perkins 2007; Wormstone and Wride 2011).   
The zebrafish (Danio rerio) has emerged as an ideal model to study early development 
and disease of the visual system, including the lens of the eye. Some of the zebrafish 
advantages to study overall embryonic development are: external fertilization, their rapid 
development compared to other vertebrate model organisms, embryonic development occurs 
ex utero. The embryo is transparent which facilitates visual identification of morphogenetic 
movements and organogenesis with a standard dissection microscope. Zebrafish are easily 
adapted to laboratory settings and can be maintained in a relatively small space compared to 
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other vertebrate model systems. These freshwater fish reach sexual maturity in just 3-4 months 
and a single pair of fish can produce >200 fertilized eggs per mating. These characteristics 
have made zebrafish embryos ideal for the discovery of the function of genes implicated in 
regulating embryonic development, including lens morphogenesis (Glass and Dahm 2004; 
Fadool and Dowling 2008; Greiling and Clark 2009).  
Zebrafish are very visually oriented and their lenses show much the same morphology 
as other vertebrates, including humans (Glass and Dahm 2004). Their visual system is first 
identified as a functional structure between the third and fourth days post fertilization (dpf; 
Easter and Nicola 1996). Moreover, the lens shape and overall structure suggests it is a 
functional optical element in the visual pathway as early as 3dpf (Greiling and Clark 2009). 
All the aspects mentioned above make zebrafish well suited for examining lens development, 
function and disease.  
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Chapter 2. Research aims 
 
 
 2.1 General objective 
 
• Identify and investigate the role of Cugbp1 protein in early zebrafish (Danio 
rerio) lens development.  
 
 2.2 Specific objectives 
 
• Detect if there is cugbp1 mRNA expression in zebrafish early lens 
development, and if so, where inside the lens and at what developmental stages 
is it expressed. 
 
• Identify a promoter at the cugbp1 gene that directs expression at the zebrafish 
lens to estimate Cugbp1 protein expression. 
 
• Identify if a specific cugbp1 morpholino alters splicing of cugbp1 mRNA. 
 
• Identify phenotypical defects in whole embryos, at first sight, due to down 
regulation of cugbp1 and compare them with defects previously reported at 
DM1 disease where cugbp1 expression is also disrupted. 
 
• Observe if lens development is affected when cugbp1 expression is down 
regulated and recognize a role for Cugbp1 protein in zebrafish early lens 
development.  
 
• Detect if Cugbp1 is necessary for zebrafish lens cell proliferation. 
  
• Identify if Cugbp1 is required for the expression of Aqp0 protein to detect if 
Cugbp1 is necessary for zebrafish lens fibers early differentiation. 
  
• Recognize if cugbp1 has a role in F-actin distribution and/or arrangement in 
zebrafish lens fibers. 
  
• Identify if Cugbp1 is involved in nuclei degradation in zebrafish lens fibers to 
recognize if Cugbp1 is needed for lens fibers maturation.  
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Chapter 3. Theoretical Framework 
 
3.1 Zebrafish lens early development 
 
Zebrafish lens establishment starts at the 14-15 somite stage (~16hpf; hours post 
fertilization) with a contact between the surface cranial ectoderm and an evaginating solid 
mass of cells that comes from the diencephalon (more posterior and ventral part of the 
forebrain) and constitutes the optic primordium. The optic primordium is a solid mass of cells 
that emerges from the anterior portion of the neural tube and will eventually give rise to the 
retina. The forebrain or prosencephalon refers to the most anterior region of the brain and it 
includes the diencephalon (Schmitt and Dowling 1994; Kimmel et al. 1995; Soules and Link 
2005; Dahm et al. 2007; Greiling and Clark 2008). 
The surface ectoderm-optic primordium interaction results in the thickening of the lens 
placode and in zebrafish, this occurs at 16hpf. This thickening starts as a columnar epithelium 
by doubling of the basal to apical height of cells from simple cuboidal epithelium of the 
cranial surface ectoderm (Schmitt and Dowling 1994; Greiling and Clark 2008; Greiling and 
Clark 2009). The lens placode is defined as the ectodermal primordium of the lens and it 
overlies the center of the developing retina (Kimmel et al. 1995; Dahm et al. 2007; Greiling 
and Clark 2009). 
When observed from the surface the lens placode, from 16hpf zebrafish embryos, 
looks circular, of approximately 8 cells in diameter, and it is composed of columnar cells 
relatively uniform in size and shape. At this point, the lens placode of the zebrafish resembles 
the mammalian or avian placode (Greiling and Clark 2009). 
By 18hpf, many of the cells in the lens placode have more than double in height as 
compared to 16hpf, and look as a solid mass of cells ordered as a flattened spheroid (plate-like 
thickening organization). The lens mass is two or three cell-layers thick at the center with a 
single layer remaining laterally. The change in morphology has made elongated cells of the 
lens placode clearly distinguishable from cuboidal cells of the surface ectoderm. In the 
anteromedial region of the lens mass, cells are shorter and more rounded than the elongated 
cells present at the posterior and lateral lens borders (Greiling and Clark 2009). At the 
analogous moment in development, the mammalian and avian single layered lens placodes 
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start to invaginate instead of undergoing a delamination growth process as in zebrafish 
embryos (Fadool and Dowling 2008; Greiling and Clark 2008).  
At 20hpf the thickness of the lens mass increases bulging towards the retina and 
narrows in the equatorial dimension. At this moment, it is quite obvious that the lens placode 
has changed from a plate-like structure to a lentoid solid mass of cells that will eventually 
acquire a more spherical shape (Fadool and Dowling 2008; Greiling and Clark 2008; Greiling 
and Clark 2009). Elongated fiber-like cells appeared along the deep and lateral boundaries of 
the lens mass surrounding a central core of rounded, undifferentiated cells. Three distinct cell 
morphologies can be seen at this stage: (1) cells at the posterior and lateral surfaces are tall 
and similar in height to the elongated cells at 18hpf. These cells formed a single layer that 
establishes a posterior and lateral border of the lens and have a basal cell surface 2-3 times 
wider than the apical surface. (2) Cells in the center of the elongated lens mass with round or 
ovoid shape and irregularly clustered in the center of the lens core and stalk (region located in 
the anterior-middle). (3) Cells at the anterior lens border in contact with the surface epithelium 
are elongated and with a more parallel orientation to the surface ectoderm (Greiling and Clark 
2009).  
At 22hpf cells attached to the surface ectoderm narrow to form a stalk 2 to 3 cells wide 
connecting the developing cornea with the developing lens. At this moment of development 
the shape of the lens mass is rounded. Three morphologically distinct cell types are clearly 
present: (1) the lateral and posterior borders of the lens are formed by a single-layer of tall 
columnar cells with wider basal than apical cell surfaces. These cells radiated out from the 
central core. (2) The central core is a cluster of cells in the middle of the lens; these cells 
appear to have a tear-drop shape with their narrow edges facing towards the center. (3) Cells at 
the anterior-middle of the lens and the surface ectoderm in contact with the lens are rounded or 
cuboidal in shape with an irregular arrangement. These 3 cell types correspond to the primary 
fiber cells, the embryonic nucleus, and undifferentiated cells of the original lens mass, 
respectively (Greiling and Clark 2009). The analogous lens developmental stage of mammals 
and birds shows a different formation pattern. In these superior vertebrates the lens placode 
continues its invagination process forming a cavity that pinches off from the surface ectoderm 
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as a fluid-filled lens vesicle surrounded by a single layer of epithelial cells (Reza and Yasuda 
2004; Soules and Link 2005; Greiling and Clark 2008).  
The lens mass remains connected to the surface ectoderm at 23hpf by a stalk that is 
only one cell wide. The surface ectoderm is a single-layer of flat, cuboidal epithelium above 
the lens except where it is still attached to the lens in the very anterior-middle border. Fiber-
like cells begin to curve and appear to wrap around the central core. Cells in the central core of 
the lens mass remain large and tear-drop shaped with their narrow edges facing the lens center. 
The cells at the anterior-middle of the lens remained rounded or cuboidal in shape and in an 
irregular arrangement (Greiling and Clark 2009). 
At 24hpf the lens mass separates completely from the surface ectoderm which remains 
a continuous single layer of epithelial cells at the surface of the head of the fish. Cells in the 
posterior-middle region continue to enlarge and take on a rounded shape forming an 
organizing center around which primary fiber cells elongate and migrate. Lateral columnar 
cells elongate further to form arcs or layers of primary lens fibers surrounding the nucleus. 
Cells at the anterior border organize into a single-layer of epithelium and cells deep to the 
developing anterior epithelium are still disorganized and undifferentiated (Schmitt and 
Dowling 1994; Greiling and Clark 2009). 
The morphology of the differentiated lens cells at 28hpf represents the cell types 
expected in the adult lens: (1) A single-layer of tall, cuboidal epithelium that covers the entire 
anterior hemisphere of the lens and that in zebrafish, but not mammals, extends posteriorly 
beyond the lens equator, but not in the posterior-most surface of the lens. (2) Primary fiber 
cells that wrap around the large round cells in the core of the lens nucleus. (3) Secondary fiber 
cells that elongate and migrate from a developing transition region (Dahm et al. 2007; 
Greiling and Clark 2009). In the zebrafish lens, this transition region is located more 
posteriorly as compared to the mammalian and avian lenses that possess this region at their 
equator. This type of region in the lens is common among vertebrates and it is where epithelial 
cells exit the cell cycle and start differentiating into secondary lens fibers (Soules and Link 
2005; Griep 2006; Weber and Menko 2006b; Greiling and Clark 2008). 
By 36hpf the lens seems spherical in the equatorial dimension and lentoid in the 
anterior-posterior dimension. Newly added fiber cells are smaller and more compact than at 
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28hpf and the height of the anterior epithelial cells is decreased by half. Cell membranes 
between the central cells look jagged like establishing shallow interdigitations between them 
(Greiling and Clark 2009).  
By 2dpf zebrafish embryos start their hatching period (Kimmel et al. 1995; Easter and 
Nicola 1996; Easter and Nicola 1997). At 48hpf, the lens still appears spherical at the equator 
and lentoid in the anterior-posterior direction. By 2days the lens has increased in size and cells 
of the anterior epithelium continue to decrease in height and form a flat cuboidal epithelium. 
Fiber cells in the cortex are narrow and elongated. The posterior tips of newly added 
elongating fiber cells meet at the midline establishing a posterior suture. Borders between cells 
in the lens mass are increasingly jagged (Greiling and Clark 2009).  
At 72hpf (3dpf; first day post hatch; Kimmel et al. 1995), the width of the lens 
increases at the equator making the lens shape spherical in all dimensions. An umbilical suture 
(point-like) can be seen at both the anterior and posterior poles (Greiling and Clark 2009). A 
thin extracellular capsule is apparent, which is an uninterrupted basement membrane 
completely enclosing and protecting the lens. Newly generated lens fibers possess 
interdigitations that have not yet achieve an eventual ball and socket organization (Soules and 
Link 2005; Danysh and Duncan 2009). Between the third and fourth dpf the still growing 
zebrafish visual system is first identified as a functional structure (Easter and Nicola 1996). By 
4dpf the lens is a larger spherical version of the 3dpf lens, that increases in size by additional 
layers of secondary fiber cells (Greiling and Clark 2009). 
As lens development and growth proceeds through embryogenesis into postnatal 
(mice) or larval (zebrafish) and subsequently throughout adult life a distinguished organization 
of regions with high or low proliferative index arises at the lens epithelium. This epithelial 
tissue has 4 distinct subpopulations: (1) a central zone (CZ) that comprises the biggest portion 
of lens epithelial tissue covering most of the anterior surface of the lens. This region has a low 
proliferative index with most of its cells in a quiescent state (G0); although they retain their 
proliferative potential. (2) A pregerminative zone (PGZ) that constitutes cells comprising a 
narrow, latitudinal band or ring peripheral to and limiting the CZ. A small portion of these 
cells undergo mitosis to add to the lens epithelial mono-layer as the lens increases in size 
throughout life. Only rarely, the daughter cells differentiate into lens fibers. (3) Cells in the 
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germinative zone (GZ) are located at a narrow, latitudinal band peripheral and posterior to the 
PGZ. In the GZ cells have a high proliferative index. Daughter cells from the GZ migrate into 
the transition region of the lens. (4) A transition zone (TZ) is found posterior to the GZ at the 
equatorial (mice) or posterior to the equatorial (zebrafish) arc or bow region of the lens. This 
zone is a narrow ring of cells where proliferation does not happen. Cells in this place exit the 
cell cycle, elongate and differentiate into secondary lens fibers as they form concentric layers 
around previously formed lens fibers. This summarizes how cells are continuously added to 
the differentiated fiber cell mass that originates from the epithelium (Graw 1999; Soules and 
Link 2005; Griep 2006; Kuszak and Costello 2006; Mathias et al. 2010). 
In addition, it is important to mention that as the lens matures, its fiber cells become 
flattened and band-like shaped with a width to thickness ratio between 10:1 and 15:1. Lens 
fibers develop interdigitating lateral membrane protrusions at their narrow edges and ball and 
socket-like joints on their broad surfaces (Dahm et al. 2007).        
                                                                                               
3.2 Differences between mammalian and zebrafish lens development and early 
morphology 
    
Although the mammalian, bird and zebrafish lens are all derived from surface 
ectoderm, zebrafish early lens development possess noteworthy differences compared to 
mammals and birds. During embryonic development, the mammalian and avian lens placode 
invaginates to form a hollow lens vesicle bordered by a monolayer of ectoderm that constitutes 
epithelial cells. Instead, in zebrafish the lens placode delaminates as a solid cluster of cells 
from the surface ectoderm (Schmitt and Dowling 1994; Easter and Nicola 1996; Soules and 
Link 2005; Dahm et al. 2007). 
In birds and mammals, primary lens fibers are formed from epithelial cells located in 
the posterior half of the lens vesicle. These posterior epithelial cells elongate in a posterior to 
anterior direction and a parallel-like way. They differentiate to fill the lens vesicle cavity as 
primary fibers. In contrast, in zebrafish primary lens fibers differentiate from cells in the 
center of the delaminated solid cluster of cells by elongating in a circular fashion. Thus, giving 
rise to concentrically arranged primary lens fibers. In both cases, primary lens fibers give rise 
to the lens nucleus (Dahm et al. 2007; Greiling and Clark 2008; Greiling and Clark 2009).  
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Cells in the anterior half of the still fluid-filled lens vesicle in birds and mammals as 
well as cells in the anterior-most border of the lens solid mass in zebrafish become the lens 
anterior epithelium. These epithelial cells exhibit a high mitotic activity to form a mono-layer 
of epithelial cells that extends along the anterior and equatorial surface of the lens. However, 
in contrast to birds and mammals, in zebrafish the epithelial single layer extends farther 
towards the posterior-lateral surface of the lens. And, like birds and mammals, the epithelial 
cell layer does not extend to the most-posterior border area in zebrafish lenses. At this region, 
lens fibers are in direct contact with the lens capsule (Dahm et al. 2007; Greiling and Clark 
2008).    
As mentioned before, another difference corresponds to the location of the transition 
region where epithelial cells differentiate to give rise to secondary lens fibers. In mammals 
and birds this region is located at the lens equator; whereas in zebrafish, this transition zone is 
at a more posterior region compared with the lens equator (Soules and Link 2005; Griep 2006; 
Weber and Menko 2006b; Greiling and Clark 2008). 
Lens suture formation as fibers elongate and meet at their narrow edges with another 
fiber is another variant. Zebrafish, as well as avian lenses exhibit two umbilical sutures (point-
like), one at the center of the anterior pole and the other one at the center of the posterior pole. 
In these types of sutures fiber cells are meridians and taper at the ends as they extend from 
pole to pole. All fibers are sequentially overlaid onto existing growth shells of fibers, resulting 
in radial cell columns that extend from the center (at the transitional zone) to both the anterior 
and posterior poles of the lens. These fibers are seen as straight meridians (circular arcs) that 
extend from pole to pole (Al-Ghoul et al. 2003). Dahm et al. (2007) have shown that when the 
lens capsule, the monolayer of epithelial cells and some of the outer-most fiber cells are 
removed the umbilical anterior lens suture, from zebrafish whole lens samples becomes 
visible. Scanning electron microscopy micrograph pictures show that the secondary lens fibers 
converge in a single point at each lens pole.         
In contrast, the fibers of other superior vertebrates are not meridians. These lens fibers 
possess ends that flare (spread gradually outward) and curve away from the poles in opposite 
directions. As a result the end-to-end arrangement, where opposing fibers meet produces lens 
suture branches instead of just a suture point in t
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(e.g., rabbit and frog lenses), feature two anterior branches oriented at 180º to each other to 
form a vertical line-like suture. Opposite end curvature results in two posterior branches 
forming a horizontal line-like suture (Al-Ghoul et al. 2003).    
 Other vertebrates (e.g., mice, rat, pig, cat, dog, bovine and primates at birth) have 
lenses with Y-like sutures. In this type of lenses three anterior branches orient at 120º to each 
other to form a Y-like suture. Opposite end curvature results in three posterior branches that 
form an inverted Y-like suture. In primates, the overall type of suture changes over time. 
During fetal development the previously described Y-like sutures form. During infancy an 
anterior and posterior six branch suture, referred as simple star develops. At adolescence, both 
sutures evolve to become nine branch sutures, known as star. Later on, at the adult stage the 
sutures are gradually transformed and become 12 branch sutures, referred as complex star (Al-
Ghoul et al. 2003; Kuszak et al. 2004).          
These differences must be taken into account when interpreting results of molecular 
biology studies (Dahm et al. 2007). The present work is an example of this type of studies in 
which the purpose is to try to identify the function of a gene (cugbp1) in early zebrafish lens 
development. The results obtained have the ultimate goal to try to understand what can happen 
if the pathway of the human ortholog CUGBP1 is interrupted in embryonic development and 
unravel its early function in lens formation.    
  
3.3 Lens fiber cells differentiation 
 
At the TZ of the lens, epithelial cells initiate their differentiation to become fibers, a 
process that comprises dramatic changes in gene expression as well as in cell shape. It has 
been observed that actin filament reorganization is necessary for both types of changes to 
happen (Weber and Menko 2006a). In the cortical region (outer layers, which are comprised of 
differentiating lens fibers that still have not lost their organelles) of the embryonic lens, the 
fiber cells elongation process occurs in parallel with the accumulation of lens differentiation-
specific proteins (e.g., AQP0; Varadaraj et al. 2007).  
In fact, lens fibers can elongate more than 1,000 fold to reach the lens sutures. The 
stretched fiber cells are arranged as a series of concentric layers in which they appear as 
flattened hexagons in sections along the equator (Nowak et al. 2009) with two broad and four 
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narrow lateral faces. The broad lateral faces are oriented parallel to the lens surface (Kuszak 
and Costello 2006). After the morphogenetic changes associated with elongation have 
happened, the maturing fiber cells lose their organelles, including nuclei to enable 
transparency (Weber and Menko 2006a).   
 
3.3.1 Aquaporin0 (AQP0) expression and function 
 
Epithelial cells at the transition bow of the lens initiate a change in the pattern of gene 
expression as they start to differentiate into lens fibers. The new pattern includes the 
expression of structural proteins that can be soluble (e.g. crystallins) and also membrane 
proteins (e.g. water channels) in the lens fibers. Crystalline proteins contribute to the 
transparency and appropriate refractive index of the lens. This happens due to the crystallins 
elevated concentration and short-range interaction. Membrane proteins maintain the 
architecture needed for lens appropriate function, also contributing to lens transparency 
(Chepelinsky 2009). Aquaporin proteins (AQPs) are transmembrane water channels that 
mediate the permeation of water across cell membranes (Agre et al. 1998). 
The lens lacks blood vessels since they would scatter the incident light (deviate light 
from its original trajectory). Hence, this avascular region of the eye has evolved a standing and 
efficient circulatory current known as microcirculatory system. This current enters at both the 
anterior and posterior poles of the lens; then passes into and through the lens fibers. Finally, 
the current exists at the equatorial region of the lens. This circulatory system depends on water 
channels (Mathias et al. 2010). 
In mice, it has been observed that Aquaporin0 (Aqp0; previously known as Mip) 
mRNA as well as protein expression is observed in the lens. It begins at embryonic day 11.25 
(E11.25) when the posterior lens epithelial cells simultaneously start to differentiate into 
primary lens fibers. This expression continues throughout lens development and in the adult 
lens. AQP0 protein is exclusively expressed at the cell membranes of primary and secondary 
lens fibers since their early cell differentiation. This membrane location remains permanently 
(Varadaraj et al. 2007).    
It has also been shown that a second aquaporin gene, Aquaporin1 (Aqp1) is expressed 
in mice lens. However, this protein is expressed in lens epithelial cell membranes and not at 
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lens fibers. AQP1 expression at the lens starts at E17.5, 7.25 hours later than APQ0 expression 
begins at lens fibers. This happens even though lens anterior epithelium develops earlier than 
primary and secondary lens fibers. Secondary lens fibers that differentiate from epithelial cells 
that have already expressed AQP1 show progressive decrease of AQP1 protein expression as 
they differentiate (Varadaraj et al. 2007).    
The temporal pattern of expression between AQP0 (E11.5) and AQP1 (E17.5) suggests 
that as the lens body increases in size by the addition of new lens fibers, there is a growing 
demand for higher epithelial membrane water permeability to establish the microcirculatory 
system. In addition, the lens switch from AQP1 expression in epithelial cells, located at the 
transitional ring of the lens, to AQP0 in the differentiating secondary lens fibers. This 
indicates that AQP0 may have other important membrane functions. AQP0 might also 
function as an adhesion protein to join adjacent fiber cells. AQP0 probably contributes to 
reduce the extracellular space between lens fibers and to diminish light scattering (Varadaraj 
et al. 2007).    
It is thought that after the two principal evolutionary radiations of jawed vertebrate life 
that separated the ray-finned fish (class Actinopterygia; includes the zebrafish) and the 
sarcopterygian lineage (from where the land vertebrates evolved), a genome-wide duplication 
event happened in a zebrafish early ancestor (Meyer and Schartl 1999). This possible incident 
might explain why many single copy genes in mammals can be observed as duplicates in 
zebrafish where the function and temporal-spatial expression of the single-copy mammalian 
gene can be split up between both duplicates (Postlethwait et al. 2004). 
Indeed, it has been shown that the zebrafish genome has two aqp0 genes referred as 
aqp0a and aqp0b. Both genes are expressed during lens development in fiber membranes and 
persist in the adult lens (Froger et al. 2010; Tingaud-Sequeira et al. 2010). Moreover, 
knocking down aqp0a and/or aqp0b in zebrafish embryos by translation altering morpholino 
results in an obvious cataract phenotype as early as 3dpf (Froger et al. 2010). Morpholinos are 
chemically modified oligonucleotide analogous with a morpholino moiety instead of a ribose. 
They also possess a non-ionic phosphorodiamidate linkage instead of an anionic 
phosphodiester bond resulting in a neutrally charged backbone. These mentioned variations 
form a modified and highly soluble polymer that hybridizes RNA molecules with high affinity 
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and little cellular toxicity. Moreover, morpholinos are resistant to digestion by nucleases 
(Ekker 2000; Corey and Abrams 2001).  
Froger et al. (2010) experiments have indicated that both aqp0a and aqp0b are needed 
for lens transparency. Nevertheless, water permeability assays suggest that Aqp0a protein 
functions as a water channel, whereas Aqp0b does not. Aqp0b might supply adhesion and/or 
interactions with other lens components. Mammalian Aqp0 functions might be distributed 
between aqp0a and Aqp0b in zebrafish. However, additional work is needed to figure out 
aqp0b function on the zebrafish lens.   
The unique eye expression of Aqp0 protein in lens fibers as they start their 
differentiation process from initial epithelial cells makes this protein an excellent marker to 
asses for early fiber cell differentiation in the lens.      
 
3.3.2 Lens actin cytoskeleton 
 
During fibergenesis, epithelial cells undergo elongation, with the anterior and posterior 
tips of the elongating lens fibers sliding along the epithelium and capsule at the anterior and 
posterior direction, respectively and as these cells migrate inward. Lens fibers finally detach 
from the epithelium and capsule when they reach the anterior and posterior sutures. At the 
sutures, fiber cells form contacts with their counterparts from the opposite side of the lens. All 
these cellular movements are greatly coordinated through actin cytoskeleton remodeling 
events (Rao and Maddala 2006). Thus, the actin cytoskeleton plays an important role in 
regulating fiber cell elongation, migration, lens capsule-cell and intercellular interactions, cell 
packing, overall geometry and in the maintenance of fiber cell symmetry. Therefore, the 
activities of the actin cytoskeleton are critical for the establishment of lens overall shape, 
symmetry and ultimately, for lens optical properties (Rao and Maddala 2006).  
The actin cytoskeleton is composed of F-actin (actin filaments or microfilaments) and 
other accessory proteins that vary depending on the type of structure formed. F-actin 
represents a helical protein filament formed by polymerization of globular actin molecules (G-
actin). During remodeling of the actin cytoskeleton, F-actin undergoes disassembly and 
reassembly (Alberts et al. 2008). 
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Studies performed in Quails (Coturnix japonica; class Aves) during embryonic lens 
development by Weber and Menko (2006a) have shown that a disassembly of actin stress 
fibers (contractile large bundle/parallel arrays of F-actin crosslinked by α-actinin) happens as 
lens fiber differentiation is initiated. In central epithelial cells at the anterior region of the lens, 
actin stress fibers are organized along these cells basal surfaces (face linked to the lens 
capsule). Indeed, actin stress fibers are the primary actin filament structures of the 
undifferentiated lens epithelium and are most possibly linked to extracellular matrix 
components of the lens capsule through integrin receptors. In general, integrins are 
transmembrane adhesion proteins that play part in cell-matrix junctions. The extracellular 
domains of integrins bind to components of the extracellular matrix (in these case: lens 
capsule), while the cytoplasmic tail binds indirectly to F-actin. This type of cell-extracellular 
matrix junction in which there is an intracellular coupling to F-actin is called focal adhesion 
(Cooper 2000; Alberts et al. 2008). Lamellipodial-like extensions are broad membrane 
protrusions that contain a three-dimensional network of F-actin and can contribute in focal 
adhesion formation (Cooper 2000; Lodish et al. 2000). These extensions were observed at the 
central epithelial cells basal edges. At the apicolateral (apical: faces the center of the lens) 
aspects of these cells in the region of tight junctions (physical attachments that seal the gaps 
between cells in the apical side of epithelia making the sheet an impermeable or selectively 
permeable barrier), F-actin had a cortical arrangement (Weber and Menko 2006a). 
However, at the equatorial epithelium where differentiation has started, a different F-
actin organization was observed. In the anterior-most region of the equatorial epithelium, F-
actin staining in the cells basal and basolateral aspects was amorphous and diffused indicating 
that actin stress fibers were no longer present. This loss of actin stress fibers was concomitant 
with lens cell differentiation. At the cells lateral borders (region of cell to cell interfaces) few 
F-actin was detected. F-actin at the apical domain remains cortical. At the very center of the 
equator, F-actin staining was disorganized and diffuse in the basal surfaces. The latter is 
indicative of a transition due to actin filament reorganization as cells moved through the 
transition region. As cells moved to the posterior-most aspects of the equatorial epithelium, F-
actin became localized at the cell to cell interfaces at their basal surfaces as well as along the 
lateral sides. Moreover, dense clusters of F-actin in the center of the cell that radiated out to 
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the cell borders were evident at the basal surfaces of these cells. Cortical F-actin at the cells 
lateral borders is consistent with their function in the assembly of stable N-cadherin cell-cell 
junctions (Weber and Menko 2006a). Cadherins are transmembrane proteins that mediate 
contacts between cells to form adherence junctions. Inside the cell, cadherins bind indirectly to 
F-actin (Cooper 2000; Alberts et al. 2008). 
At the most cortical fiber cell region in the posterior pole of the lens, F-actin was 
present at the basal tips of lens fibers and organized in a dense meshwork pattern. The basal 
tips of these newly formed cortical lens fibers correspond to the surface in contact with the 
lens basement membrane/capsule at the posterior region of the lens. At the basal and 
basolateral aspects, F-actin is present along all sides of the already hexagonal cells, but is 
missing from the vertices (region where three cells meet). At the lateral surfaces of these lens 
fibers, cortical F-actin extended around the entire perimeter of the cells and along the length of 
these elongating lens fibers. Cortical F-actin became much more organized than at earlier 
moments of differentiation probably helping to stabilize lens elongated and hexagonally 
packed morphology (Weber and Menko 2006a). 
In summary, Weber and Menko (2006a) have demonstrated that the initiation of lens 
cells differentiation is coincident with the disassembly of the cellular projections 
(lamellipodia) and actin stress fibers that provide cell attachment between the extracellular 
matrix (capsule) and the undifferentiated lens epithelia. F-actin is reorganized as cortical actin 
in the differentiating lens fibers. Indeed, stress fibers disassembly is sufficient to induce lens 
fibers differentiation. Actin filaments organized as stress fibers interact with integrin receptors 
at focal adhesion complexes where they mediate integrin/matrix adhesion. The lens epithelium 
is the only region of the embryonic lens that expresses high levels of α5β1 integrin and 
fibronectin (extracellular matrix ligand of α5β1 integrin). The interaction of both molecules 
promotes actin stress fibers organization and their loss could signal stress fibers disassembly 
that activates lens cell differentiation.  
Moreover, lens cell culture studies have evidenced that actin stress fiber disassembly 
as well as cortical F-actin organization are dependent on the assembly of N-cadherin cell-cell 
adhesions. However, in the undifferentiated epithelium adhesion corresponds primarily to 
integrin/matrix interactions. Epithelial cells lose their tight associations with the lens capsule 
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(integrin/matrix adhesions) as they differentiate and cadherin based cell-cell junctions become 
the principal form of adhesion as lens fibers develop. This switch may promote the 
disassembly of actin stress fibers and induces lens fibers differentiation (Weber and Menko 
2006a). 
In addition, Fischer et al. (2000) experiments realized in chick lens cell cultures 
determined that in undifferentiated epithelial cells F-actin was organized in polygonal arrays 
of actin stress fibers that intersect with an adhesion belt (a type of cadherin cell-cell junction in 
epithelial cells located just below the tight junctions and forming a continuous belt-like 
structure around each cell in which an underlying contractile bundle of actin filaments is 
linked to the plasma membrane; Cooper 2000; Alberts et al. 2008). As cells elongated to form 
lentoid bodies (lens fiber-like cells) the arrays of stress fibers were lost. Actin filaments in 
differentiated lentoid cells were predominantly associated with membranes in a reticular 
pattern. Moreover, in late-stage differentiated lentoid cells, F-actin colocalized with N-
cadherin molecules in complex curvilinear patterns outlining membranes (Fischer et al. 2000). 
Cortical actin filaments are also part of a complex structure in lens fibers, besides N-
cadherin cell-cell adhesions, referred as membrane skeleton. The membrane skeleton is a 
highly cross-linked network of spectrin (a long thin flexible rod protein) tetramers linked to 
short F-actin, and together they are associated with membrane attachment and actin regulatory 
proteins. The membrane skeleton is associated with the inner surface of the lens fiber plasma 
membrane. In this complex structure, F-actin stability depends on capping proteins at filament 
ends that prevent assembly as well as disassembly, and on tropomyosins (TMs). TMs bind 
along the sides of microfilaments blocking severing and reducing subunit dissociation. 
Tropomodulins (Tmods) are actin pointed end-capping proteins that bind to TMs and cap TM-
coated F-actin preventing polymerization and depolymerization in post-mitotic cells like lens 
fibers. Thus, Tmods and TMs regulate actin filament lengths and provide stability to the 
membrane skeleton (Alberts et al. 2008; Nowak et al. 2009).    
A Tmod1 viable knock out mice line with no detectable TMOD1 protein in the lens 
indicated that the membrane skeleton is necessary for maintenance of fiber cell hexagonal 
shape, packing geometry during maturation of lens fibers and radial column organization in 
the lens cortex. Patches of disordered fiber cells were observed in Tmod1 knock out mice 
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lenses in comparison with hexagonally packed geometry of controls. These patches exhibited 
polygonal and often somewhat rounded fiber cell shapes with variable numbers of vertices per 
cell and irregular lengths of connecting membranes, rather than regular flattened hexagonal 
shapes. The fibers are also not arranged in precise radial columns as seen in normal equatorial 
sections. At the transition zone of the lens (equator), regions displaying disordered fiber cell 
packing tended to be located 20-30 cell layers in from the epithelium; in the region where 
TMOD1 normally assembles on the fiber membranes. The latter showed that the absence of 
TMOD1 affects geometry of maturing lens fibers, rather than initial elongation and 
organization (Nowak et al. 2009). 
Nowak et al. (2009) determined that TMOD1 appears to selectively stabilize the subset 
of F-actin that belongs to the membrane skeleton, which corresponds to a part of the F-actin in 
lateral broad and narrow sides, but not the vertices of maturing fibers. Absence of TMOD1 
(and consequently a disrupted membrane skeleton) does not affect fiber cell initial 
differentiation or cell shape morphogenesis. Instead, TMOD1 protein stabilizes F-actin in the 
membrane skeleton during cortical fiber cell maturation before organelle loss. This indicates a 
role in maintaining cell shape and packing geometry.  
In addition, Quail lens cell culture experiments have proven that the actin cytoskeleton 
also supports cell survival, and a prolonged disruption of the latter induces apoptotic events 
that result in cell death. Depolymerization of F-actin in lens epithelial cell cultures for a 
prolonged time (48h) induces extensive membrane blebbing and cell rounding, indicative of 
late stage apoptosis. Induced loss of cortical F-actin in cell cultures containing differentiating 
lentoid cells also resulted in blebbing of the plasma membrane. The latter proved that F-actin 
provides an essential survival signal to both lens epithelial and differentiating fiber cells 
(Weber and Menko 2006a).          
Furthermore, a short-term induced F-actin disassembly on lens epithelial cell cultures 
does not induce apoptosis. Rather, it triggers the expression of fiber cell differentiation 
specific markers, cell cycle withdrawal and the loss of actin stress fibers with a subsequent 
reorganization into cortical F-actin as fibers differentiate. In addition, BCL-2 (a suppressor of 
apoptosis) expression is increased in lens cell cultures that loss their actin stress fibers but also 
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organize actin as cortical filaments and survive. The latter suggests that the F-actin survival 
signal in differentiating lens fibers may be conveyed by BCL-2 (Weber and Menko 2006a). 
 
3.3.3 Organelle degradation in lens fibers: emphasis in nuclei 
 
During lens fibers differentiation, all structures large enough to scatter light including 
nuclei, mitochondria, Golgi apparatus and endoplasmic reticulum are broken down and 
removed from the developing fiber cells (Greiling and Clark 2008; Bassnett 2009). Despite all 
these changes, lens fibers survive and are maintained within the lens throughout the life span 
of the individual (Counis et al. 1998). 
Chicken studies have demonstrated that in embryonic lenses organelles are present 
initially throughout all the cells in the developing tissue. Then, in a specific moment in early 
development (embryonic day 12 in chick embryos) organelles are eliminated in cells located at 
the center of the lens (primary lens fibers). The latter results in the formation of a central area 
without membrane-bound organelles, including nuclei, termed organelle free zone (OFZ). 
After its initial establishment, the OFZ becomes larger as the lens grows and new fibers are 
continuously added. Then, organelles are present only in those fiber cells located at the 
periphery of the lens (Bassnett and Mataic 1997). The only cells in the lens located in the 
visual axis that do not lose their organelles are cells in the central-anterior epithelium. 
Nevertheless, they constitute a very thin layer. So, since light scattering is proportional to path 
length, the light scattering due to organelles in the lens epithelium is insignificant (Bassnett 
2009). 
It has been observed that during epithelial cell differentiation into lens fibers, the shape 
of nuclei changes along the course of this process. In lens epithelial cells, nuclei appear to be 
round and relatively large. In superficial lens fibers, nuclei appear ovoid, and as lens fibers 
mature nuclei seem to elongate along with fiber elongation. However, just prior to 
disintegration, nuclei remnants assume a much smaller and more spherical shape (Bassnett and 
Beebe 1992; Counis et al. 1998; De María and Arruti 2004). 
Nucleated fiber cells can perform transcription and this process might be stopped until 
sometime prior to remodeling of the nuclear lamina (thin sheet-like meshwork beneath the 
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inner nuclear membrane). Afterwards, chromatin disintegration occurs. This order of events 
has been reported in bovine and chick lenses (Bassnett and Mataic 1997; Bassnett 2009). 
It has been suggested that the nuclei degradation process might be different in primary 
and secondary lens fibers. Although, the only difference observed in nuclei degradation is that 
in primary lens fibers denucleation occurs simultaneously in a cluster of cells during early 
development. Afterwards, nuclei degradation in secondary lens fibers occurs as each cell 
differentiates (Bassnett 2009).  
Nuclear breakdown happens at the same time as other organelles are rapidly being 
disintegrated. However, it is believed that organelle disintegration occurs through independent 
pathways (Bassnett 2009). Mitochondria degenerate more rapidly than nuclei. In lens 
epithelial cells, mitochondria are present in perinuclear (around the nucleus) clusters. When 
lens fibers are differentiating, mitochondria become elongated and distributed throughout the 
cytoplasm. Prior to disintegration, mitochondria become swollen and fragmented in cells 
bordering the organelle free zone (OFZ; Bassnett and Beebe 1992).  
Most lens mutations that led to cataracts affect organelle degradation to some extent. 
Some of these mutations can directly affect organelle breakdown. However, any mutation that 
disrupts lens homeostasis sufficiently may have the potential to disrupt organelle degradation 
indirectly due to its obvious complex series of interdependent steps (Bassnett 2009). 
DNase IIβ (aka DLAD; DNase II-like group: acidic and with no cation dependence) is 
an enzyme expressed at significant levels at the lens and liver (Counis et al. 1998). DNase IIβ 
knock out mice retain undigested DNA in the lens nuclear fibers leading to nuclear cataracts. 
This implies that DNase IIβ has a fundamental role in lens fiber denucleation. DNase IIβ 
cleaves DNA producing 3'-phosphoryl and 5'-hydroxy ends. Since 3'-hydroxy ends rather than 
5'-hydroxy ends accumulate when lens fibers denucleation takes place, it has been suggested 
that endogenous phosphatases might convert 3'-phosphoryl ends in 3'-hydroxy ends (Appleby 
and Modak 1977; Bassnett 2009). 
DNase IIβ is up regulated in differentiating lens fibers. Moreover, it is believed that 
most of the acid nuclease activity in lens fiber cells is due to DNase IIβ activity as a lysosomal 
enzyme. This enzyme might gain access to the nuclear compartment by fusion of lysosomes to 
the nuclear envelope and a subsequent release of DNase IIβ in the nuclear compartment. 
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However, even though DNase IIβ is critical for lens fibers denucleation, it might not be the 
only nuclease in lens fibers. DNase IIβ null mice lens exhibit persistent nuclei but chromatin 
fragmentation and clumping is still observed suggesting that there might be other nucleases 
involved (Bassnett 2009).   
De María and Arruti (2004) studied the presence of DNase I (DNase I-like: absolute 
Ca2+, Mg2+ dependence; Counis et al. 1998) in lens fibers from adult bovine eyes. In lens 
epithelial cells, DNase I is present at the cytoplasm. In epithelial cells from the proliferative 
zone and in cells at the onset of fibergenesis in the transition region DNase I is still located in 
the cytoplasmic fraction. In more elongated fibers, DNase I is mainly concentrated in close 
proximity to the cell membrane, but it also starts to be observed in the nuclear territory. 
Indeed, as fibers elongate DNase I becomes concentrated in patches distributed at the nuclear 
surface. Then, it becomes tightly associated with highly condensed and fragmented chromatin 
as lens differentiation proceeds. Furthermore, at the last stages of nuclei degradation DNase I 
is still associated to nuclear remnants. The obtained results suggest that DNase I might have a 
role in DNA degradation during the last stages of nuclei degeneration (De María and Arruti 
2004). 
 At the bovine lens secondary fiber nuclear breakdown, the following sequence is 
observed: onset of chromatin condensation, production of DNA breaks having 3-OH free ends 
in condensed chromatin, spreading of condensation and fragmentation through the whole 
chromatin. Then, beginning of nuclear envelope (lamina) degradation and association of 
DNase I with condensed and fragmented chromatin happens. Lastly, nuclear remnants that 
remain associated with DNase I are evident at the final stages of nuclear breakdown (De María 
and Arruti 2004). In addition, regulation of DNase activities might also need the effect of post-
translational modifications, mitochondrial release molecules and growth factors (Counis et al. 
1998).  
When lens fibers reach the organelle free zone, they lose their ability to perform 
protein synthesis, intracellular membrane trafficking, oxidative phosphorylation and all 
functions realized by organelles. Alongside, terminal differentiation occurs (Bassnett 2009). 
However, lens fibers retain their cytoplasm (Counis et al. 1998).   
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3.4 CUG binding protein 1 (CUGBP1): an mRNA binding protein  
 
CUGBP1 is an mRNA binding protein and a founding member of the CELF (CUGBP1 
and ETR-3 like factors) protein family. Members of this family regulate gene expression at the 
nuclear as well as the cytoplasmic levels. Their main nuclear function corresponds to the 
regulation of pre-mRNA alternative splicing. In the cytoplasm, they are implicated in the 
control of mRNA translation and stability. CUGBP1 performs all these functions (Barreau et 
al. 2006).   
What characterizes a RNA binding protein is the presence of at least one RNA-binding 
domain (RBD), also known as ribonucleoprotein (RNP) domain or RNA recognition motif 
(RRM). This domain is sufficient for RNA binding with a wide range of specificities. 
Moreover, RRMs possess two consensus sequences. In this paper, we will refer to the domain 
as RRM and to the consensus sequences within the RRM as RNPs. The first RNP consensus 
sequence identified is referred as RNP1; and it is an octamer positioned at the center of the 
RRM domain. A second RNP sequence, RNP2 is a hexamer and is located at the N-terminus 
region of the RRM. The RRM consists of a four-stranded anti-parallel β-sheet packed against 
two α-helices (βαββαβ) topology. The two conserved motifs, RNP2 and RNP1 correspond to 
the first and third β-strands, respectively. In eukaryotes, RRMs are often found as multiple 
copies within a protein (Maris et al. 2005; Tsuda et al. 2009; Teplova et al. 2010). 
CELF proteins are highly similar in their structural organization. They possess three 
RRMs, two in the N-terminal region (RRM1, RRM2) and one in the C-terminal site (RRM3) 
of the protein. They also have a less well conserved linker region between the second and third 
RRMs (Barreau et al. 2006).    
Human CUGBP1 was first identified using a band shift assay. By this technique, it was 
determined that this protein (extracted from cytoplasmic extracts of Hela cells, fibroblasts and 
myotubes) binds to (CUG)8 RNA repeats (Timchenko et al. 1993). This specific binding 
activity led to the correlation of CUGBP1 with Myotonic Dystrophy 1 (DM1) pathology, 
which is a neuromuscular disease. This association was derived from the observation that 
DM1 is a genetic disease characterized by a (CUG)n trinucleotide repeat expansion in the 3ʹ-
untranslated region (UTR) of the dystrophia myotonica protein kinase (DMPK) gene 
(Timchenko et al. 1996). 
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3.5 Myotonic Dystrophy 1 (DM1)  
 
DM1 is an autosomal dominant, multisystemic disease. The human mutation lies on 
the long arm of chromosome 19, band 13q as an expansion of CTG repeats in the 3ʹ UTR of 
the dystrophia myotonica protein kinase gene (DMPK) that encodes a serine/threonine protein 
kinase that contains coiled-coil, C-terminal membrane association and autoregulatory 
domains. A CTG expansion from ~80 to 4000 repeats results in DM1 disease. DM1 exists in 
four basic forms depending on the age of appearance of the symptoms: CDM (Congenital 
Myotonic Dystrophy), childhood onset, classical/adult and late-onset/asymptomatic; the last 
three forms are commonly referred as DM1 (Harmon et al. 2008; Schoser and Timchenko 
2010; Turner and Hilton-Jones 2010). 
 
3.5.1 CDM phenotype 
 
At the congenital form of DM1, referred as Congenital Myotonic Dystrophy (CDM) 
the largest CTG repeat expansions (˃ 1,500) have been identified. CDM patients may be born 
as premature infants due to these large repeat expansions. Polyhydramnios (excess of amniotic 
fluid in amniotic sac) and the reduction of fetal movements have been reported during the 
pregnancies of infants with CDM. After the patient is born, first symptoms include postnatal 
hypotonia (diminished resistance of muscles to passive stretching) and immobility (Leyenaar 
et al. 2005; Schoser and Timchenko 2010; Turner and Hilton-Jones 2010). In up to 50% of 
affected patients, bilateral talipes (also known as club feet; feet appear rotated internally at 
their ankles) and other contractures are present at birth. Facial diplegia (paralysis affecting 
symmetrical parts of the body) is another characteristic feature of CDM. Newborns have an 
open mouth with a tent-formed upper lip and a high-arched palate. A weak cry and the 
inability to suck are present in nearly 75% of affected babies. These latter features are due to 
weakness of facial jaw and palatal muscles. In the patients that survive, hypotonia improves 
steadily and is only rarely prominent after 3-4 years of age. However, facial diplegia becomes 
more apparent leading to a typical facial carp-mouth appearance. Speech development is 
delayed. The latter is caused by hypotonia of the facial, palatal and jaw muscles (Schara and 
Schoser 2006; Schoser and Timchenko 2010). 
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Despite the severe muscular phenotype of this disorder, myotonia (muscle stiffness and 
delayed relaxation after muscle contraction) is not present at the neonatal period in CDM 
patients and it is seldom present before school age. However, in CDM survivors myotonia 
becomes a more prominent feature at the second decade of life (Schara and Schoser 2006; 
Ekström 2009; Schoser and Timchenko 2010).   
Neonatal respiratory complications are frequent and in severe cases that require 
ventilation for more than four weeks; this symptom will most likely result in death. At 
postnatal stages, delayed motor development is very common; however most children that 
survive become able to walk independently. Although normal mental development is possible, 
mental retardation is observed to a variable degree in a great number of patients. Depression, 
attention deficit hyperactivity, autism and anxiety disorders have been reported in childhood, 
but not commonly (Schoser and Timchenko 2010).  
Other CDM associated abnormalities of high frequency include: inguinal (at the groin) 
or hiatus (at superior part of the stomach) hernia (protrusion of an organ or tissue through an 
abnormal opening in the body), undescended testis, congenital dislocation of the hip and 
torticollis (stiff neck). Congenital heart defect (as elevated diaphragm), hydrocephalus 
(abnormal accumulation of cerebrospinal fluid in the cavities of the brain), spasticity 
(excessive contraction of muscles leading to stiff or rigid muscles, blocked nasolacrimal duct 
and cleft lip (Schara and Schoser 2006; Schoser and Timchenko 2010). 
  
 3.5.2 DM1 phenotypes 
 
Childhood-onset DM1 is defined by the beginning of symptoms approximately after 
one year of age (Longman 2006). Early motor development is normal or only slightly delayed. 
Neuromuscular problems may be weakness of facial and neck muscles but without the typical 
features of CDM (e.g., carp-mouth). Distal weakness, audiologic problems and recurrent 
abdominal pain have been reported. Mental handicap leading to speech and learning 
difficulties is most commonly recognized during school age. Motor disabilities or respiratory 
difficulties are no prominent features (Schara and Schoser 2006). Myotonia and distal limb 
muscle weakness develop during the teenage years (Longman 2006). 
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Cardiologic problems may become important in later life as how it can also happen in 
CDM survivors. It has been reported that cardiac arrhythmias (abnormal rate or rhythm of the 
heartbeat) or cardiomyopathy (deterioration of the heart muscle) may occur in the second 
decade of life in childhood onset DM1. These problems could lead to sudden death. When 
growing older, childhood onset patients may show symptoms of the adult onset form in their 
twenties (Schara and Schoser 2006).       
Adult onset DM1 is the most common form of Myotonic Dystrophy and is frequently 
referred as the classical form. Facial weakness with bilateral mild ptosis (dropping of the 
eyelid) and distal muscle weakness are the most common features. Grip (when difficulty in 
releasing grip or opening the hand after making a fist) and percussion myotonias (after a brief 
mechanical stimulation) are regular features, but myotonia also affects other muscles like 
bulbar (muscles that control speech, swallowing and chewing), facial and tongue muscles. The 
latter causes problems with swallowing, chewing and talking. Cardiac defects include dilated 
cardiomyopathy (the heart becomes enlarged and debilitated and cannot pump blood 
efficiently), conduction abnormalities with arrhythmia and conduction blocks up to cardiac 
death (Schara and Schoser 2006).        
The central nervous system is also affected (e.g., mental retardation, affected 
personality traits and excessive daytime sleepiness). Pigmentary retinal degeneration has been 
reported, but the most common eye defects are posterior subcapsular cataracts (starting at the 
cortical fibers situated at the posterior pole). There are also gastrointestinal problems like 
irritable bowel syndrome and symptomatic gall stones. Testicular atrophy, hypotestosteronism 
(low levels of testosterone activity) and insulin resistance with usually mild type 2 diabetes 
(insulin resistance) are other features (Schara and Schoser 2006; Schoser and Timchenko 
2010; Turner and Hilton-Jones 2010).       
Furthermore, there are patients that have a late-onset/asymptomatic form of DM1. The 
presence of cataracts in middle or older age is its characteristic feature. Signs of muscle 
weakness or myotonia can be present, but these symptoms are very rare. No major cognitive 
impairment has been detected, other than mild verbal memory dysfunction (Ekström 2009). 
One of the most important reasons in detecting the repeat expansion mutation, in these late-
onset carriers, is to identify other affected family members and enable genetic counseling to 
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more affected patients due to the genetic anticipation (successive generations inherit 
increasing disease severity with decreasing age of onset) phenomenon observed in this disease 
(Cho and Tapscott 2007; Turner and Hilton-Jones 2010). Anticipation has been suggested to 
occur as the trinucleotide expansions are highly unstable resulting in a progressive increase in 
the repeat length during gametogenesis. This eventually leads to an infant with CDM as this 
affected group of patients has been reported to possess the longest CTG expansions (Campbell 
et al. 2004; Ekström 2009). Besides, germ-line instability, the mutant expanded repeats exhibit 
somatic mosaicism, in which variable repeat size in different tissues of a single patient has 
been observed. In addition, increasing expansion in the length of the mutant CTG repeats with 
increasing age, in a single patient, has also been observed (Ekström 2009). 
 
3.5.3 Molecular mechanisms of Myotonic dystrophy 1 
 
Although some of the symptoms of DM1 may be attributed to decreased levels of 
DMPK protein, a much more complex mechanism takes place. As DM1 is a multisystemic 
disease with variable expressivity of its symptoms, the features are unlikely to be explained by 
a defect in the DMPK gene alone (Winchester et al. 1999). Hence, three distinct mechanisms 
have been proposed to contribute simultaneously with DM1 pathogenesis: (1) 
Haploinsufficiency of DMPK, (2) altered expression of neighboring genes and (3) RNA 
toxicity. These mechanisms link the trinucleotide repeat expansion with DM1 disease 
(Kaliman and Llagostera 2008; Ekström 2009). In all, the trinucleotide repeat expansions are 
suggested to disturb normal cellular processes at the RNA, protein and/or chromatin level 
(Cho and Tapscott 2007).  
Haploinsufficiency happens when a normal phenotype needs a protein product from 
both alleles of a particular gene. If one gene copy is flawed, the reduction by half of the gene 
product will result in a defective phenotype. Initial research was aimed to identify the function 
of DMPK protein since several studies showed that cytoplasmic amounts of this protein were 
reduced in DM1 patients. In DM1, the DMPK gene with the triplet repeat expansion in its 3' 
UTR is transcribed into non-decreased mRNA with the CUG repeats. However, a part of the 
mRNAs containing CUG repeats tends to be retained in nuclear foci (ribonucleoprotein 
precipitates) preventing transport to the cytoplasm (Berul et al. 1999; Cho and Tapscott 2007; 
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Kaliman and Llagostera 2008; Ekström 2009). These aggregated forms reduce the processing 
of mutant DMPK mRNA by the CUG repeat tract. Hence, there is a reduction in the 
translation of DMPK protein (Ekström 2009). 
To test if decreased DMPK protein translation may account for DM1 phenotype 
several studies have observed what happens if DMPK function is eliminated in mice. Dmpk 
null mice developed late onset mild myopathy. In addition, mice heterozygous and 
homozygous for disrupted Dmpk gene also exhibited cardiac conduction defects (Berul et al. 
1999; Cho and Tapscott 2007). Hence, haploinsufficiency of DMPK protein may contribute to 
DM1 features specially in skeletal and cardiac muscles but does not account for all the clinical 
spectrum of DM1 (Cho and Tapscott 2007; Ekström 2009).   
The expanded CTG repeats in the DMPK gene may affect the expression of other 
genes. The CTG mutation is a strong nucleosome-binding site that could modify chromatin 
structure having regional effects on the expression of DMPK and other genes close to DMPK. 
In fact, SIX5/DMAHP (homeodomain-containing transcription factor) has been implicated as a 
second candidate for DM1 pathogenesis. This because the mutant DMPK (CTG)n repeat 
overlaps not only the 3'end of the DMPK gene, but also a 5' promoter (or more strictly 
speaking, enhancer-promoter) region of the downstream neighboring gene SIX5 (Winchester 
et al. 1999; Ranum and Day 2004).  
In more detail, first it was demonstrated that a DNase I hypersensitive site was 
positioned adjacent and downstream the CTG repeat at the wild type DMPK gene. Expanded 
CTG repeats seen in DM1 eliminate this hypersensitive site and transform the region that 
surrounds the repeats into a more condensed chromatin structure (Otten and Tapscott 1995). 
This hypersensitive site contains a promoter element that regulates transcription of SIX5. 
Allele-specific analysis of SIX5 expression demonstrated that steady-state transcript levels 
from the allele with the CTG repeat expansion were significantly reduced in comparison to 
those from the wild type allele. Hence, CTG repeat expansions can suppress local gene 
expression of SIX5 in DM1 disease (Klesert et al. 1997). SIX5 mRNAs are expressed in DM1 
affected tissues such as brain, eye, heart and skeletal muscle (Ekström 2009).   
In addition, another target gene which its disrupted expression due to altered chromatin 
structure may contribute to DM1 is DMWD. DMWD is located immediately upstream of 
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DMPK. In mice, Northern blotting and RNA in situ hybridization assays have revealed 
ubiquitous low expression in all tissues of the mouse embryo. Strong RNA expression has 
been detected in the brain and testis of adult mice; thus it has been suggested that DMWD gene 
could be involved in the mental and testicular symptoms observed in severe cases of DM1 
(Jansen et al. 1995). Moreover, Alwazzan et al. (1999) have demonstrated that levels of 
cytoplasmic DMWD RNA from the allele adjacent to mutant DMPK (with expanded CTG 
repeats) are reduced in DM1 cells. This model explains some but not all disrupted features of 
DM1 (Ekström 2009).      
Even though it has been proven that expanded CTG repeats affect translation of DMPK 
protein and the transcription of other genes in the DMPK locus; pathological features of DM1 
disease are mainly linked with the accumulation of non-coding CUG repeats (Ekström 2009). 
As previously mentioned, posttranscriptional DMPK mRNAs containing expanded CUG 
repeats accumulate in large nuclear foci. The latter was first observed by Taneja et al. (1995) 
in DM1 primary skin fibroblast cells from two affected patients and a DM1 adult muscle 
tissue. Large amounts of mutant DMPK transcripts were also detected in the cytoplasm of 
DM1 fibroblasts, but in smaller complexes and not as large aggregated forms. However, data 
for the cytoplasmic as well as for nuclear localization of mutant DMPK mRNA in DM1 has 
been controversial. Different studies have observed that mutant DMPK transcripts are blocked 
and present only in nuclei. But, it has also been suggested that non-aggregated mutant DMPK 
transcripts are also present in nuclei. Other studies found that aggregated forms are found in 
both the nucleus and cytoplasm of DM1 cells (Schoser and Timchenko 2010).         
Despite the discrepancies related to the locations of mutant DMPK mRNA inside the 
cell, Junghans (2009) has proposed a DM1 model based on previously obtained data. In this 
viewpoint mechanism, foci are not the only forms of mutant RNA in DM1 cells. There are 
also smaller complexes of soluble mutant DMPK mRNA. In addition, CUGBP1 and MBNL1 
(zinc finger protein and mammalian homologue of Drosophila muscle-blind which is required 
for muscle and photoreceptor development; Fardaei et al. 2002; Huang et al. 2008) are RNA-
binding proteins that regulate post-transcriptional processes. Binding of CUGBP1 and 
MBNL1 proteins to different forms of expanded CUG repeats causes DM1 pathology because 
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the regulation of gene expression of both proteins (especially alternative splicing) is disrupted 
upon mutant DMPK mRNA binding (Junghans 2009).  
Mutant expanded CUG repeats in DMPK mRNA form double stranded (duplex) 
hairpins in nuclei. First, MBNL1 protein binds to the double stranded regions of these hairpin 
regions and these fusions lead to insoluble foci (aggregated form). Indeed, binding of each 
MBNL1 clamps the adjacent duplex to facilitate the binding of the next MBNL1 protein. Each 
bound MBNL1 gives the duplex more stability by a closing zipper-like mechanism. Hence, 
MBNL1 binding stabilizes these hairpins. In addition, this zipper-like mechanism excludes 
CUGBP1 from binding to insoluble foci. As MBNL1 is coprecipitated with mutant DMPK 
RNA into insoluble foci, free MBNL1 in solution is gradually depleted and less able to 
exclude CUGBP1 protein from binding to expanded CUG repeats. Then, CUGBP1 binds to 
soluble single stranded mutant DMPK CUG repeats. In addition, CUGBP1 protein binds to 
single stranded tails at the hairpin bases (Junghans 2009). 
Binding to soluble single stranded mutant CUG repeats protects CUGBP1 protein from 
normal rapid catabolism, prolonging the normally short half-life of CUGBP1 protein. The 
latter induces higher CUGBP1 protein concentrations and increased CUGBP1-dependent 
splice variants. In cytoplasm, there are also un-aggregated expanded CUG repeats in DM1 
cells. Hence, in cytoplasm, CUGBP1 also binds mutant DMPK mRNA and its protein levels 
are also increased. The elevated CUGBP1 protein also alters normal translation and stability of 
its cytoplasmic mRNA targets in DM1. Differently, binding to double stranded insoluble 
mutant RNAs leads to sequestration of MBNL1 and, thus, leading to decreased MBNL1-
dependent splice variants. In addition, there are transcription factors (TF) that also bind to 
soluble ssCUG repeats; this leads to TF leaching (depletion) from chromatin and diminished 
transcription of specific genes in DM1 (Junghans 2009; Schoser and Timchenko 2010). 
Hence, transcriptional and post transcriptional expression mechanisms are disrupted in cells 
expressing mutant DMPK mRNA with expanded CUG repeats leading to DM1 clinical 
features. 
 
 
 
 
 40 
3.5.4 CUGBP1 and its involvement in DM1 models and tissues  
 
Transient expression of RNAs containing Dmpk 3ʹ-UTR with 960 CUG repeats 
(Dmpk-CUG960 mRNA) in COS M6 cells (monkey cell line) induced hyper-phosphorylation 
of nuclear, but not cytoplasmic CUGBP1 protein. These cells also exhibited CUGBP1 
increased steady state levels in nuclear fractions. DM1 cell cultures of skin fibroblasts 
converted to muscle cells and DM1 heart tissues also exhibited elevated CUGBP1 protein 
levels compared to controls. CUGBP1 was also hyper-phosphorylated in both types of DM1 
samples. However, these samples were not separated in nuclear and cytoplasmic extracts 
(Kuyumcu-Martínez et al. 2007). 
A bitransgenic inducible (by tamoxifen) and heart-specific DM1 mice model 
expressing 960 CUG repeats in the context of the Dmpk 3ʹ-UTR was created. These transgenic 
mice develop cardiac features of DM1 disease after tamoxifen administration including dilated 
cardiomyopathy (weakened and enlarged heart). They demonstrated elevated CUGBP1 protein 
levels specifically in nuclei containing foci of CUG repeat RNA. Bitransgenic mice exhibited 
colocalization of MBNL1 with RNA foci and increased CUGBP1 as early as 6 hours after 
tamoxifen administration. These observations indicate that up regulation of CUGBP1 is an 
early and primary response to expression of expanded CUG repeats (Wang et al. 2007). 
Besides CUGBP1 increased steady state levels in induced heart tissues; these tissues 
demonstrated CUGBP1 hyperphosphorylation. These results indicate that CUGBP1 
hyperphosphorylation induces protein stabilization and is also a direct effect of Dmpk-CUG 
expanded repeat expression (Kuyumcu-Martínez et al. 2007).  
Numerous assays performed with Dmpk-CUG960 COS M6 cells and heart tissues from 
Dmpk-CUG960 heart-specific mice model and DM1 patients have shown that PKC (protein 
kinase C) is activated (by phosphorylation) when there is expression of DMPK-CUG 
expanded repeats. PKC activation (induced by these mRNA mutant repeats) is required for 
CUGBP1 hyperphosphorylation and its subsequently steady state levels (Kuyumcu-Martínez 
et al. 2007). 
Additionally, Koshelev et al. (2010) demonstrated that 2-6 month old bitransgenic 
mice overexpressing CUGBP1 in hearts (tetracycline inducible and heart-specific) reproduce 
functional and molecular abnormalities observed in DM1 patients and DM1 mice models, 
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including the line previously described developed by Wang et al. (2007). These bitransgenic 
mice exhibited dilated cardiomyopathy and reproduce histopathological abnormalities 
observed in Wang et al. (2007) transgenic mice line (DMPK-CTG960) and DM1 patient 
tissues. These abnormalities included necrosis, degeneration and loss of myocardial fibers 
(Koshelev et al. 2010).   
Since it is well known that DM1 impairs skeletal muscle function, an inducible and 
skeletal muscle-specific CUGBP1 transgenic mice line was created by Ward et al. (2010). 
This phenotype aimed to determine whether CUGBP1 overexpression in skeletal muscle from 
adult mice reproduces features of DM1 patients and of a DM1 mice model (DMPK-CTG960 
inducible and skeletal muscle-specific) previously created by Orengo et al. (2008). At 2-3 
months of age, these transgenic mice were induced to express CUGBP1 protein. These mice 
had a strong observable phenotype by 2 weeks of inducing CUGBP1 overexpression. They 
exhibited impaired movement, abnormal gait, an 18% reduction in total body weight and 
histology characteristic features observed in DM1 including a large number of myofibers 
containing central nuclei. Furthermore, during the periods of time with high CUGBP1 
induction (1-4 weeks) transgenic mice exhibited a significant reduction in muscle function. 
However, muscle performance improved by 8 weeks of induction when it was shown that 
CUGBP1 expression levels were significantly reduced. The latter suggests a tight correlation 
between the severity of muscle function and CUGBP1 protein levels of expression during 
DM1 (Ward et al. 2010). 
 
3.6 CUGBP1 and early development  
 
The zebrafish CUGBP1 ortholog: cugbp1, formerly known as Bruno-like (brul) was 
first identified as a maternal factor (Suzuki et al. 2000). Maternal factors are gene products 
present in the egg at and before fertilization. They are synthesized during oogenesis and are 
crucial before zygotic genome activation which occurs at a developmental moment referred as 
midblastula transition (MBT). In zebrafish, the MBT occurs gradually between the beginning 
of cell cycle 10 (512 cells) and the ending of cycle 13 (sphere stage; Kane and Kimmel 1993; 
Pelegri 2003).  
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In zebrafish, maternal cugbp1 mRNA expression has been observed during oogenesis 
as well as at early embryonic development. At oogenesis, cugbp1 mRNA was distributed 
ubiquitously at stage IB (primary growth, oocytes reside within a definitive follicle). At stage 
II (cortical alveolus stage), mRNA expression was observed at the vegetal cortex. By the stage 
III (vitellogenesis), cugbp1 mRNA was still accumulated at the vegetal cortex, although it was 
also located around the germinal vesicle (nucleus; Suzuki et al. 2000). 
 Once the egg has been fertilized, maternal cugbp1 mRNA was observed in the vegetal 
pole at the onset of embryogenesis. Then, streaming of cugbp1 mRNA towards the blastodisc 
was observed as early as 30 minutes post fertilization (minpf, 1 cell stage; Suzuki et al. 2000). 
At the 4 cell stage (1hpf), cugbp1 mRNA was detected at the cytoplasm of the distal ends of 
cleavage furrows; hence suggesting a role as a germ lineage determinant. In addition, it was 
still apparent at the vegetal pole and a weaker signal was observed in the blastomeres. At the 
sphere stage (4hpf), cugbp1 mRNA was concentrated in a four-cell/cluster pattern that is 
reminiscent of primordial germ cells. In addition, a ubiquitous mRNA weaker signal was 
observed in the blastomeres (Hashimoto et al. 2004). Afterwards, the maternal mRNA 
gradually decreased during successive cleavage stages. Then, at 24hpf, zygotic cugbp1 mRNA 
was observed at the lens specifically in lens fiber cells. Zygotic cugbp1 mRNA expression was 
reported to be uniform throughout zebrafish embryos before 24hpf, although no specific 
moments of first appearance were specified (Suzuki et al. 2000). 
Later on, immunostaining assays showed that zebrafish Cugbp1 protein is distributed 
all over the embryo from the 1 cell stage to 28hpf (not including the yolk). At the 1 cell 
period, Cugbp1 accumulated at the animal pole followed by a distribution throughout the 
whole blastomere. At 28hpf, Cugbp1 expression was observed at the whole embryo with 
stronger signals at the lens and somites (Hashimoto et al. 2006).   
In Xenopus (genus of highly aquatic frogs), the ortholog of human CUGBP1, eden-bp 
(Embryo deadenylation element binding protein) has been identified as a maternal factor that 
recognizes a short element referred as EDEN on the 3ʹUTR of maternal mRNAs. The core 
motif of this element is a U(G/A) repeat. eden-bp protein activity is turned on at, or just after, 
fertilization triggering deadenylation [poly(A) tail shortening] and subsequent translational 
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repression and  degradation of mRNAs bearing an EDEN (Paillard et al. 1998; Graindorge et 
al. 2008). 
Gautier-Courteille et al. (2004) have monitored eden-bp mRNA and eden-bp protein 
expression by Xenopus whole-mount in situ hybridization and immunohistochemistry assays, 
respectively. Both eden-bp mRNA and protein expression were found to have very similar 
patterns of expression. At the blastula and gastrula stages, eden-bp was expressed 
homogenously in whole Xenopus embryos. By the neurula stage, expression was more 
concentrated in the paraxial mesoderm (which gives rise to somites, facial muscle and 
cartilage) flanking the neural tube. In early tailbuds (stage 20-44, including beginning of 
hatching at stage 35-36), eden-bp was more abundant in the dorsal mesoderm and in the head 
area (including the eye). This preferential expression in the dorsal mesoderm and in the head 
was more marked in late tailbud and tadpole embryos. eden-bp expression in dorsal mesoderm 
is particularly obvious in the posterior presomitic mesoderm (PSM). eden-bp mRNA and 
protein relocation to preferred regions at the neurula and tailbud stages most likely relies on 
zygotic transcription and translation.  
Moreover, eden-bp down regulation in Xenopus embryos by antisense morpholino or 
anti eden-bp antibody impairs somitic segmentation. The latter was evidenced by a lack of a 
periodic pattern of somites separated by chevron-shaped borders. Hence, eden-bp is required 
for the metamerization of the somites during embryonic development (Gautier-Courteille et al. 
2004). 
etr-1, identified in the nematode Caenorhabditis elegans, is the ortholog of human 
CUGBP1 which whom it shares 74% identity within the RRMs. A promoter element within 
etr-1 gene linked to the GFP (green fluorescent protein) showed an expression pattern with 
high muscle specificity. By 300minpf, embryos exhibited GFP expression in the muscle sheet. 
The muscle sheet, in early embryos, is the term used to refer to the muscle cells that are 
initially seen as a continuous sheet on the lateral side of the embryo. Between 300-350minpf, 
the muscle sheet begins to separate, starting from the anterior, as the cells move to form two 
dorsal and two ventral muscle quadrants. By 430minpf, GFP expression is present at these 
four quadrants along the length of the embryo. Moreover, expression is evident in adult 
animals. GFP is observed in striated body-wall muscles along the length of the animal, 
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especially in the head. Expression was also seen in the intestinal and sphincter muscles, the 
sex-specific muscles of the male tail and the vulval muscles (vulva: hermaphrodite 
reproductive structure that serves to allow eggs to be laid and male sperm to be deposited; 
Milne and Hodgkin 1999). 
Inactivation of etr-1 caused embryonic lethality. First, embryos could not elongate and 
became paralyzed, a phenotype characteristic of a mutant line defective in muscle formation 
and function. ETR-1 protein is essential for muscle development and it may play a role in 
post-transcriptional regulation of some muscle components. Hence, a possible conservation of 
gene function between etr-1 and CUGBP1 was suggested (Milne and Hodgkin 1999). 
The mice CUGBP1 ortholog has also been implicated in early embryonic development. 
Kress et al. (2007) developed a Cugbp1 null mice line (Cugbp1-/-) by homologous 
recombination. These homozygous mutants were viable, but a significant portion of them did 
not survive after their first few days of being born. They were smaller and their growth 
deficiency was already apparent just before birth. Cugbp1-/- mice weighted significantly less 
than controls. These differences remained stable throughout life and the null mice never 
reached the size and weight of controls. Impaired fertility was another feature observed in 
most Cugbp1-/- males and females. A more thorough analysis of male infertility showed an 
arrest of spermatogenesis (Kress et al. 2007).  
Cugbp1 expression was also tested in whole mice embryos by two different 
approaches: measurement of Cugbp1 promoter activity by β-galactosidase; and protein 
detection by immunohistochemistry. Cugbp1 promoter activity starts at the two-cell stage 
(time of first main zygotic activation) and it continues at least until the blastocyst stage. The 
promoter activity was also present in the oocyte; this expression was very strong and sustained 
during the preimplantation period. Evaluation of Cugbp1 expression pattern later on 
development showed wide expression at 10 and 11 days post coitum (dpc). The highest 
expression levels were seen in the limb buds, cephalic structure, tail region and somites. 
Immunohistochemistry assay revealed the same temporal and spatial pattern. Cugbp1 
promoter activity in internal tissues from 12dpf embryos revealed that the expression was 
extensive and variable in intensity (Kress et al. 2007).  
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Furthermore, Kuyumcu-Martínez et al. (2007) examined endogenous levels of 
CUGBP1 protein from heart muscles of embryonic day 16 and 17 (E16, E17) and from heart 
and skeletal muscles of newborn and adult (6 months old) normal mice. This was done to try 
to identify a relationship between CUGBP1 phosphorylation and regulation of protein steady 
state levels during early development. Results indicated that CUGBP1 was more acidic in e17 
and newborn tissues examined compared to adult tissues. This acidic shift was proved to be 
due to hyper-phosphorylation. In addition, there was an increase of CUGBP1 protein steady 
state levels due to hyperphosphorylation in adults from Wang et al. (2007) DM1 mice model 
(DMPK-CUG960) and DM1 patient tissues, as explained previously. Also, the abundance of 
CUGBP1 in normal embryonic and newborn cardiac and skeletal muscle was due to its 
hyperphosphorylation. There was no sign of CUGBP1 hyperphosphorylation in normal adult 
tissues. 
These results lead Kuyumcu-Martínez et al. (2007) to conclude that a developmental 
change in the phosphorylation state of CUGBP1 in heart and skeletal muscle correlates 
directly with its steady state levels. This developmental normal change might not occur in 
DM1 patients leading to abnormal increased steady state levels of CUGBP1; and ultimately 
contribute to the abnormal pathogenic phenotype. 
More specifically, it has been widely observed that the expanded CUG repeats in DM1 
disrupt an alternative splicing program (Cooper et al. 2009). Alternatively spliced mRNAs can 
be regulated according to cell type, in response to external cues or depending on the 
developmental stage. RNA binding proteins, like CUGBP1, are involved in this regulation by 
binding to specific regions within pre-mRNAs. Additionally, it has been proven that 
alternative splicing regulation can involve the activities of antagonistic factors by promoting 
different pathways (Ranum and Cooper 2006). 
In DM1, an alternative splicing transition mechanism regulated antagonistically by 
MBNL1 and CUGBP1 in striated (skeletal and heart) muscle is disrupted. In normal 
conditions, this mechanism is dependent on the developmental stage. First, CUGBP1 protein 
is up regulated in early embryonic development and as development proceeds CUGBP1 is 
down regulated; concomitantly MBNL1 is up regulated. CUGBP1 and MBNL1 reproduce 
embryonic and postnatal/adult alternatively spliced expression patterns, respectively. Since 
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DM1 is characterized by an elevation of CUGBP1 protein levels and sequestration of MBNL1 
protein, the disruption of this mechanism results in an inappropriate expression of embryonic 
rather than adult splice variants in adult tissues. This results in DM1 pathogenesis (Kalsotra et 
al. 2008; Cooper et al. 2009; Schoser and Timchenko 2010).      
Ladd et al. (2001) have also detected developmentally regulated expression of 
CUGBP1 protein. They showed that the abundance of CUGBP1 from mice skeletal muscle 
decreased significantly from strong expression during embryonic development (E14), NB 
(new born) and PN4 (postnatal day 4) to very low levels in adult thigh muscles. But, this 
stage-dependent pattern of expression was not limited to skeletal muscle. CUGBP1 protein 
expression stayed constant throughout early stages of mice brain development (E14, NB, and 
PN4) and decreased to a very low but still detectable level in the adult brain. In addition, 
Western Blot assays also revealed CUGBP1 expression in diaphragm, uterus, spleen, 
mammary gland, lung and adipose mice adult tissues. However, a possible change in CUGBP1 
levels of expression throughout development was not studied in these last mentioned tissues.    
To determine if increased CUGBP1 expression is sufficient to reproduce disrupted 
alternative splicing activity observed in DM1, Ho et al. (2005) generated transgenic mice that 
specifically express human CUGBP1 (MCKCUG-BP1; MCK: creatine kinase promoter) in 
striated muscle tissues. Transgenic mice with CUGBP1 expression 4-6 fold above endogenous 
levels in neonatal heart and skeletal muscle were stillborn (it is likely that its mutant founder 
was chimeric).  
To find out if CUGBP1 alternative splicing activity was disrupted in neonatal hearts 
from MCKCUG-BP1 transgenic mice, Ho et al. (2005) compared splicing of Tnnt2 (the mice 
ortholog of human CTNT: Cardiac Troponin T) in transgenic vs. WT (wild type) littermates. 
CTNT is a striated muscle protein that plays an important role in the regulation of muscle 
contraction. This protein contains different isoforms that are stage-dependent and regulated by 
alternative splicing (Cooper and Ordahl 1985; Filatov et al. 1999). Transgenic mice (~74%) 
exhibited increased levels of Tnnt2 exon5 inclusion when compared with non-transgenic 
neonates (~35%). In DM1 patients, cardiac tissues show an inappropriate retention of the 
CTNT fetal exon5. Hence, increased Tnnt2 exon5 inclusion in MCKCUG-BP1 mice is 
consistent with disrupted splicing and CUGBP1 increased steady state levels in DM1 (Ho et 
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al. 2005). In addition, it has been proven that MBNL1 protein has an antagonistic role in 
Tnnt2 and CTNT alterative splicing as MBNL1 represses inclusion of exon5 (Kanadia et al. 
2003; Ho et al. 2004). 
Human myotubularin-related 1 gene (MTMR1) and its mice ortholog Mtmr1 belong to 
a highly conserved family of eukaryotic phosphatases. At differentiation of muscle cells in 
culture (mouse myoblast cell line C2C12 and human fetal myoblasts) two major MTMR1 
isoforms (A and B) were identified in myoblasts prior to fusion into myotubes. After early 
induction of myoblast differentiation, a third isoform (C) was detected and its levels increased 
to become the major isoform when myotubes were predominant. At normal heart as well as 
skeletal muscle development, it has been proven that MTMR1 undergoes a transition from the 
fetal (A and B) to the postnatal/adult (C) isoform (Buj-Bello et al. 2002; Ho et al. 2005).  
Analysis of splicing in neonatal hearts and skeletal muscle samples revealed that mice 
overexpressing CUGBP1 express more of the fetal MTMR1 isoforms. In contrast, the 
predominant isoform in neonatal WT mice is C and adult WT mice express only the adult 
isoform suggesting that MCKCUG-BP1 transgenic mice display a delay in the expression of 
the adult isoform (Ho et al. 2005). Furthermore, the splicing pattern of MTMR1 mRNA was 
studied in congenital myotonic dystrophy muscle cells. Human fetal congenital DM1 myoblast 
cultures were induced to differentiate, and as myogenesis took place MTMR1 isoform C 
decreases instead of increasing as shown in normal cell cultures. Additionally, after medium-
induced differentiation, an abnormal MTMR1 transcript isoform (G) appears in human 
congenital DM1 cell cultures. The G isoform was not detected in control cultures. Skeletal 
muscle tissues from congenital DM1 fetuses (aged 15-37weeks) also revealed the presence of 
the abnormal G isoform, suggesting that disrupted splicing of MTMR1 also happens in human 
muscle affected by congenital myotonic dystrophy (Buj-Bello et al. 2002). However Ho et al. 
(2005) do not mention any studies performed to find out if MTMR1 isoform G is present in 
MCKCUG-BP1 transgenic mice. 
In addition, sections of mice skeletal muscle from neonates overexpressing CUGBP1 
displayed abnormalities that resembled features of congenital myotonic dystrophy. Light and 
electron microscopy observations showed myofibers with chains of centrally located nuclei, 
degenerating muscle fibers surrounded by nuclei and irregularly shaped nuclei. When 
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compared with controls, WT neonatal tissues displayed small fibers with central nuclei 
consistent with normal still immature skeletal muscle. In contrast, transgenic animals 
possessed increased number of internal nuclei in individual fibers. In congenital myotonic 
dystrophy, skeletal muscle development is impaired, several of its abnormalities include: 
chains of centrally located nuclei, large variations in muscle fiber size and poor fiber type 
differentiation. The results in transgenic mice suggest that mice overexpressing human 
CUGBP1 in skeletal muscle display pathological features observed in DM1 disease (Ho et al. 
2005). 
  
  3.7 DM1 and the lens 
 
To date, most of the efforts to try to understand the causes and features of DM1 disease 
have been oriented to the study of heart and skeletal muscle defects (Schoser and Timchenko 
2010). The study of the mechanisms underlying the development of cataracts, in DM1, needs 
further investigation.  
Adult lens samples from individuals who had suffered DM1 have been studied to 
observe the cataract morphology in this disease. The first lesion of the lens has been described 
as fine points mixed with colored crystals or iridescent-like dust in a thin band of anterior and 
posterior cortex beneath the capsule. The second and more advanced lesion is a stellate 
grouping of opacities at the posterior pole along the posterior suture lines of the lens. The 
stellate arrangement of opacities is considered a later stage than that of the colored crystals 
due to a condensation of the point-like opacities along the sutures (Eshaghian et al. 1978). 
By transmission electron microscopy imaging, Eshaghian et al. (1978) observed 
numerous small, round globular bodies at the posterior pole of DM1 cataractous lenses. The 
accumulation of these abnormal bodies was associated with swirling membrane configurations 
that resembled myelin-like figures (whorls). Small amounts of cytoplasm were layered 
between the whorls. Hence, it was proposed that plasma membranes may wind around 
themselves to form the myelin-like figures. And that these whorls could correspond to the 
iridescent crystals seen in DM1 cataracts of adult patients at slit lamp views. If this is true, 
then there are no crystals, but derivatives of the plasma membrane which refract light to give 
the appearance of colored crystals. The accumulation of the myelin-like bodies along the 
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posterior suture could account for the stellate opacity observed. These observations suggest 
that the plasma membranes of lens fibers in DM1 may be defective. In addition, the general 
morphology of the anterior lens structure in adult DM1 patients was not normal. Central and 
peripheral epithelial cells contained nuclei with clumped chromatin, degenerating 
mitochondria and enlarged intercellular clefts or cisternae.   
 One of the first steps to try to identify what causes cataracts in DM1 was to determine 
if the DMPK gene is expressed in the lens. Dunne et al. (1996) probed that DMPK RNA is 
expressed in normal adult human lenses by RT-PCR (Reverse Transcriptase PCR). The same 
type of samples was used to demonstrate that DMPK protein is expressed at adult human 
lenses by Western Blot. The same size band had been previously detected in both human 
cardiac and skeletal muscles.  
Immunohistochemistry assays with anti-DMPK antibody were performed on sagittal 
sections (vertical cut from front to rear, divides human body into right and left; equals to 
transverse sections in zebrafish lenses) from normal and DM1 human adult lenses. Normal 
adult lenses showed cytoplasmic staining with increased intensity in the perinuclear region 
(cytoplasmic region just around the nucleus) in epithelial cells. A more uniform cytoplasmic 
labeling was observed in anterior and posterior subcapsular cortical lens fibers. Nuclei were 
not labeled in any type of normal cell. The depth of fiber cells staining varied, it was most 
shallow at the posterior pole and it had the greatest depth in the equatorial region. Mature 
organelle-free nuclear lens fibers were not stained (Dunne et al. 1996).  
One human adult lens sample from a DM1 patient with cataracts exhibited a 
significantly different distribution of DMPK protein. Staining was primarily detected inside 
the cell nucleus in epithelial cells. The difference in DMPK labeling between normal and a 
DM1 lens, although tentative due to limited samples, is consistent with an alteration in the 
localization of DMPK protein as a gain of function effect in DM1 (Dunne et al. 1996). 
DMPK mRNA and protein expression in adult human lenses and Eshaghian et al. 
(1978) observation that whorls of multilaminate membranes were present at the posterior pole 
in DM1 lens samples; led Dunne et al. (1996) to hypothesized that altered expression of 
DMPK protein in DM1 could alter the regulation of organelle loss during normal lens fiber 
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maturation. An abnormal presence of membrane-enclosed organelles could produce these 
whorls in lenses from DM1 patients.   
DMPK expression at the lens was further studied by Winchester et al. (1999). Three 
adult human eyes and two fetal eyes (12 weeks old) were used for RT-PCR (Reverse 
transcriptase-PCR) analyses and western blotting. DMPK mRNA was not detected at human 
adult lens samples, but it was present at the fetal eyes; however this last assay does not give 
specific information of the fetal lens. Analysis of DMPK protein by western blot did not show 
expression at adult lenses or fetal eyes extracts. DMPK mature mRNA and protein expression 
results disagree with the previously mentioned results since Dunne et al. (1996) did observe 
expression at both the protein and transcriptional levels in normal adult human lenses.  
In situ hybridization results showed no DMPK mature mRNA expression in adult 
lenses from 8 human samples. DMPK protein expression was also not detected in any specific 
regions of 8 human adult lenses by immunodetection experiments on lens sections 
(Winchester et al. 1999). These observations were incongruent with earlier results. Dunne et 
al. (1996) obtained positive results in DMPK protein expression at human adult lenses, 
specifically at both the lens epithelial cells and cortical lens fibers. Unfortunately, this paper 
did not publish any positive or negative in situ hybridization results of DMPK transcripts or 
immunodetection assays of DMPK protein in fetal lenses (Winchester et al. 1999).  
More recently, Harmon et al. (2008) have produced a highly specific and sensitive 
monoclonal antibody against the coiled-coil region of DMPK protein. With this antibody 
DMPK protein was detected at the mice embryo ocular lens. In addition, specific DMPK 
staining in the chick embryo revealed expression restricted to postmitotic lens fiber cells 
(stage 26; 4.5-5 days). DMPK protein expression in both the murine and avian embryos lenses 
suggests a conserved function for DMPK in early development. Expression in postmitotic 
cells further suggests a possible role for DMPK during cell differentiation (Harmon et al. 
2008).      
To try to identify what possible role does DMPK protein have in lens cells, Jin et al. 
(2000) overexpressed coding regions of human DMPK (20-fold increase compared to 
endogenous DMPK) in the human lens epithelial cell line known as B3. After 24-40hours after 
transient transfection multiple blebs and protrusions from near the plasma membrane were 
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observed. This cellular phenotype (blebbing) resembled the protrusions observed in the 
execution stage of apoptosis. Moreover, immunohistochemistry assays proved that the 
localization of DMPK completely overlapped with the formed blebs. Overexpression of 
cytoplasmic DMPK protein induced the apoptotic-like blebs where it was concentrated. The 
blebs also contained markers of the ER lumen and the outer membrane of the blebs exhibited a 
marker of the plasma membrane. This observations were consistent with the condensation of 
cytoplasm and the generation of outer membranes (forming the protrusions) from the plasma 
membrane, characteristics seen in apoptotic blebs. 
Although DMPK overexpression induced blebbing formation, there were other 
behaviors that did not mimic the classical model of apoptosis. In conjunction with blebbing 
(24h post transfection), chromatin condensation and DNA fragmentation were monitored as 
these are two hallmarks of classical apoptosis (Mills et al. 1998; Jin et al. 2000). These two 
characteristics were not significantly observed in the blebbing cells. Moreover, a negative 
regulator transgene of classical apoptosis was co-transfected with the DMPK transgene. This 
bi-transgenic cell cultures did not show a decrease in blebbing. These results suggested that 
DMPK overexpression participates in a mechanism that is different from the classical model 
of apoptosis (Jin et al. 2000).   
To identify if apoptotic-like blebbing was an effect produced by biological actions of 
DMPK protein or by recombinant protein nonphysiological dominant negative interactions, 
two B3 derived transgenic cultures were created. One of the lines was generated by 
transfecting a mutant DMPK transgene with blocked kinase activity. The other transgenic line 
was transfected with wild type DMPK. Striking differences were observed between these 
lines. Cells expressing WT DMPK possessed significant blebbing. These cells also exhibited 
enhanced labeling of F-actin-containing structures and increased organization of the actin 
cytoskeleton as evident stress fibers or cortical rings. The surrounding cells in the same culture 
that were not expressing wild type DMPK showed more diffuse and less intense F-actin 
signals (Jin et al. 2000). 
On the other hand, cells expressing enzymatically inactive DMPK did not show 
blebbing. F-actin labeling did not exhibit any enhancement. There were no differences in F-
actin staining between cells expressing mutant DMPK and the cells in the same culture that 
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did not express flawed DMPK protein. These results suggest that kinase activity from DMPK 
is needed for the induction of apoptotic-like blebbing in lens epithelial cells (Jin et al. 2000). 
Due to the later results, DMPK overexpression in lens epithelial cell line B3 was 
related with the organization of F-actin cytoskeleton and membrane dynamics in the lens. 
Hence, RHOA was transiently transfected in the B3 cell line. RHOA is a GTPase that activates 
protein kinases structurally similar to DMPK in their catalytic protein kinase domain (Jin et al. 
2000). RHOA promotes bundling of actin filaments with myosin II filaments to form stress 
fibers and focal adhesions (Ridley and Hall 1992; Chrzanowska-Wodnicka and Burridge 
1996) and apoptotic membrane blebbing (Milles et al. 1998). Hence, a comparison between 
the effects of RHOA when transiently transfected and expressed in B3 cells and the previous 
results of wild type DMPK overexpression was done. Indeed, overexpression of RHOA 
produced both blebbing and the changes in actin cytoskeleton seen after DMPK 
overexpression in lens epithelial cell cultures. Control experiments and the latter results 
suggested that the similar effects observed due to DMPK and RHOA expression are due to the 
fact that DMPK may function as well in regulating the organization of F-actin cytoskeleton 
and membrane dynamics in the lens. The functions of both proteins (DMPK and RHOA) 
might overlap in lens cells (Jin et al. 2000). 
Jin et al. (2000) concluded that although other pathogenetic mechanisms such as a 
gain-of function from the abnormal properties of expanded CTG repeats cannot be ruled out; 
decreased expression and activity of normal DMPK may be at least one of the causes of 
cataracts in DM1. Overexpression of DMPK induces apoptotic-like processes. So, this protein 
may be part of the regulatory network that promotes apoptotic-like mechanisms to remove 
membrane organelles within developing lens fibers. 
As mentioned before, SIX5 has also been directly implicated as a candidate gene of 
DM1 since DMPK CTG repeat expansions decrease the expression of SIX5 (Klesert et al. 
2000). Hence, expression assays have been performed to identify if SIX5 disrupted expression 
might trigger a cataract phenotype. RT-PCR (Reverse transcriptase-PCR) experiments were 
done in three adult human eyes and two fetal eyes (12 weeks old). SIX5 mRNA was present in 
adult lens samples, but absent in whole eye fetal samples. SIX5 mRNA expression by in situ 
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hybridization was observed in the lens epithelium of 8 adult human eyes, but not in any 
location in 6 samples of human fetal lenses (6-14 weeks; Winchester et al. 1999).  
To determine if SIX5 deficiency is at least in part responsible of DM1 features; a Six5 
deficient mice line was created. The Six5 gene was disrupted by replacing its first exon with a 
β-galactosidase reporter. This made transgenic embryos to exhibit β-galactosidase expression 
driven by the Six5 promoter. At 12.5 and 14.5dpc (days post coitum) faint staining was 
visualized at the lens fibers. In addition, few scattered spots of more intense staining at lens 
fibers were present at 14.5dpc (Klesert et al. 2000). 
Klesert et al. (2000) also examined Six5 knock out mice aged 5-7 and 8-10 months for 
presenile cataracts development under slip-lamp illumination. At both periods of time tested 
homozygous mutants had a higher grade of lens opacities compared to wild type littermates. 
Heterozygous mutants showed a trend toward a higher-grade cataract phenotype that 
augmented with age. However, the differences between heterozygous and wild type mice were 
not statistically significant at both periods of time analyzed. Anterior views of 10-month old 
Six5 mutant mice lenses showed concentric refractile rings in the lens of null mice. Slit-lamp 
views revealed light scattering in the lens nucleus of homozygous mice. There were no 
differences observed between wild type and the heterozygous littermates. Hence, Klesert et al. 
(2000) hypothesized that the increased incidence of cataracts in mice deficient in SIX5 
indicates that a deficit of this protein in DM1 patients may be the reason of cataracts. 
However, Ranum and Day (2004) have questioned the latter since the cataracts observed in 
Six5 knock out mice do not possess the typical iridescent opacities and the posterior location 
that is observed in DM1.  
As stated before, MBNL1 protein expression is altered in DM1 tissues due to its 
sequestration by mutant mRNAs with expanded CUG repeats into nuclear foci (Jiang et al. 
2004; Cardani et al. 2006). Hence, to observe if MBNL1 protein sequestration contributes to 
the DM1 defective phenotype, Kanadia et al. (2003) developed a Mbnl1 knock out mice line. 
Data showing 18-week-old mutants lenses revealed the development of dust-like opacities. 
Anterior sections evidenced disorganized and cleft-like abnormalities in the anterior region of 
the lens mass. However, this study did not display a full description about the morphology and 
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progression of the development of cataracts in these mutants. Sections of the posterior region 
of Mbnl1 mutant lenses were not shown either. 
In all forms of DM1 (including CDM), the lens appears clear at birth and cataracts 
have not been described in anyone younger than at least 10 years old (Rhodes, unpublished). 
Ekström (2009) performed an ophthalmic study on 49 individuals with congenital (n=30) and 
childhood-onset (n=19) myotonic dystrophy 1 (females: n=20, 7.3-21.4 years; males: n=29, 
1.6-21.9 years). Although, no true cataracts were reported in all individuals; bilateral subtle 
haze or condensation in the posterior lens pole was found in 39% of the individuals. The latter 
abnormality in the lens is suggestive of early stages of cataract development.    
In the present literature review, the only identified published data directly relating 
cugbp1 and the lens of the eye corresponds to early embryonic mRNA and protein expression 
in the zebrafish lens (Suzuki et al. 2000; Hashimoto et al. 2006). Hence, an important role of 
CUGBP1 at early lens development can be hypothesized. In addition, DMPK expression has 
been identified in embryonic development in chick and mice lenses (Harmon et al. 2008). 
Cataracts are a common feature in DM1 patients and the accumulation of mutant DMPK 
mRNA with expanded CUG repeats has been implicated in DM1 features; in part because 
soluble repeats lead to an augment in steady state levels of CUGBP1 increasing its post-
transcriptional activity (Schoser and Timchenko 2010). So, it seems logical to think that 
DMPK mutant mRNA retention in lens cells may affect lens embryonic development by 
altering CUGBP1 levels and functions. Although cataracts are not present at birth in DM1 
(Rhodes, unpublished), disrupted CUGBP1 expression could lead to lens lesions that may 
affect lens structure and clarity in posterior life. Other disrupted pathways could also 
contribute to the development of cataracts (i.e. MBNL1 depletion; Kanadia et al. 2003) in 
addition to CUGBP1 in DM1 patients.     
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Chapter 4. Materials and Methods 
 
All experiments were realized at The Gross Lab, Molecular Cell and Developmental 
Biology, University of Texas at Austin. DNA sequencing was performed at the Institute for 
Cellular and Molecular Biology (ICMB) Core Facilities, University of Texas at Austin.   
Wild-type AB and TL Zebrafish (Danio rerio) strains were used and maintained at 
28.5°C on a 14hour light/10hour dark cycle. Animals were treated in accordance with 
University of Texas at Austin, Institutional Animal Care and Use Committee (IACUC) 
provisions. 
 
4.1 RNA in situ hybridization with digoxigenin-labeled probe 
 
An in situ hybridization assay was performed to try to identify the temporal and spatial 
cugbp1 mRNA expression in the lens during early zebrafish development. 
 
 4.1.1 cugbp1 cDNA cloning  
 
Previously, zebrafish cugbp1 mRNA was isolated and Reverse Transcriptase PCR 
(RT-PCR) was performed to obtain cugbp1 cDNA. The cugbp1 cDNA was cloned into CS10R 
plasmid (4.1kb; Annex 2). Afterwards, the cugbp1-CS10R construct was stored in The Gross 
Lab bacterial stock as D4 cugbp1 CS10R.  
(4.1.1 Section was performed by Dr. Jeffrey Gross, Principal Investigator). 
 
4.1.2 cDNA sequencing and protein sequence alignment 
 
To confirm that the cloned cDNA indeed encodes a zebrafish Cugbp1 protein and that 
it was produced by reverse transcription of cugbp1 mature messenger RNA (mRNA), the 
previously cloned cDNA was sequenced. D4 cugbp1 CS10R plasmid DNA was sequenced at 
the DNA Sequencing Facility of the ICBM at The University of Texas at Austin.  
With the cDNA sequencing results (Annex 3, Probe), the amino acid sequence was 
deduced (Annex 4) to compare it with previously reported protein sequences. This was 
performed by using the translate application from the Molecular Toolkit online site (Colorado 
State University). The amino acid sequence obtained in the present study was aligned with a 
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501aa zebrafish Cugbp1 protein sequence already identified by Suzuki et al. (2000; DDBJ, 
accession number AB032726; Ensembl, ID ENSDARP00000026582, DDBJ). The latter was 
done using the ClustalW2 online program (EMBL-EBI, European Bioinformatics Institute).    
 
4.1.3 Digoxigenin-labeled probe synthesis 
 
Antisense and sense probes were generated in order to perform the in situ hybridization 
assay. An mRNA antisense probe is a labeled RNA-like sequence that is complementary to the 
sequence of a specific mRNA, in this case to cugbp1 mRNA. Since antisense probe is 
complementary to cugbp1 mRNA, the former can hybridize to the latter in the euthanized 
body of an organism, in this case to zebrafish embryos. The mRNA sense probe has the same 
sequence that cugbp1 mRNA. So, it should not hybridize with the mRNA in question and it 
serves as a control.    
Circular DNA purification from a D4 (cugbp1 CS10R plasmid) bacterial stock culture 
was performed using the QIAprep Spin Miniprep Kit and a microcentrifuge (Qiagen). Plasmid 
digestion followed by incubation for 2 hours at 37˚C was performed using the following 
amounts of reagents: 10µl plasmid DNA, 10µl Nebuffer 3 or Nebuffer 1, 2µl restriction 
enzyme SalI or KpnI (New England Biolabs) and 78µl H2O for a total volume of 100µl for 
antisense probe and sense probe, respectively. Purification of linearized DNA template was 
done using the PCR clean-up Kit Epoch Biolabs. Antisense and sense probes were synthesized 
following the DIG RNA Labeling Mix 10X conc. Protocol (Roche Applied Science; Annex 5) 
using T7 or SP6 RNA polymerase, respectively. Probes were labeled by adding to the 
synthesis mixture, in addition to the standard uridine triphosphate (UTP), a UTP conjugated 
with digoxigenin. Digoxigenin is a compound isolated and made by a limited group of plants 
and not found in animals. Hence, it will make any mRNA bound to the probe recognizably 
different from any other mRNA in the tissue being studied.      
 
  4.1.4 In situ hybridization 
 
To suggest that cugbp1 expression has a possible role in normal zebrafish early lens 
development, an mRNA expression assay was first performed. 1, 2, 3 and 4dpf embryo 
fixation, permeabilization, hybridization, anti-digoxigenin alkaline phosphatase (AP) labeling 
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and colorization were performed as described by Jowett and Lettice (2004; Annex 6). Fixation 
was realized to preserve the samples morphology and to avoid the loss of mRNA from the 
cells. The permeabilization treatment allows maximum exposure of target mRNAs to probe by 
facilitating probe diffusion in the cell and out when it is unbound. The hybridization step 
permits the binding of antisense probe to the target mRNA due to sequence complementarity. 
Labeling is done with an antibody against digoxigenin. The only places where the antibody 
should bind are where the antisense probe has bounded, thus where the target mRNA is. 
Moreover the antibody has been linked to the AP enzyme. At colorization, BCIP/NBT is used. 
BCIP/NBT reacts with AP generating a purple-blue precipitate where the antibody is located. 
The latter serves to indicate that the target mRNA is present where the insoluble purple/blue 
dye is at.   
To observe in more detail the spatial and temporal cugbp1 mRNA expression in the 
lens, transverse sections of the center of the eye from embryos submitted to in situ 
hybridization at 1, 2, 3 and 4dpf were analyzed. Cryosectioning was performed according to 
Uribe and Gross (2007; Annex 7). After sections were adhered to the slides, 50-55µls of DPX 
mounting medium were added directly to the slides. Afterwards a no. 1 thickness cover slip 
was placed on top. Mounting medium was left to harden overnight at room temperature. 
Imaging and pictures taken of cryosections were done using the Leica Microscope DM 2500. 
Figure 5.1.2a represents a transverse section of the zebrafish lens.   
 
4.2 cugbp1 promoter activity in microinjected and transgenic zebrafish embryos 
 
To try to identify when and where inside the lens can Cugbp1 protein be present, a 
cugbp1 potential enhancer-promoter (aka promoter) region was first sought. The latter since a 
promoter is a part of a gene where RNA polymerase first binds for subsequent DNA 
transcription. An enhancer is a part that tells where and when a promoter is used. Both are cis-
DNA elements of a particular gene. Recognition of these sequences will help to observe the 
protein temporal and spatial pattern of expression driven by the identified cugbp1 promoter 
when fused to a reporter gene (e.g., Enhanced Green Fluorescent Protein, EGFP).    
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4.2.1 Search and cloning of a zebrafish cugbp1 promoter region 
 
To try to find a potential promoter region of the zebrafish cugbp1 gene, the 
Evolutionary Conserved Region (ECR) Browser website was consulted. Special emphasis was 
given on conserved regions localized upstream of the start codon (ATG lies at exon4) of the 
zebrafish cugbp1 gene, since promoter regions tend to be at this sites. A 1.2kb cugbp1 
potential promoter fragment was identified. This region was amplified from genomic zebrafish 
DNA and recognition sites for KpnI and SpeI restriction enzymes (Annex 8, purple shades) 
were created (for further subcloning see Section 4.2.3) by PCR using the following designed 
primers respectively:   
 5ʹ-GTACAGGTACCGCTTTCTCTTCCTGC-3ʹ and 
5ʹ-GTAGACACTAGTTTCTTCAGGCCTTC-3ʹ       
Afterwards, the 1.2kb PCR amplicon was cloned using the TA Cloning Strategy (Zhou 
and Gomez-Sanchez 2000) into linearized pGEM-T Easy Vector (3.015Kb). For this, 3ʹA-
tailing of the PCR product was realized to create complementarity with the vectors single 3ʹ-
terminal thymidines (T-overhangs). Purification and 3ʹA-tailing of the potential promoter 
DNA fragment, ligation reaction and transformation were performed according to the pGEM-
T and pGEM-T Easy Vector Systems Manual (Promega). 
(4.2.1 Section was performed by Richard Nuckels, Research Associate). 
 
4.2.2 Location of the cugbp1 promoter region in the zebrafish genome 
 
To confirm that the potential promoter region previously cloned is part of the cugbp1 
zebrafish gene, an identification of its location was realized by using the cugbp1 Ensemble 
genome sequence (ID ENSDARG00000005315). The latter sequence was submitted to in 
silico PCR with the primers mentioned above (4.2.1 Section). FastPCR 6.1 program was 
utilized. A cugbp1 transcript sequence (ID ENSDART00000018448) was used to find the 
position of the promoter in relation to the ATG start codon and the transcription start site (1+).   
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4.2.3 Plasmids construction 
 
An in vitro site-specific recombination approach (Hartley et al. 2000; Kwan et al. 
2007) was used to create two expression constructs. An expression construct is basically a 
[promoter]-[coding sequence]-[3ʹ tag or polyadenylation signal] construct in a Tol2 transposon 
backbone (Tol2 element function is explained in Section 4.2.4). In the present work, two 
constructs were generated: [cugbp1 1.2kb promoter]-[membrane or nuclear EGFP]-[SV40 
polyA] to be introduced on an expression system (Zebrafish) and therefore to monitor the 
cugbp1 promoter fragment activity in vivo. Site-specific recombinational cloning allows 
simultaneous cloning of multiple DNA fragments on one step and with a defined orientation. 
 The following steps were performed according to The MultiSite Gateway Three 
Fragment Vector Construction Kit (Invitrogen) and The Tol2kit (Kwan et al. 2007). The 
cugbp1 promoter pGEM-T Easy Vector (from Section 4.2.1) was digested with KpnI and SpeI 
restriction enzymes and the 1.2kb cugbp1 fragment was purified for posterior subcloning into 
p5E-MCS plasmid. The p5E-MCS vector contains the pBluescript multiple cloning site which 
includes a restriction site for KpnI and another for SpeI. A plasmid referred as p5E in the 
Tol2kit (Kwan et al. 2007) is a 5ʹ entry clone where the DNA insert that is going to become 
part of the expression construct (and the multiple cloning site) is flanked by attL4 and attR1 
sites for the posterior LR recombination reaction. Hence, the p5E-MCS construct was digested 
with KpnI and SpeI. The 1.2kb purified cugbp1 promoter fragment and the digested p5E-MCS 
were submitted to a ligation reaction for subcloning of the 1.2kb cugbp1 fragment into the 
p5E-MCS plasmid.    
Two separate multisite gateway LR recombination reactions were performed to create 
two expression constructs that differ by their middle entry clones. Both reactions were 
performed with pDESTol2p2A (destination vector; with attR4, attR3 and Tol2 transposon 
ends), p5E-cugbp1-MCS (5' entry clone), nuclear-localized EGFP (pME-nlsEGFP) or 
membrane-localized EGFP (pME-EGFPCAAX) (middle entry clones; with attL1 and attL2) 
and SV40 late polyA signal sequence (p3E-polyA) (3' entry clone; with attR2 and attL3). Two 
expression plasmids were created with the LR recombination reaction: cugbp1:EGFPCAAX-
polyA and cugbp1:nlsEGFP-polyA. In both constructs, the cugbp1 promoter 5ʹ element is 
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destined to drive expression of the nuclear or membrane- localized EGFP in zebrafish 
development.  
(4.2.3 Section was performed by Research Associate Richard Nuckels). 
 
4.2.4 Transposase mRNA synthesis 
 
Both expression constructs previously generated (Section 4.2.3) possess two ~500bp 
sequences from each end of the Tol2 transposon gene, one upstream of the 5ʹ element and the 
other one downstream of a polyA signal (Kwan et al. 2007). These Tol2 ends are necessary for 
transposition of the cugbp1:EGFPCAAX-polyA or the cugbp1:nlsEGFP-polyA fragments of 
the expression constructs with Tol2 transposase in the DNA of an expression system. Hence, 
for zebrafish transgenesis each expression plasmid has to be coinjected with in vitro 
transcribed transposase mRNA. The latter since this mRNA is capable of synthesizing a fully 
functional Tol2 transposase protein after being injected in 1-cell stage zebrafish embryos 
(Kawakami and Shima 1999; Kawakami 2007). 
For Tol2 transposase mRNA synthesis, circular DNA purification from stock bacteria 
pCS2FA-transposase plasmid (Kwan et al. 2007) was performed using the QIAprep Spin 
Miniprep Kit and a microcentrifuge (Qiagen). Plasmid digestion followed by incubation for 2 
hours at 37˚C was performed using the following amounts of reagents: 10µl plasmid DNA, 
10µl Nebuffer 3, 2µl restriction enzyme NotI (New England Biolabs) and 78µl H2O for a total 
volume of 100µl. Purification of linearized DNA template was done using the PCR clean-up 
Kit Epoch Biolabs. Capped mRNA synthesis from the DNA template was done with the 
mMESSAGE mMACHINE Kit from Applied Biosystems using SP6 RNA polymerase and 
lithium chloride precipitation for the recovery of the RNA. 
 
4.2.5 Injections 
 
For transgenesis, 25pg (pictograms) of either DNA expression construct and 25pg of 
transposase mRNA were injected into 1-cell stage embryos using a microinjector (Harvard 
Apparatus, Medical Systems Research Products). Injections were done directly to the cell and 
not the yolk for early transgene incorporation. 
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Injected embryos were examined under a fluorescence microscope (Leica Microscope 
MZ 16F) at different time points to assess for expression of the EGFP reporter gene under the 
control of the 1.2kb cugbp1 promoter. EGFP+ injected embryos (F0; founder fish) were grown 
up 3-4 months. F0 fish harboring the transgene were mated with wild type fish to generate 
transgenic stable lines (F1).  
 
4.2.6 Immunohistochemistry on transverse cryosections from embryonic 
zebrafish eyes 
 
To observe the pattern of expression driven by the cugbp1 1.2kb promoter fragment in 
the lens, an immunohistochemistry assay to detect EGFP was performed in transverse sections 
of the center of the eye from transgenic embryos at 1, 2, 3, 4 and 6dpf. Tissue fixation, 
cryosectioning and immunostaining assays were performed on F1 EGFP+ embryos as 
described in Uribe and Gross (2007; Annex 7). The anti-GFP primary antibody (1:100; Santa 
Cruz Biotech) was used. Images were taken using a Zeiss LSM5 Pascal laser scanning 
confocal microscope. 
  
4.3 cugbp1 down regulation by splice-altering morpholino injections 
 
In order to identify the function of Cugbp1 protein during zebrafish lens development, 
cugbp1 pre-mRNA was targeted by injecting fertilized eggs with an antisense splice-altering 
morpholino (cugbp1-MO) to knock down protein expression (Morcos 2007). As a negative 
control, a second group of embryos of the same batch in every injection round were injected 
with a control mismatch morpholino (cugbp1-MM) which should not alter splicing events. 
Mismatch morpholino injections serve to guarantee that any phenotypic differences in cugbp1-
MO injected embryos are not just due to the injection procedure, but indeed to the specific 
MO splice-altering activity.  
 
 4.3.1 Splice-altering morpholino injections 
 
cugbp1 antisense (cugbp1-MO) and cugbp1 mismatch (cugbp1-MM; 5 mispair 
compared to the MO) morpholinos (MOs) were purchased from Open Biosystems and Gene 
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Tools, respectively. Both MOs were injected with a concentration of 2.2ng/embryo at the 1-4 
cell stage into wild type embryos. MOs sequences are the following:  
cugbp1-MO  5'-AACATTTTCTCACCCCTGGAAGAAT-3' and   
cugbp1-MM 5'-AAGATTTTGTCACCGCTGCAACAAT-3' 
Injections were performed with the same equipment as mentioned before (Section 
4.2.5). An uninjected control group of embryos of the same batch of every single injection 
round was also maintained to compare them with the cugbp1-MM embryos. If both uninjected 
and cugbp1-MM embryos presented any unusual phenotypes, it meant that the whole batch 
was defective and all uninjected, cugbp1-MM and cugbp1-MO treated embryos had to be 
discarded. Injections can be directed to the yolk of the embryo since an active process in 
which mRNAs at the yolk are transported to the overlying blastomeres takes place at early 
embryonic zebrafish development (Bill et al. 2009).    
     
4.3.2 Test of morpholino activity by reverse transcription PCR (RT-PCR). 
 
To confirm the splice-altering efficacy of the morpholino, RT-PCR was performed on 
both groups of injected zebrafish embryos (cugbp1-MO and cugbp1-MM). For RT-PCR, RNA 
isolation was performed according to The Trizol Reagent–Isolates RNA from Embryo 
Protocol (Invitrogen) from 1dpf injected embryos. Production of cDNA was done following 
the iScript cDNA Synthesis Kit (BIO-RAD). PCR was performed using Taq polymerase with 
the following conditions: 94°C for 2min; 39 cycles of 94°C for 30s / 55°C for 45s / 72°C for 
1min. The following primers were utilized:  
Forward primer 5'-ATGAATGGGTCTCTGGACCAC-3' and 
Reverse primer 5'- CATTGTTTTTCTCACTGTCTGCAGG-3'   
For further confirmation of the RT-PCR results and to show the nature of the cugbp1 
pre-mRNA transcript modification, the obtained bands in the agarose gel (RT-PCR results) 
were purified with the QIAquick Gel Extraction Kit (Qiagen). The separate clean DNA 
fragment samples were sent to sequence as mentioned before (Section 4.1.2). To identify the 
positions recognized and altered by the cugbp1-MO within this gene, the cugbp1 transcript 
sequence (ID ENSDART00000018448) was utilized.  
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4.3.3 Observation of the phenotypes and behaviors of cugbp1-MO and cugbp1-
MM injected embryos 
 
MO and MM injected embryos were visualized and monitored for phenotypic 
differences and pictures were taken with a microscope (Leica Microscope MZ 16F). 
 
4.3.4 BrdU incorporation assay, immunohistochemistry on transverse 
cryosections from embryonic eyes of previously injected cugbp1-MO and cugbp1-MM 
embryos and statistical analysis 
 
An assay to visualize any differences in lens cells proliferation between cugbp1-MO 
and cugbp1-MM embryos was performed. BrdU (bromo-deoxyuridine) is an artificial thymine 
analogue that can be incorporated in the DNA of S-phase cells (Matsuoka et al. 1990) 
allowing visualization of dividing cells at specific time points. cugbp1-MO as well as cugbp1-
MM injected embryos of 2 or 3dpf were bathed in 10mM 5-Bromo-2-deoxiuridine (BrdU 
Sigma) for 2 hours; specifically from 24 to 26 or 72 to 74hpf. Embryos were euthanized 
immediately after each exposure period of time. Fixation and cryosectioning were performed 
as described in Uribe and Gross (2007; Annex 7). 
For immunohistochemistry, the area of interest in each slide with the samples was 
circled with hydrophobic PAP pen. Then, slides were rehydrated in PBTD (0.1% Tween-20, 
1%DMSO in 1X PBS) at room temperature for 2-3min in Coplin Jar. Slides were removed 
from PBTD and any excess was drained. Cryosections were treated with 4M HCl for 10min at 
37°C. 4M HCl was drained off and slides were washed 3 times in PBTD at room temperature 
in Coplin Jar. Slides were removed from PBTD, any excess was drained from slides and slides 
were placed in humid chamber. Immunohistochemistry was performed as described by Uribe 
and Gross (2007; Annex 7) from step 12 and afterwards. The anti-BrdU (1:250; Abcam, 
ab6326) antibody was used. 
Statistical analyses were realized to find out if there were any significant differences in 
the total number of S-phase cells in the lens between conditions and at the specific time points 
mentioned above. 3 sections of the center of the eye from 9 eyes (n=27) from embryos 
exposed to each one of the four conditions (2dpf cugbp1-MO vs. 2dpf cugbp1-MM and 3dpf 
cugbp1-MO vs. 3dpf cugbp1-MM) were used. Total BrdU positive cells from each eye lens 
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section were counted. Statistical significance was determined using a two-parametric unpaired 
t-test (Graphpad Prism Program) with all the counts performed.  
 
4.3.5 Aquaporin0 (Aqp0) immunohistochemistry on transverse cryosections from 
embryonic eyes of previously injected cugbp1-MO and cugbp1-MM embryos 
 
To detect if cugbp1 down regulation affects lens fiber early differentiation, an Aqp0 
detection assay was performed on cugbp1-MM and cugbp1-MO embryos. 2, 3 and 4dpf 
cugbp1-MO and cugbp1-MM injected embryos were euthanized. Fixation, cryosectioning and 
immunohistochemistry were performed as Uribe and Gross (2007; Annex 7). The anti-
aquaporin0 (1:500; Chemicon, ab3071) antibody was used to mark Aqp0 in the lens, which is 
a membrane-localized protein expressed early during differentiation of primary and secondary 
lens fibers (Varadaraj et al. 2007). 
 
4.3.6 F-actin staining on transverse cryosections from embryonic eyes of 
previously injected cugbp1-MO and cugbp1-MM embryos 
 
F-actin plays an important role in fiber cell elongation and migration (Rao and 
Maddala 2006). Moreover, it is involved in maintaining the hexagonal geometry of lens fibers 
(Nowak et al. 2009). Hence, F-actin staining was assessed in lens fibers during cugbp1 down 
regulation to observe if Cugbp1 protein has an important role in F-actin distribution and/ or 
arrangement at these lens cells. And thus, has a function in the development or in maintaining 
lens fibers shape. 
First, 4dpf cugbp1-MO and cugbp1-MM injected embryos were euthanized. Fixation 
and cryosectioning were performed according to Uribe and Gross (2007; Annex 7). For F-
actin staining, the area of interest in each slide was circled with hydrophobic PAP pen to form 
a well. Slides were rehydrated in PBTD at room temperature for 2-3min in Coplin Jar. Slides 
were removed from PBTD. Any excess of PBTD was removed and slides were placed in a 
humid chamber. Staining solution (Alexa-488 Phalloidin; 1:50; Molecular Probes) was added 
to the wells in the slides. Humid chamber was closed, a foil cover was added and they were 
incubated overnight at 4°C. Then, staining solution was eliminated by rinsing slides with 
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PBTD 3 times, 10min each time. Then, slides were treated as described in Uribe and Gross 
(2007; Annex 7) from step 21 and afterwards. 
 
4.3.7 Nuclei staining on transverse cryosections from embryonic eyes of 
previously injected cugbp1-MO and cugbp1-MM embryos 
  
An assay to detect nuclei in the lens was performed on MOs to determine if Cugbp1 is 
required for lens fiber maturation. This was done because organelle degradation, including 
nuclei is a late event during fibers differentiation (Weber and Menko 2006a).  
4 and 5dpf injected MOs were euthanized. Fixation and cryosectioning were performed 
as described in Uribe and Gross (2007; Annex 7). For nuclei staining, the area of interest in 
each slide was circled with hydrophobic PAP pen to form a well in the slide. Slides were 
rehydrated in PBTD at room temperature for 2-3min in Coplin Jar. Afterwards, the PBTD was 
removed from the slides. Any excess of PBTD was eliminated and slides were placed in a 
humid chamber. Nuclei staining solution (SytoxGreen; 1:1000; Molecular probes) was added 
to the wells in the slides. The humid chamber was closed, a foil cover was added and the slides 
were incubated overnight at 4°C. Then, staining solution was eliminated by rinsing slides with 
PBTD 3 times, 10min each time. Subsequently, slides were treated as described in Uribe and 
Gross (2007; Annex 7) from step 21 and afterwards. 
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Chapter 5. Results  
 
To estimate what cell types are present at the places where cugbp1 mRNA is expressed 
or at the regions where activity driven by the identified cugbp1 promoter takes place, Greiling 
and Clark (2009) assay of early embryonic lens development in zebrafish was used as a fate 
map. The latter work mentioned above was used as the primary reference for cellular 
localizations at all-time points tested in the present paper. And also as a guide for lens mass 
normal overall shape and development. Hence, mentioning the reference would be omitted 
from the Results (Chapter 5). 
 
5.1 RNA in situ hybridization with digoxigenin-labeled probe 
 
5.1.1 cugbp1 cDNA sequencing and protein sequence alignment 
 
The sequencing results from CS10R-cugbp1 plasmid showed that the cugbp1 cDNA 
has a length of 1494bp (Annex 3, Probe). The corresponding protein sequence has 497 amino 
acids (aa; Fig 5.1.1 A, PROBE; Annex 4). When this protein sequence was aligned with the 
501aa zebrafish Cugbp1 sequence previously reported by Suzuki et al. (2000), the 497aa 
sequence seemed to be almost identical to the 501aa sequence. The only difference was that 
the sequence identified in this study lacked 4aa (Fig 5.1.1 A) which corresponded to 231-
234aa of the Suzuki et al. (2000) protein sequence. This variation extends from 22103 to 
22114bp (location: +22103 to +22114) downstream from the transcription initiation site (+1) 
of the DNA sequence from Suzuki et al. (2000) protein. More specifically, the DNA sequence 
variation present in Suzuki et al. (2000), but absent in the sequencing results of the present 
study was located from the 4-15bp (5´-3´ direction) of exon10 of the formerly identified 
sequence. The DNA difference (12bp in tandem) that leads to the protein dissimilarity is 
shown in Figure 5.1.1 B (complete cDNA sequences are shown in Annex 3).  
 
5.1.2 In situ hybridization to detect mRNA expression 
 
At 1dpf, cells in the posterior-middle of the developing lens continue to enlarge and 
take a rounded shape forming a nuclear center. Around  this  core  region  primary  lens  fibers  
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Relevant difference between DNA sequences 
Probe sequence lacks 12bp 
Probe protein sequence is 
missing 4aa 
Length of protein 
sequences 
____________________________________________________________________________ 
A 
 
PROBE           MNGSLDHPDQPDIDSIKMFVGQIPRTWSEDQLRELFEPYGAVYEINVLRDRSQNPPQSKG 60 
DDBJ            MNGSLDHPDQPDIDSIKMFVGQIPRTWSEDQLRELFEPYGAVYEINVLRDRSQNPPQSKG 60 
                ************************************************************ 
 
PROBE           CCFVTYYTRKSALEAQNALHNMKILPGMHHPIQMKPADSEKNNAVEDRKLFVGMISKKCN 120 
DDBJ            CCFVTYYTRKSALEAQNALHNMKILPGMHHPIQMKPADSEKNNAVEDRKLFVGMISKKCN 120 
                ************************************************************ 
 
PROBE           ENDIRLMFSPYGQIEECRILRGPDGLSRGCAFVTFTARQMAQSAIKSMHQSQTMEGCSSP 180 
DDBJ            ENDIRLMFSPYGQIEECRILRGPDGLSRGCAFVTFTARQMAQSAIKSMHQSQTMEGCSSP 180 
                ************************************************************ 
 
 
PROBE           IVVKFADTQKDKEQKRIAQQLQQQMQQLNAASMWGNLTGLNSLGPQYLAL----LQQSAS 236 
DDBJ            IVVKFADTQKDKEQKRIAQQLQQQMQQLNAASMWGNLTGLNSLGPQYLALYLQLLQQSAS 240 
                **************************************************    ****** 
 
 
 
 
PROBE           SGNALNNLHPMSGLNAMQNLAALAAAASATQATPTGSSALTTSSSPLSVLTSSGTPSGQP 296 
DDBJ            SGNALNNLHPMSGLNAMQNLAALAAAASATQATPTGSSALTTSSSPLSVLTSSGTPSGQP 300 
                ************************************************************ 
 
PROBE           AQSAWDAYKAGSSPTSSTSSSVNPMASLGALQSLAAGAGAGLNMSSLASMAALNGGLGSG 356 
DDBJ            AQSAWDAYKAGSSPTSSTSSSVNPMASLGALQSLAAGAGAGLNMSSLASMAALNGGLGSG 360 
                ************************************************************ 
 
PROBE           GLSNGSGSTMEALTQAAYSGIQQYAAAALPSLYSQSLLSQQNVSAAGSQKEGPEGANLFI 416 
DDBJ            GLSNGSGSTMEALTQAAYSGIQQYAAAALPSLYSQSLLSQQNVSAAGSQKEGPEGANLFI 420 
                ************************************************************ 
 
 
PROBE           YHLPQEFGDQDLLQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSSQAAIQSMNGF 476 
DDBJ            YHLPQEFGDQDLLQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSSQAAIQSMNGF 480 
                ************************************************************ 
 
PROBE           QIGMKRLKVQLKRSKNDSKPY 497aa 
DDBJ            QIGMKRLKVQLKRSKNDSKPY 501aa 
                ********************* 
 
B 
 
Probe           AACTCACTGGGCCCACAGTACCTTGCACTT------------CTACAGCAGTCTGCTTCC 708 
DDBJ            AACTCACTGGGCCCACAGTACCTTGCACTTTATTTGCAGCTTCTACAGCAGTCTGCTTCC 720 
                ******************************            ****************** 
 
 
____________________________________________________________________________ 
 
Figure 5.1.1  Amino acid sequence alignment of cugbp1 cDNA with previously reported cugbp1 sequence 
DDBJ AB032726. A: PROBE is the protein sequence based on cDNA sequencing results from the previously 
cloned D4 cugbp1 CS10R plasmid. DDBJ is the sequence previously reported by Suzuki et al. (2000). PROBE 
protein sequence is missing 4aa that are present at the linker region of DDBJ protein. Blue shades represent the 
RRMs (RNA-recognition motifs). Gray shades represent the RNPs within the RRMs. B: The nucleotide 
differences (12bp absent in Probe cDNA) that result in protein dissimilarities are shown. Complete cDNA 
sequences are shown in Annex 3.   
Linker region 
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elongate. Hence, layers of primary lens fibers surround the developing nucleus. In accordance 
with transverse sections (Fig 5.1.2a) of embryos submitted to in situ hybridization assay, these 
are the places where cugbp1 mRNA expression appeared to be at 1dpf (Fig 5.1.2b A, B). 
Expression appeared more intense at the posterior-middle core region. The anterior region of 
the developing lens did not show cugbp1 mRNA expression during this time point.  
____________________________________________________________________________ 
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Figure 5.1.2a  Diagram representing a transverse section of the zebrafish lens. All transverse sections 
presented in Figures 5.1.2b, 5.2.2a, 5.2.2b, 5.3.3, 5.3.4, 5.3.5, 5.3.6 are in the same orientation. 
 
By 2dpf, cugbp1 mRNA expression was observed at both transition regions of the lens 
(Fig 5.1.2b C, D); place where epithelial cells have withdrawn from the cell cycle and start to 
differentiate into secondary lens fibers. Expression at the middle part of the lens was no longer 
observed. At the anterior border of the lens, where cells remain as epithelium, there was no 
detectable expression.   
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Figure 5.1.2b  Transverse sections of zebrafish eyes show expression of cugbp1 mRNA in the lens by in situ 
hybridization assay. A, B: At 1 day post fertilization (dpf) expression is shown at the posterior-middle, 
posterior-lateral and posterior regions of the lens. The former is constituted of cells that have a rounded shape 
forming a center. The last two areas are composed of primary lens fibers that surround the center. C, D: By 2dpf, 
expression was seen at both transition regions of the lens. E, F: 3dpf transverse sections showed expression at the 
posterior-middle and posterior borders of the lens, regions where secondary newly and still differentiating lens 
fibers are. G, H: Expression at the posterior border of the lens is still visible at 4dpf. 
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At 3dpf, expression of cugbp1 mRNA appeared to be more intense at the posterior 
border of the lens (Fig 5.1.2b E, F). This region is where newly formed lens fibers are 
differentiating and the tips of this outer newly formed lens fibers from both differentiating 
zones meet at the posterior suture. A little bit less intense but still very obvious cugbp1 mRNA 
expression was present at the posterior-lateral border regions which include both of the 
transition zones (TZs) of the lens (Fig 5.1.2b E, F). These TZs are located more posteriorly in 
zebrafish as compared to mammals.  
cugbp1 mRNA expression, at 4dpf, was still present at newly differentiating lens fibers 
at the posterior border of the lens (Fig 5.1.2b G, H). However this expression seemed to be 
less intense compared to the expression seen at 3dpf (Fig 5.1.2b E, F).     
 
5.2 cugbp1 promoter activity in microinjected and transgenic zebrafish embryos 
 
5.2.1 Identification of the location of the cugbp1 promoter region in the zebrafish 
genome 
 
A 1.2kb cugbp1 promoter fragment with high lens specificity was identified in 
zebrafish (Fig 5.2.1 A). This promoter is localized within the leader sequence (5'UTR) of the 
cugbp1 gene and extends from 9 808 to 10 959bp (from +9 808 to +10959) downstream the 
transcription initiation site (+1). Its length is of 1152bp according to the Ensemble genome 
sequence (ID: ENSDARG00000005315). In the 5' to 3' direction, the identified promoter 
begins 85bp downstream of exon3 start site (including its last 39bp) and also contains the first 
1113bp of intron3 (Annex 8). To avoid any confusion, it is important to clarify that the start 
codon (ATG) of the zebrafish cugbp1 gene is located at exon4.  
 
 5.2.2 EGFP expression driven by a 1.2kb cugbp1 promoter region 
 
High lens specificity was demonstrated by observing EGFP expression in the lens from 
1dpf and onwards in embryos injected with either the nuclear (Fig 5.2.1 B) or membrane (Fig 
5.2.1 C) localized EGFP constructs.  
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Figure 5.2.1  EGFP expression driven by a 1.2kb cugbp1 promoter in F0 zebrafish embryos. F0 embryos 
were microinjected at the one-cell stage with 25pg of transposase mRNA and 25pg of cugbp1:pME-nlsEGFP-
polyA (nuclear-localized EGFP) or cugbp1:pME-EGFPCAAX-polyA (membrane-localized EGFP) DNA. A: 
Schematic diagram of plasmid constructs that contain a zebrafish 1.2kb cugbp1 promoter fragment fused to the 
membrane-localized or nuclear localized EGFP. The cugbp1 gene representation (not drawn to scale) shows the 
location of the 1.2kb fragment in the zebrafish genome. B: Zebrafish embryos at 1, 2, 3 and 4dpf showing 
nuclear-localized EGFP expression. C: Zebrafish embryos at 1, 2, 3, 4 and 6dpf showing membrane-localized 
EGFP expression. Both constructs reveal expression in the lens. 
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Figure 5.2.2a  Transverse sections at the eye region from zebrafish F1
 
stable transgenic line embryos 
carrying the 1.2kb cugbp1:pME-nlsEGFP-polyA transgene. The cugbp1 promoter fragment possesses high 
lens specificity. 
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Figure 5.2.2b  Transverse sections at the eye region from zebrafish F1 stable transgenic line embryos 
carrying the 1.2kb cugbp1:pME-EGFPCAAX-polyA transgene. The cugbp1 promoter fragment possesses 
high lens specificity. 
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Transverse sections of the center of the eye from transgenic embryos (F1) showed 
EGFP expression within the lens. Both the nuclear (Fig 5.2.2a) and membrane-localized (Fig 
5.2.2b) EGFP expression driven by the 1.2kb cugbp1 promoter was detected in a more general 
pattern inside the lens compared to the results obtained by the in situ hybridization assays (Fig 
5.1.2b). 
At 1, 2 and 3dpf, transverse sections of both transgenic lines showed strong expression 
at the posterior and posterior-middle regions of the lens (Fig 5.2.2a A-C; Fig 5.2.2b A-C) 
correlating with the results obtained in the in situ hybridization assay. Both nuclear or 
membrane localized transgenic embryos also displayed expression at the anterior region of the 
lens during these time points. At 4dpf, nuclear-localized EGFP embryos showed intense 
expression at the posterior border of the lens (Fig 5.2.2a D). High levels of EGFP seemed to 
be still present in the lens fibers at the middle-posterior and middle-anterior regions of the lens 
mass in the membrane localized EGFP transgenic embryos at 4dpf and 6dpf (Fig 5-2.2b D, E). 
At 4dpf, less intense expression of mem-EGFP was visualized at the posterior and lateral 
borders of the lens. However, at 6dpf mem-EGFP was not detected at these borders of the 
lens. 
 
5.3 cugbp1 down regulation by splice-altering morpholino injections in zebrafish 
embryos 
 
5.3.1 Splice-altering morpholino activity tested by RT-PCR 
 
The cugbp1-MO binds to the splice junction of exon5/intron5 (Fig 5.3.1 A; Annex 9 
A) to disrupt correct splicing of cugbp1 pre-mRNA. RT-PCR results showed that cugbp1-MO 
injected embryos (“morphants”) possessed altered splicing by showing a 227bp band (Fig 
5.3.1 B; Annex 9, A) in agarose gel. cugbp1-MM embryos (“controls”) exhibited a 310bp 
band (Fig 5.3.1 B; Annex 9, B) and no 227bp PCR product. Splice-altering activity was not 
100% efficient since morphant samples also possessed the 310bp band. More specifically, the 
310bp band corresponds to 178bp of exon4 downstream and beginning with the ATG start 
codon, exon5 (83bp) and exon6 (49bp; Fig 5.3.1 C; Annex 9). The latter represents unaltered 
splicing. The 227bp band corresponds to a removal of exon5 (310 ̶ 83=227bp; Fig 5.3.1 C; 
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Annex 9). Exon5 exclusion at cugbp1-MO injected embryos was further confirmed after 
sequencing each purified band (Fig 5.3.1 D). Exon5 is located from +14 098 to +14 180bp.  
 
5.3.2 Morphant vs. control embryos phenotype and behavior 
 
cugbp1-MO embryos exhibited less body movement when compared with controls. 
Most morphants were not able to get out of their chorions (normally realized at the 2-3dpf 
stage) by their own. By 2dpf, it was obvious that morphants exhibited a delayed phenotype by 
having less pigmentation (2dpf MO embryos had a pigmentation pattern as if they were 1dpf), 
being of smaller size and having bigger yolks due to its lower consumption compared with 
cugbp1-MM embryos. 4dpf cugbp1-MO embryos exhibited smaller bodies, enlarged hearts, 
had smaller eyes (microphthalmia) and possessed an evident cataract phenotype when 
compared with cugbp1-MM embryos (Fig 5.3.1 E). Morphants were very still in contrast with 
cugbp1-MM embryos which swam and were in constant movement as uninjected littermates.     
 
5.3.3 Cell proliferation analysis by BrdU incorporation assay in lens cells after 
cugbp1 down regulation 
 
At 24 to 26hpf (Fig 5.3.3 A; Annex 10), cugbp1-MM lens contained an average total 
number of 8.037 ± 0.5188 BrdU+ cells, and cugbp1-MO possessed a 7.963 ± 0.4117 value 
(P=0.9114). At 72 to 74hpf (Fig 5.3.3 B; Annex 10), cugbp1-MM lens had a par of 9.222 ± 
0.6047 BrdU+ total cells and cugbp1-MO possessed a mean of 8.111 ± 0.3711 BrdU+ cells 
(P=0.1234). There were no statistical differences in the total number of BrdU+ cells between 
cugbp1-MO vs. cugbp1-MM embryos at both time periods analyzed (Fig 5.3.3 C). Hence, 
morphants epithelial lens cells retain their ability to proliferate at the same rate as epithelial 
cells of control embryos do, despite cugbp1 down regulation.  
 
5.3.4 Expression of lens fiber membrane protein Aquaporin0 as a marker of early 
fiber differentiation after cugbp1 down regulation 
 
At all-time points tested (2, 3 and 4dpf) detectable levels of Aqp0 protein were present 
in cugbp1-MM as well as in cugbp1-MO embryos lenses (Fig 5.3.4 A-F). Demarcation of lens 
fiber  membranes by  Aqp0  immunology  assay showed a considerable difference in size and  
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Figure 5.3.1  Knock down of cugbp1 function in zebrafish embryonic development by splice-altering 
morpholino results in a cataract phenotype and other features that resemble DM1 disease. A: Ensembl 
diagram (ENSDARP00000026582) of cugbp1 gene showing the region where the splice-altering morpholino 
binds to cugbp1 pre-mRNA (exon5/intron5). B: RT-PCR results from cugbp1-MO and cugbp1-MM embryos 
show splice-altering activity in cugbp1-MO samples evidenced by a 227bp band (DNA ladder was superimposed 
on agarose gel photo). C: Schematic representation (not drawn to scale) of altered splicing vs. normal splicing 
and its corresponding RT-PCR results. The 310bp band corresponds to 178bp of exon4, 83bp of exon5 and 49bp 
of exon6. The 227bp band is present due to a removal of 83bp from exon5 D: Automatic sequencing results of 
each purified band exhibit removal of exon5 from the 227bp band detected only on the cugbp1-MO RT-PCR 
products. E: Lateral view of 4dpf cugbp1-MO and cugbp1-MM embryos. Whereas cugbp1-MM embryos 
displayed normal early development, cugbp1-MO embryos showed a defective phenotype which included 
opacification of the lens. 
 
shape of the lens fiber mass of cugbp1-MM vs. cugbp1-MO embryos. At 2dpf, MM lenses 
seemed spherical along the equator and lentoid along the anterior to posterior region (Fig 5.3.4 
A). Whereas, 2dpf MO lenses appeared to have an oval shape with an equatorial diameter that 
seemed longer than the anterior to posterior diameter and a squeezed-like phenotype at both 
equatorial regions of the lens (Fig 5.3.4 B). By 3dpf, MM lens mass seemed to have a 
spherical form in all dimensions (Fig 5.3.4 C). But, 3dpf MO lens mass appeared to retain the 
oval shape with the squeezed-like phenotype at the equatorial regions (Fig 5.3.4 D). The 4dpf 
MM injected embryos exhibited a lens mass form that looked as a larger and still spherical 
version of the 3dpf lenses (Fig 5.3.4 E). However, 4dpf MO lenses still retain the squeezed 
phenotype at both equatorial zones (Fig 5.3.4 F). Mismatch morpholino injected embryos 
possessed a lens overall shape that appeared to be as expected in normal development during 
all periods of time analyzed. Nevertheless, this was not the case for embryos submitted to 
cugbp1 down regulation as early as the 1-4 cell stage.  
Moreover, 2 and 3dpf cugbp1-MO embryos showed obvious Aqp0 protein presence in 
the lens nucleus, place where primary fibers reside. Aqp0 expression was also observed in the 
secondary fibers immediately surrounding the lens primary fibers (Fig 5.3.4 B, D). However, 
in cugbp1-MM embryos, Aqp0 expression in the center of the lens could not be detected (Fig 
5.3.4 A, C). At the outer-most lens fibers, Aqp0 protein was observed in morphants (MO) as 
well as in controls (MM) in all times tested.  
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Figure 5.3.3  BrdU incorporation assay at 24-26 or 72-74hpf showed that there were no differences in the 
total number of proliferative cells in the lens between cugbp1-MO and cugbp1-MM embryos. A: 2dpf 
control embryos and morphants show proliferative cells in the lens. B: 3dpf control embryos and morphants show 
proliferative cells in the lens C: Chart showing the number of BrdU+ cells in each condition (n = 27; p < 0.05). 
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Figure 5.3.4  Lens fibers express differentiation marker Aqp0 in cugbp1-MO embryos. A,C,E: 2, 3 and 4dpf 
lens sections from control embryos, respectively. B,D,F: 2, 3, and 4dpf lens sections from morphants. All 
conditions tested showed Aqp0 expression. In addition, cugbp1-MO embryos have smaller lenses and abnormal 
lens shape. 
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5.3.5 F-actin organization in the lens after knocking down cugbp1 expression 
 
Since Aqp0 protein detection assay demonstrated that the initiation of fiber cell 
differentiation happened, but lens overall form is affected due to down regulation of cugbp1 
expression, an F-actin marker was used to longer examine lens fiber morphology. Lens fibers 
from 4dpf cugbp1-MM embryos displayed normal F-actin organization. This was shown as a 
ring-like structure with concentric thin rings or layers surrounding the center of the lens (Fig 
5.3.5 A). This ring-like F-actin staining pattern was present at the region of the lens where 
newly formed secondary lens fibers are being constantly added and subsequently displaced 
inward for younger fiber cells to be at the periphery. No F-actin staining was visible at the lens 
nucleus, probably because this region has very compacted primary and surrounding secondary 
lens fibers. An evident posterior lens suture (Fig 5.3.5 A, cyan arrows) was observed in 
cugbp1-MM embryos, but an anterior lens suture was still not apparent.  
In contrast, 4dpf cugbp1-MO embryos seem to have a diverse defective phenotype. A 
medium flawed phenotype (Fig 5.3.5 B) showed smaller lenses as observed before (Fig 5.3.4 
F). The innermost region of the lens was not stained, although this area was not as big as the 
stained-free region observed in MM embryos. F-actin arrangement showed that lens fibers 
appear as concentric rings of outer fibers surrounding the rings of inner fibers. A posterior-like 
suture is evident (Fig 5.3.5 B, cyan arrow), but it does not have the same appearance of the 
one seen in controls (Fig 5-3.5 A). A severe phenotype (Fig 5.3.5 C) did not show F-actin 
concentric rings from fibers, rather a disorganized pattern (wave-like) of actin filaments was 
present. There was no evidence of a posterior suture in this severe phenotype (Fig 5.3.5 C). 
 
5.3.6 Lens fiber nuclei degradation in cugbp1-MM vs. cugbp1-MO embryos 
 
4 and 5dpf cugbp1-MM embryos (Fig 5.3.6 A, B) had rounded shape lens morphology 
and lens fiber nuclei appeared to be localized at the lateral-posterior (including the TZ) and 
very posterior borders of the fiber lens mass. No lens fiber nuclei were detected at the anterior, 
posterior-middle or the core of the lens mass at both periods of time.  
Differently, 4 and 5dpf cugbp1-MO embryos (Fig 5.3.6 C, D) further exhibited a 
cataract  phenotype, due to retained  nuclei  obstructing the light  path.  Morphant lenses were  
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Figure 5.3.5  F-actin organization in the lens mass shows differences between cugbp1-MO and cugbp1-MM 
embryos. A: 4dpf cugbp1-MM embryos lenses exhibit a ring-like structure where concentric rings of outer fibers 
are surrounding the rings of inner fibers. No staining is visible at the lens nucleus. A posterior lens suture is 
evident (cyan arrows). B, C: 4dpf cugbp1-MO embryos exhibit a diverse defective phenotype. B: A medium 
flawed phenotype shows a smaller lens with a concentric ring-like structure. A posterior-like suture is visible 
(cyan arrow), but it does not look like the suture observed in A. C: Severe lens morphology exhibits a completely 
disorganized cortical microfilament organization at the lens fibers and no posterior lens suture at all. 
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Figure 5.3.6  Nuclei staining (Sytox Green) exhibits a flawed lens fiber late differentiation after knocking 
down cugbp1 expression. A,B: 4dpf and 5dpf cugbp1-MM embryos lens. At both time points embryos exhibit 
round shape lenses with lens fiber nuclei only at the posterior and lateral-posterior borders of the lens mass. C,D: 
4dpf and 5dpf cugbp1-MO embryos lens. At both periods of time embryos exhibit a cataract phenotype with 
smaller, not rounded-shape lenses and fibers that still retain their nuclei in the center and the posterior-middle 
regions of the lens mass.   
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smaller than control lenses and their overall shape was not spherical, as evidenced before (Fig 
5.3.4; Fig 5.3.5). These abnormal lenses had a squeezed-like phenotype still evident at 5dpf. 
During both time points, nuclei were still visible in the central and posterior-middle regions of 
the lens mass demonstrating flawed fiber late differentiation at these regions of the lens. 
Moreover, lens fiber nuclei signals at the posterior and posterior-lateral fibers observed 
in transverse sections from controls looked elongated and they seemed to become thinner 
before disappearing in an outer to inner direction. Elongated nuclei positions appeared as 
concentric rings and/or dashed lines at the posterior and posterior-lateral borders (Fig 5.3.6 A, 
B). On the other hand, 4dpf cugbp1-MO lenses (Fig 5.3.6 C) had spherical nuclei in the central 
region where primary lens fibers reside. Ovoid-like shape or irregular-shaped nuclei were also 
present at the center and middle-posterior regions of the lens, but in both cases they did not 
look as elongated as in control lenses. 5dpf morphant lenses (Fig 5.3.6 D) also exhibited nuclei 
that were not as elongated as in control lenses. They exhibited ovoid-like or irregularly shaped 
nuclei; however the center of the lens had fewer nuclei signals compared to 4dpf morphant 
lenses (Fig 5.3.6 C).      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 84 
Chapter 6. Discussion and Conclusions     
 
6.1 cugbp1 expression on zebrafish early lens development 
 
 6.1.1 cugbp1 cDNA sequencing and protein sequence alignment 
  
The 497aa protein sequence identified in the present study contained the same three 
RNA-recognition motifs (RRMs; Fig 5.1.1 A, blue shade) with their corresponding RNP2 
(hexamer) and RNP1 (octamer) motifs (Fig 5.1.1 A, gray shade) as the previously reported 
Cugbp1 protein of 501aa from zebrafish (Suzuki et al. 2000). Two RRMs are at the N-
terminal region and a third one in the C-terminal site. The linker region corresponds to the 
whole sequence between the second and third RRMs (Barreau et al. 2006). The only 
difference between the 497aa and 501aa sequences (lack of four in tandem amino acids) 
appeared to be within this linker region (Fig 5.1.1 A). The sequence conservation of this linker 
region between the members of the CELF protein family (including CUGBP1) is much lower 
in comparison with the RRMs. In fact, there is no significant conservation of sequence identity 
for this region between some CELF proteins (Barreau et al. 2006). BLAST searches have 
revealed that these linker regions are unique divergent domains in each CELF protein. No 
known predicted secondary structures have been identified within this domain (Ladd et al. 
2001).      
 
6.1.2 cugbp1 mRNA expression and promoter activity 
  
Zebrafish cugbp1 mRNA specific and strong expression in the lens was previously 
identified as early as 24hpf and embryo sectioning proved it was abundant in lens fiber cells 
(Suzuki et al. 2000) supporting the results of the present study (Fig 5.1.2b A, B). At 24hpf, the 
current study revealed that expression of cugbp1 mRNA was more intense at the posterior-
middle region of the lens, place where rounded cells form a nuclear organizing center 
(Greiling and Clark 2009). All the cells in this nuclear center are considered part of the lens 
primary fiber cell mass (Greiling et al. 2010). There was also mRNA expression at the lateral-
posterior and posterior borders, regions of the lens where still elongating lens fibers are 
surrounding the nuclear center (Greiling and Clark 2009), but this expression was less strong 
than the expression seen at the posterior-middle region of the lens.  
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At 24hpf, there was no detectable mRNA expression at the anterior and anterior-
middle regions and borders of the lens; areas where the cells within it are destined to organize 
into a single layer of lens epithelium (Soules and Link 2005; Greiling and Clark 2009; 
Greiling et al. 2010). In contrast, Suzuki et al. (2000) exhibited strong expression at the 
anterior-middle region of the lens at the same time point. This difference might have happened 
because it is common that different zebrafish embryos develop at slightly different rates and 
this happens even within a single clutch (Kimmel et al. 1995). Hence, the anterior-middle 
region from embryo lenses, in the present results, might have been composed of still 
disorganized and undifferentiated cells that have not yet migrated to the anterior and anterior-
lateral borders of the lens to constitute the lens epithelium. Differently, in Suzuki et al. (2000) 
24hpf embryo lenses, the cells destined to become epithelium may have already migrated to 
the anterior and anterior middle borders of the lens epithelium. Then, the anterior-middle 
region might have been already comprised of differentiating lens fibers as how this region is 
supposed to be formed of at slightly later moments in development (Greiling and Clark 2009) 
in comparison with the present data. In fact, in Suzuki et al. (2000) results, the 24hpf lens 
section looks slightly more developed and bigger than the lens seen in the present results.  
The detection of mRNA expression at specific patterns allows the visualization of the 
expression of a determined gene at the transcriptional level. But if the gene encodes a protein 
product, it is important to detect the protein location as some proteins are made at one type of 
cell, and then migrate to other tissues where they perform their function. Moreover, the 
mRNA of a specific protein can be degraded and no longer synthesized at a certain time point; 
whereas the protein can remain in the cells where it was previously produced to perform its 
function(s) (Alberts et al. 2008). Due to technical difficulties it was not possible to detect 
Cugbp1 protein expression by performing an immunohistochemistry assay on lens transverse 
sections, specifically with anti-CUGBP1 (sc-21076, Santa Cruz Biotech) antibody. 
Hence, two zebrafish lines were created with a transgene composed of membrane or 
nuclear localized EGFP (as a reporter gene) driven by a 1.2kb cugbp1 potential promoter 
fragment. The purpose of this was to estimate the pattern of Cugbp1 protein expression in wild 
type zebrafish embryos due to the activity of the specific promoter fragment on the expression 
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of EGFP in transgenic embryos. Whole mount embryos showed that the promoter fragment 
had high lens specificity in both transgenic lines (Fig 5.2.1 B, C).  
At 24hpf and onwards, EGFP showed to be strongly expressed at the lens (Fig 5.2.1). 
In addition, it is important to mention that even though all embryos that expressed EGFP 
showed strong signals at the lens, some few F0 embryos also exhibited EGFP expression at the 
head and/or at diverse middle and posterior parts of their bodies. These posterior or middle 
regions constitute the places where the somites are. These expression patterns were seen 
sporadically, in small regions and not in all somites nor at the whole head at the same time.  
Hashimoto et al. (2006) have previously reported Cugbp1 protein expression on whole 
mount zebrafish embryos by immunohistochemistry and Western Blot assays; hence 
supporting the latter results of the present work. A broader Cugbp1 protein expression pattern 
in their whole mount embryos was observed compared to the embryos from both transgenic 
lines in this study. Hashimoto et al. (2006), reported protein expression distributed all over the 
embryo (but not the yolk) from the 1-cell stage to 28hpf, including the head and somites. 
Indeed, by 28hpf their results showed expression throughout the whole embryo and stronger 
signals were seen in the lens and somites. These two regions of higher levels of expression 
correlate with EGFP expression in the transgenic embryos developed in these work. Since 
every transient (F0) and stable (F1) transgenic embryo showed EGFP in the lens, it can be 
concluded that the promoter identified has high lens specificity. The differences observed 
might be because the 1.2kb cugbp1 promoter fragment lacks the sequence portion or portions 
that contribute to the expression in the whole embryo at early stages of developmental activity. 
The broad expression promoter and/or enhancer sequence(s) may also be present as separate 
units and not in tandem from the 1.2kb fragment. But, the promoter identified might also 
contain a small portion of the sequence(s) that direct expression in somites and in the head; 
this would explain why the EGFP is detected not very often and in small different regions of 
the head and somites in a few transient transgenics.  
Transverse sections from 24hpf transgenic embryos (Fig 5.2.2a A; Fig 5.2.2b A) 
showed a similar pattern of expression as the in situ hybridization results (Fig 5.1.2b A, B). 
Intense expression was seen at the nuclear center of the lens mass in both transgenic lines and 
less concentrated EGFP in the surrounding primary lens fibers as in mRNA expression assay. 
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The anterior-middle regions of the lens showed more expression of EGFP than the mRNA 
expression results. This might have been because of the same reasons mentioned above that 
explained the differences between the in situ data from the present study and the Suzuki et al. 
(2000) results. The anterior-middle region in the lens from the transgenic embryos might have 
differentiating lens fibers. Whereas, the anterior-middle region at 24hpf lenses from the 
mRNA expression assay are probably comprised of undifferentiated cells that will migrate and 
give rise to lens epithelial cells.  
By 2dpf, cugbp1 mRNA seemed to be localized only at both bow regions of the lens 
(Fig 5.1.2b C, D), zones that are located more posteriorly in comparison to the transition 
regions in mammalian lenses (Soules and Link 2005). So, it seemed that mRNA is being 
synthesized at cells that are in a conversion moment in which they are in their first moments of 
differentiating from epithelial cells to secondary lens fibers. Since both transgenic lines 
demonstrated intense EGFP expression at these same transition positions of the lens at 2dpf 
(Fig 5.2.2a B; Fig 5.2.2b B), translation of cugbp1 most probably happens quickly and early in 
differentiation as soon as cugbp1 mature mRNA is synthesized. It is possible that Cugbp1 
might be needed for the proper differentiation of lens fibers by playing a post-transcriptional 
regulatory role. The latter since Cugbp1 is well known as an mRNA binding protein that 
regulates gene expression at the post-transcriptional level (Barreau et al. 2006) and dramatic 
changes in gene expression happen early in fibergenesis (Weber and Menko 2006a). In 
addition, Cugbp1 protein may contribute to the correct morphology of lens fibers, at least at 
very early lens development, as cell shape changes happen early during differentiation (Weber 
and Menko 2006a; Varadaraj et al. 2007). Hence, playing a role in lens overall shape and 
function as fiber cells proper formation and migration are key determinants of the lens 
structure as a whole (Rao and Maddala 2006). 
2dpf transgenic fish also showed strong EGFP expression at the most posterior region 
of the lens. In this region, newly synthesized fibers had elongated and form contacts with their 
counterparts from the opposite side of the lens (Rao and Maddala 2006; Greiling and Clark 
2009). This EGFP might have been translated when the fibers were starting to change in 
morphology at the transition regions of the lens because no mRNA was seen at the most 
posterior border of the lens at 2dpf. Most probably, during this time point, most of the cugbp1 
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mRNA had already been translated or degraded before it could reach a posterior-most location 
as the fibers elongated.   
At 3dpf, cugbp1 transcript expression was present at both transition zones of the lens 
(Fig 5.1.2b E, F) as in 2dpf. Hence, at 3dpf, cugbp1 mRNA is also present where future fiber 
cells are in their transitional moment from epithelial to lens fibers. In addition, the strongest 
mRNA expression was present at the most posterior border of the lens. This intense mRNA 
expression, at 3dpf might be from mRNA that was previously synthesized when the cells that 
contain it were in earlier stages of differentiation and still at one of the bow regions. At least 
some of that very-posterior located mRNA might still be quickly translated, since the 
translation machinery is still functional in cortical differentiating fibers (Li et al. 2001). 
Otherwise, that mRNA will probably become degraded because as lens fibers mature they loss 
all their compartments and their machinery to perform translation (Bassnet 2009). However, 
the possibility that the mRNA located at the posterior-most lens fibers could have been 
synthesized when the fibers were already located at that region cannot be discarded as these 
fiber cells are not completely differentiated and still contain nuclei. Indeed, cortical lens fibers 
are transcriptionally active until quite late in differentiation. Once nuclear degradation is 
complete, the capacity of transcription is lost (Bassnett 2009).  
4dpf in situ hybridization assay (Fig 5.1.2b G, H) evidenced cugbp1 mRNA expression 
at the posterior border of the lens, region where there are newly formed already elongated and 
still differentiating secondary lens fibers (Greiling and Clark 2009). As mentioned in 3dpf, this 
mRNA might have been synthesized when those cells where at the bow regions of the lens at 
an earlier time point. And at least a part of it is possibly going to be translated before these 
fibers lose their capacity to do so.  
EGFP expression from 1-3dpf (Fig 5.2.2a A-C; Fig 5.2.2b A-C) showed an interesting 
pattern where strong promoter activity seems to be happening in the regions where cells are 
going to become and/or are already turning into lens fibers. Whereas, the 4-6dpf (Fig 5.2.2a D; 
Fig 5.2.2b D, E) pattern looks like most EGFP is at the cells that synthesized it at earlier 
moments of development and when they were still capable of translating mRNA. 3dpf EGFP 
is strongly present at the bow regions of lenses and also at the posterior border and the middle-
posterior zone of the lens. But at 4dpf, membrane-localized EGFP showed that it is more 
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intensively located at more inner fibers of the lens. This EGFP might have been synthesized 
when the fibers where at a more outer position, probably at the posterior-lateral and posterior 
borders of the lens as they were on their differentiation process. Less strong expression at 
outer fibers might have been due to a progressive decrease in the cugbp1 promoter activity at 
posterior moments in development. At 6dpf, membrane-localized EGFP is present at inner 
fibers, but is no longer seen at any border region of the lens, including the bow zone and 
posterior area of the lens. It seems that EGFP expression is located at the fibers that 
synthesized this protein at earlier moments of development, but there is no more EGFP 
synthesis in the younger fibers (outer) or the cells in the transition differentiating state.  
The transgenic promoter fused to EGFP approach gave valuable results. Nevertheless, 
it is important to bear in mind that there might be differences in the moments of expression, 
retention and/or degradation between Cugbp1 zebrafish protein and EGFP. For example, 
EGFP presence in inner fibers that are devoid of organelles may just reflect where Cugbp1 
used to be at earlier moments of development and/or when these cells were at other and/or 
outer positions within the lens mass. The latter could happen because there is not a pathway 
that eliminates EGFP from lens cells as zebrafish do not express EGFP under normal 
conditions. Hence, EGFP presence in inner fibers might not mean that Cugbp1 actually 
remains in these differentiated cells. 
Differences may have also occurred because the promoter fragment might be missing 
other units that could act as repressors or/and enhancers at certain specific moments or places 
during development. There was also EGFP seen at the anterior border of lenses, where 
epithelial cells reside and no cugbp1 mRNA expression was detected. This might have 
happened because there may be a basal level of expression at the epithelial cells as it has been 
mentioned that cugbp1 is expressed ubiquitously at the zebrafish embryo (Hashimoto et al. 
2004; Hashimoto et al. 2006). In normal conditions, Cugbp1 protein might be present at 1dpf 
in the lens epithelium due to synthesize from mRNA transcribed before 1dpf. Or maybe the 
promoter fragment used is missing a repressor region that in normal circumstances suppresses 
cugbp1 expression at 1dpf and/or later moments of development in lens epithelial cells. But, 
since the promoter fragment might lack at least a part of that repressor region, there is 
detectable EGFP in the anterior border of the lens.   
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The pattern of cugbp1 mRNA expression and the cugbp1 promoter fragment activity 
seemed to indicate that, at early development, cugbp1 is expressed at the lens in cells that are 
in their differentiation process to become the mass of the lens (cells in the nuclear central core 
and surrounding lens fibers). Afterwards, cugbp1 is expressed at the first cells that are 
becoming secondary lens fibers (fibers in the bow region). But at posterior moments (~5-6dpf) 
of development it seems that cugbp1 is no longer being expressed at new differentiating fibers. 
If the latter is true, Cugbp1 might no longer be needed for proper morphogenesis of newly 
synthesized secondary lens fibers at further development. Another protein may switch places 
with Cugbp1 to continue performing modified regulatory functions. Actually, a postnatal 
switch has been reported between CUGBP1 and MBNL1 during striated muscle development. 
CUGBP1 is expressed at early embryonic development. Then, as development proceeds 
CUGBP1 is down regulated and MBNL1 is concomitantly up regulated in these tissues. This 
shift reprograms embryonic (by CUGBP1) to postnatal/adult (by MBNL1) alternative splicing 
patterns of other proteins expressed in skeletal and heart tissues (Kalsotra et al. 2008; Cooper 
et al. 2009; Schoser and Timchenko 2010). In fact, it has been observed that adult MBNL1 
knock out mice develop cataracts (Kanadia et al. 2003).  
However, further expression studies should be performed to corroborate if Cugbp1 
protein is no longer expressed in the lens as development proceeds (~5dpf and onwards) 
Moreover, protein detection experiments with an appropriate anti-cugbp1 antibody for 
zebrafish could elucidate the region(s) inside the fiber cells where Cugbp1 is located.  
EGFP expression at transgenic fish was monitored until 9dpf and whole mount fish 
still showed EGFP expression. Although this expression was real, it might not reflect the real 
promoter activity or Cugbp1 spatial and temporal locations. The latter could be because, as 
mentioned before, EGFP might remain in lens cells as there is not a pathway that eliminates 
this protein from zebrafish cells. In conclusion, cugbp1 mRNA and promoter activity have 
been observed in the lens of zebrafish embryos. So, cugbp1 should have a role in lens early 
development. 
Additionally, other distinctions in expression could occur because it is not possible to 
control where the transgene is inserted within the zebrafish genome using this approach. So, 
the transgenes may be inserted in regions with nearby DNA sequences (enhancers, repressors, 
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etc.) that could contribute to dissimilar patterns of expression as compared with the wild type 
location of the zebrafish cugbp1 gene. This could account for differences in expression 
between EGFP and cugbp1 mRNA and also between different transient transgenics and their 
descendants. However, since EGFP expression at the lens was observed at every transient and 
stable transgenic embryo; this shows that cugbp1 promoter truly drives expression in the lens. 
And this expression is not just a consequence of where the transgene was inserted.   
 
6.2 cugbp1 down regulation by splice-altering morpholino injections in zebrafish 
embryos 
 
It is important to clarify that even though knocking down cugbp1 expression by 
morpholino injections was performed at 1-4 cell stage embryos, there might have been 
uninterrupted cugbp1 expression at early embryonic development. The latter because it has 
been shown that Cugbp1 is a maternal factor and cugbp1 mRNA as well as protein expression 
have been found at unfertilized eggs, 1 cell stage embryos and afterwards (Hashimoto et al. 
2004; Hashimoto et al. 2006; Suzuki et al. 2000). Since we utilized a splice-altering 
morpholino, it targets expression at the level of pre-mRNA. Therefore, any cugbp1 mature 
mRNA and Cugbp1 protein already present at the moment of injections or before was 
expected to function normally. 
 
6.2.1 Splice-altering morpholino activity tested by RT-PCR 
 
RT-PCR and sequencing results confirmed that the cugbp1 morpholino altered correct 
splicing by removing exon5 from cugbp1 mature mRNA (Fig 5.3.1). In normal cugbp1 
translation, the amino acid number 60 (Fig 6.2.1 A) corresponds to Glycine (G) and it is 
encoded by the last nucleotide (G) of exon4 and the first (G) and second (T) nucleotides of 
exon5. Since exon5 was removed from cugbp1 mature mRNA of MO injected embryos, a 
frameshift was generated. The first frameshift occurred in the amino acid number 60 (D, 
Aspartic acid; Fig 6.2.1 B) because it was encoded by a nucleotide triplet composed by the last 
nucleotide from exon4 (G) and the first (A) and second (T) nucleotides of exon6, instead of 
exon5. The sequence downstream from this first site (GGT→GAT) was frameshifted as well. 
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Figure 6.2.1  Splice-altering cugbp1 morpholino activity generates a frameshift and a premature stop 
codon by removing exon5. A: Normal cugbp1 translation (Annex3 has the complete translated sequence). 
Amino acid 60 corresponds to glycine (first amino acid shaded in yellow). B: cugbp1-MO caused a frameshift 
(yellow shade) as the MO disrupted exon5 junction between exons4 and 6 during cugbp1 mRNA splicing. In 
addition, a premature stop codon in-frame is generated at amino acid 72 (GCA→TGA=STOP). C: The frameshift 
begins at the first C-terminal RRM of Cugbp1 protein. Figure 5.1.1 indicates the three RRMs. Blue shades 
represent the RRMs (RNA-recognition motifs). Gray shades represent the RNPs within the RRMs. Cross out 
represents the frameshift downstream sequence.  
 
In fact, a premature stop codon in-frame (TGA) was produced at position 72 in the 
frameshifted mature mRNA sequence (Fig 6.2.1 B). Early termination codons trigger 
nonsense-mediated decay (NMD) of transcripts after passing through a ribosome as a 
mechanism to monitor defective mature mRNAs. NMD degrades mRNAs by deadenylation-
independent decapping and, subsequent 5' to 3' decay of the transcript body by exonuclease 
activity. Another pathway involves accelerated deadenylation followed by 3' to 5' decay of the 
mRNA body by exonuclease activity (Isken and Maquat 2007). So, at least part of the 
defective mature mRNA variant generated by the cugbp1-MO is probably eliminated by 
nonsense mediated decay, and hence Cugbp1 protein synthesis is down regulated.  
Any protein synthesized from the flawed cugbp1 mature mRNA should generate a 
truncated protein since the excision of exon5 should produce a frameshift downstream 
sequence by altering the amino acids encoded by and downstream of exon5. In fact, the first 
amino acid that is changed due to the morpholino activity is part of the RNP1 from the first 
RNA-recognition motif of Cugbp1 protein (Fig 6.2.1 C, G→D). The premature stop codon is 
generated twelve amino acids downstream from the first frameshifted amino acid. It is also 
located in the first RRM where there is an L-alanine in wild type zebrafish Cugbp1 protein 
(Fig 6.2.1 C, A→STOP). This means that any MO-dependent truncated Cugbp1 protein 
should be composed of only 71aa. It does not have the most important fractions of the protein-
coding regions, as a part of the amino acids that generate the first RRM and the complete 
second and third RRMs should be eliminated. RRMs are the functional motifs of RNA-
binding proteins, including Cugbp1; hence are required for regulation of post-transcriptional 
expression of specific gene targets (Maris et al. 2005; Barreau et al. 2006). Therefore, any 
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truncated Cugbp1 protein generated by the morpholino activity of the present study should not 
be functional.  
In addition it is important to mention that splice-altering activity using morpholinos is 
not 100% efficient (Heasman 2002; Morcos 2007). This was shown at the RT-PCR assay 
where cugbp1-MO samples also possessed the 310bp band, in addition to the 227bp band (Fig 
5.3.1 B). So, there is always going to be a reduced, but still functional amount of protein.  
 
6.2.2 Morphant (MO) vs. control (MM) embryos phenotype and behavior 
 
As anticipated, knocking down Cugbp1 protein expression resulted in a defective 
phenotype (Fig 5.3.1 E) confirming that the correct expression of this protein is fundamental 
for proper early embryonic zebrafish development. It was interesting to observe that the 
flawed characteristics observed in cugbp1-MO injected zebrafish embryos correlate with 
symptoms observed in Myotonic dystrophy 1 (DM1), especially in the congenital form (CDM) 
of this disease. Similarities occurred even though CUGBP1 protein levels are elevated in all 
forms of DM1 (Schoser and Timchenko 2010). In contrast, Cugbp1 protein expression was 
decreased in the present study during zebrafish morphants early development. The latter 
suggests that CUGBP1 protein levels have to be tightly regulated for normal early 
development in vertebrates.   
 In DM1, increased CUGBP1 protein half-life and steady state levels are responsible 
for part of the DM1 defective features. It has been shown that in DM1 cells nuclei these 
increased levels occur due to binding of CUGBP1 to soluble mutant DMPK mRNA and hyper-
phosphorylation of CUGBP1 by protein kinase C (PKC) which is activated by expanded 
DMPK-CUG RNAs. PKC-dependent hyperphosphorylation of nuclear CUGBP1 has been 
shown in COS M6 cells expressing DMPK-CUG960 RNA, DM1 cell cultures, DM1 tissues 
and in heart-specific DMPK-CUG960 inducible DM1 mice model. Likewise, 
hyperphosphorylation of CUGBP1 was demonstrated in normal heart tissues from mice at 
embryonic days 16 and 17 (E16, E17) and normal newborn heart and skeletal muscle tissues 
from mice, but not in normal adult heart or skeletal mice tissues (Kuyumcu-Martinez et al. 
2007). This is concomitant to the proposed pattern of expression of Cugbp1 protein in the lens. 
As a possibility, Cugbp1 might have a role at lens fiber differentiation at early embryonic 
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development but later on (beginning at ~4-5dpf) Cugbp1 is no longer needed in the fibers 
differentiation process. As mentioned before, another post-transcriptional regulatory protein 
might replace Cugbp1 as lens development proceeds. However, Cugbp1 activity as lenses 
grow throughout life cannot be discarded until further investigation and also as CUGBP1 
strong expression in mice has been observed in various adult tissues (Ladd et al. 2001). In 
addition, if Cugbp1 protein expressed in lens early development is hyperphosphorylated also 
remains to be studied.    
As morphant embryos were examined, it was noteworthy that at 1-4dpf they seemed 
very still and most of them had to be taken out of their chorions with tweezers. Otherwise they 
would not have come out by their own. In CDM, it has been reported that human fetal 
movements are reduced in pregnancies. Immobility and delayed motor development are also 
one of the first postnatal symptoms (Schoser and Timchenko 2010). 
cugbp1-MO embryos also exhibited a delay in development and smaller size compared 
with controls. Although, this traits have been previously associated with a non-specific effect 
of morpholino injections (Uribe and Gross 2010) this does not seem to be the case because 
control injected embryos (cugbp1-MM) did not show these traits. Indeed, it is common for 
CDM children to be born as premature infants (Schoser and Timchenko 2010). Forsberg et al. 
(1990) have observed that patients (ages 11-27 years old) with CDM are thinner than normal 
(body mass index ˂20kg/m2). Likewise a recent report showed that a transgenic mice line, in 
which Cugbp1 gene was inactivated, displayed growth retardation already apparent at the 
embryonic stage and it was not compensated in postnatal life. Cugbp1 null mice never reached 
the size and average weight of their control littermates (Kress et al. 2007). In addition, 
transgenic mice overexpressing CUGBP1 in skeletal muscle during early embryonic 
development were also underdeveloped, growth-retarded and had less weight than controls 
(Timchenko et al. 2004).  
Skeletal muscle (responsible for conscious movement) develops from somites (Heather 
et al. 2000) and Cugbp1 is normally expressed in somites during early development as 
demonstrated in some of the transgenic zebrafish embryos of the present study and previously 
reported in mice (Kress et al. 2007), zebrafish embryos (Hashimoto et al. 2006), Xenopus 
(Gautier-Courteille et al. 2004) and in the muscle sheet of Caenorhabditis elegans (Milne and 
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Hodgkin 1999). Moreover, it has been shown that CUGBP1 regulates the expression of 
several genes important for muscle development at a transcriptional and/or a translational level 
(Timchenko et al. 2001; Timchenko et al. 2004; Charlet-B et al. 2002; Kalsotra et al. 2008).  
As an example, it has been demonstrated that CUGBP1 is required in myogenesis by 
enhancing fibroblast conversion into myoblast as well as in myoblast differentiation into 
myotubes. It has been reported that CUGBP1 can enhance myogenesis by ~50% via direct 
translational regulation of MEF2A (a DNA-binding transcription factor). Moreover, CUGBP1 
protein is required for the increase of MEF2A and p21 protein levels in differentiating 
myoblasts. Then, MEF2A induces myosin for proper fusion of myotubes and myotubes give 
rise to skeletal muscle (Timchenko et al. 2004). So, flawed traits and a motionless behavior 
seen in zebrafish cugbp1 morphants are probably, at least in part because of an impaired 
embryonic development of skeletal muscle. Fibroblast conversion into myoblasts might 
happen at a lower rate in morphants because there is not enough Cugbp1 to enhance Mef2a. 
This could be one of the reasons why MO-injected embryos appear delayed and smaller. They 
possibly have lower levels of myosin. If this is true, then their myoblasts might not align 
properly and in turn they would not fuse correctly for myotube synthesis; hence leading to 
impaired skeletal muscle tissues and immobility of cugbp1-MO injected embryos.       
Additionally, in DM1 disease CUGBP1 levels are higher in proliferating myoblasts 
and lower in differentiating cells compared to normal cells. So, since the latter leads to lower 
levels of MEF2A in differentiating myoblasts; these cells have lower levels of myosin and 
myoblasts do not fuse correctly. Muscular dystrophy and delay of muscle development are 
attributed to the above mentioned impaired CUGBP1 translational activity in DM1 illness 
(Timchenko et al. 2004). So, less body movement and a delayed appearance in cugbp1-MO 
injected embryos as well as immaturity of skeletal muscle (Sarnat and Silbert 1976; Silver et 
al. 1984; Furling et al. 2001; Timchenko et al. 2004), fetal and postnatal immobility and natal 
premature appearance in CDM are due to (at least in part) CUGBP1 protein abnormal levels 
that lead to CUGBP1 disrupted post-transcriptional activity.          
Another feature shared by cugbp1 knock down zebrafish embryos and DM1 disease is 
the presence of an enlarged and weakened heart. Dilated cardiomyopathy and arrhythmias are 
common features in DM1 disease. Sudden cardiac death is not uncommon, even in young 
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patients (Schoser and Timchenko 2010). Also, a heart-specific Dmpk-CUG960 inducible DM1 
mice model exhibited dilated cardiomyopathy and elevated CUGBP1 steady state levels 
(Kuyumcu-Martinez et al. 2007). Moreover, to test the hypothesis that CUGBP1 up regulation 
also contributes to the cardiac phenotype in DM1; Koshelev et al. (2010) created a 
tetracycline-inducible and heart-specific Cugbp1 mice line. These transgenic mice displayed 
enlarged hearts as a sign of cardiomyopathy when compared with controls. Histology analysis 
revealed that these transgenic mice reproduce DM1 features in heart tissues like widespread 
degeneration and necrosis (Koshelev et al. 2010). So, enlarged hearts in cugbp1-MO embryos 
are due to Cugbp1 disrupted levels. 
A wide range of different studies have suggested that at least several of the DM1 
symptoms are caused by increased steady state levels of CUGBP1 protein and/or a reduction 
of MBNL1 protein (Schoser and Timchenko 2010). MBNL1 protein decrease in DM1 is 
caused due to its sequestration by insoluble mutant long DMPK-CUG repeats (Cardani et al. 
2006). MBNL1 and CUGBP1 proteins regulate alternative splicing in an antagonistic manner 
during normal heart and skeletal muscle development (Kalsotra et al. 2008; Cooper et al. 
2009; Schoser and Timchenko 2010).   
In normal heart development, for instance, it has been shown that CUGBP1 protein is 
expressed at low levels in adults compared with embryonic high levels in hearts. In mice heart, 
CUGBP1 protein levels begin to decrease by postnatal day 6 (PN6). In contrast, MBNL1 
protein levels in mice hearts start increasing at PN5. This postnatal switch of CUGBP1 and 
MBNL1 protein expression controls fetal to postnatal/adult transitions for a subset of 
alternative splicing events. There are also alternative splicing events that are under the control 
of CUGBP1 and not MBNL1 and vice versa. Since in DM1 human tissues and animal models, 
CUGBP1 protein levels are increased and MBNL1 protein levels are decreased this leads to an 
aberrant expression of CUGBP1-dependent embryonic alternative splicing variants in 
postnatal/adult tissues (Kalsotra et al. 2008). In fact, Ho et al. (2005) observed that 
overexpression of CUGBP1 in neonatal transgenic mice reproduces alternative splicing 
alterations observed in DM1.  
Hence, abnormal enlarged hearts observed in cugbp1-MO injected embryos are most 
probably caused by a reduction in the expression of embryonic splicing variants that are 
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Cugbp1 targets and are essential for proper early embryonic development of the heart. Other 
post-transcriptional regulation processes performed by Cugbp1 should also be altered in MO 
cardiac tissues that contribute to an abnormal embryonic development of heart. It would be 
interesting to observe if histopathological features observed in DM1 tissues and DM1 models 
that present abnormally enlarged hearts are reproduced in cugbp1-MO injected zebrafish 
embryos hearts.   
Morpholino induced down regulation of cugbp1 in zebrafish embryos could also lead 
to failure or reduction of expression of embryonic protein isoforms in other tissues that are 
dependent on CUGBP1 regulation. The latter since CUGBP1 protein has been reported to be 
ubiquitously expressed at early embryonic development in zebrafish (Hashimoto et al. 2006) 
and other vertebrate species (Gautier-Courteille et al. 2004; Kress et al. 2007). An abnormal 
induction of embryonic splicing variants by up regulation of CUGBP1 expression in 
postnatal/adult tissues has also been shown in skeletal muscle (Ward et al. 2010). Therefore, 
Cugbp1 protein is important for proper skeletal muscle and probably overall embryonic 
development and consequently for a healthy phenotype. The latter since cugbp1-MO injected 
embryos possessed smaller bodies with a delayed appearance. In addition, inactivation of 
CUGBP1 ortholog in Caenorhabditis elegans caused embryonic lethality (Milne and Hodgkin 
1999), and in mice it causes a significant augmentation of neonatal deaths (Kress et al. 2007).  
In fact, it has been demonstrated that a Mbnl1 knock out mice line that disrupts 
MBNL1 isoforms associated with expanded (CUG)n and (CCUG)n RNAs is sufficient to 
cause physical features, like myotonia and RNA splicing defects that resemble those seen in 
adult DM1. Nevertheless, there were no defects at early embryonic/postnatal transgenic mice 
development that resembled those observed at newborn or neonatal CDM patients or CDM 
animal models (Kanadia et al. 2003). CDM patients display severe underdeveloped muscles 
(Timchenko et al. 2004) and older studies revealed higher mortality rates (17-41%) due to 
respiratory muscle weakness and complications of prematurity. Nevertheless, with the 
improvement of neonatal care survival rates have increased (Longman 2006).  
In contrast, Mbnl1 knock out mice did not show any visibly or higher rates of lethality 
in embryos and/or early newborns compared to controls (Kanadia et al. 2003). However, an 8-
10 fold elevation of CUGBP1 in skeletal muscle of transgenic mice leads to in utero or after 
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birth death and a severely underdeveloped phenotype (Timchenko et al. 2004). Transgenic 
mice overexpressing CUGBP1 (4-6 fold), specifically in heart and skeletal muscle, were also 
stillbirth (Ho et al. 2005). The latter suggests that overexpression of CUGBP1 in embryos 
might have a severe effect on early embryonic development. Whereas MBNL1 inhibition may 
not have a critical impact in embryonic development and its primary function and effect on 
DM1 might occur until later stages in development. This correlates with the observation that 
transgenic mice overexpressing CUGBP1 protein so far are the only mice models reproducing 
symptoms of CDM (Timchenko et al. 2004; Schoser and Timchenko 2010). In the present 
study, morphants also resemble some of CDM first symptoms, but instead of increased steady 
state Cugbp1 protein levels at embryonic development, they had a decrease of Cugbp1 protein 
at analogous time points. Hence, normal Cugbp1 protein levels are required for normal 
embryonic and early postnatal/larval development in vertebrates.   
In addition, CDM patients do not suffer from myotonia during their first ten years of 
life even though they display a severe muscular phenotype (Longman 2006; Schoser and 
Timchenko 2010; Vanier 1960). MBNL1 knock out mice manifest myotonia beginning at 
around 6 weeks of age. Since myotonia is not present in CDM this correlates with the previous 
observation that MBNL1 protein sequestration in DM1 might not have a severe effect in 
embryonic development. Rather, it seems to have a negative effect in later stages of life 
(postnatal to adult) in DM1 animal models (that suppress expression or sequester MBNL1 
protein) and DM1 patients. This is also concomitant with the observations that MBNL1 
protein is needed for a subset of postnatal/adult alternative splicing changes during skeletal 
muscle (Lin et al. 2006) and heart (Kalsotra et al. 2008) development. Whereas normal 
CUGBP1 down regulation occurs at this postnatal switch and its up regulation happens before, 
during an embryonic/early postnatal splicing pattern (Kuyumcu-Martínez et al. 2007; Kalsotra 
et al. 2008) This is why, at least in part, a reversion to the embryonic/early postnatal splicing 
pattern is observed in DM1 adult tissues and mouse models when CUGBP1 is overexpressed 
(Ranum and Cooper 2006). 
Morpholino injected zebrafish larvae also exhibited a cataract phenotype (Fig 5.3.1 E) 
and this was evident as early as 3dpf. In addition, Kress et al. (2007) Cugbp1 null mice line 
also displayed a defective lens phenotype. In these mice, cataracts are easy to observe at 
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adulthood (~6months; Paillard, unpublished). However, no results have been published 
describing the appearance or age of onset of this lens defective phenotype in this mice line. In 
addition, cataracts are a very common feature observed in DM1 patients. An obvious cataract 
phenotype has not been described in any patient younger than at least 10 years old (Rhodes, 
unpublished). However, Ekström (2009) has reported that bilateral (both eyes) subtle haze or 
condensation in the posterior lens pole was found in 39% of 49 individuals with congenital 
(n=30) and childhood-onset (n=19) myotonic dystrophy 1 (females: n=20, 7.3-21.4 years; 
males: n=29, 1.6-21.9 years). These abnormalities are suggestive of early stages of cataract 
development. But these abnormalities are not yet registered as true cataracts, probably because 
no opacifications (white appearance, instead of a uniform black look) are evident at first sight. 
In the present study, cugbp1 mRNA expression was observed in the posterior-middle 
and very posterior regions of the developing solid cluster of cells that constitutes the lens at 
24hpf, in zebrafish (Fig 5.1.2b A, B). At this area few rounded cells constitute the core of the 
lens nucleus, and primary lens fibers are elongating and surrounding the core of the lens 
(Greiling and Clark 2009). However, in mammalian lens development instead of a solid mass 
of cells; a hollow fluid-filled vesicle forms from head ectoderm. Then, cells in the anterior 
hemisphere give rise to the lens epithelium. Cells at the posterior hemisphere elongate in a 
posterior to anterior direction and a parallel-like manner and differentiate to fill the lens 
vesicle cavity as primary lens fibers. In addition, cugbp1 mRNA expression is also evident in 
secondary lens fibers that are elongating around the primary lens fibers at zebrafish embryonic 
and early larvae development. 
Since Kress et al. (2007) Cugbp1 null mice develop cataracts (Paillard, unpublished), it 
is very probable that CUGBP1 protein function in the lens is conserved between zebrafish and 
mammals. It is likely that Cugbp1 has a role at the elongating primary fibers that fill the 
vesicle in mammals and, at least, in the first secondary lens fibers that start elongating around 
the lens center (region with primary fibers) during embryonic development. However, the 
dissimilarities observed in the formation of the lens center between mammals and zebrafish 
may account for the differences in time of onset of a cataract phenotype due to altered 
CUGBP1 levels. In zebrafish, the function of cugbp1 in the appropriate formation of the 
central area of the lens may be more important for the organization and positioning of 
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surrounding fibers and overall lens form in early development. So, cugbp1 knock down 
contributes to lens opacities early in life (3-4dpf). In contrast, in mammals the negative effect 
caused by an aberrant lens core development could be more important in the long term, 
resulting in obvious lens opacities until later in life.  
In addition, secondary lens fibers elongate in a different pattern in zebrafish as 
compared to mammals giving rise to obvious differences in lens sutures formation. In 
zebrafish, all fiber cells are meridians and taper at the ends as they extend from pole to pole 
and meet with opposing fibers to produce a suture at each pole. However, in mammals all 
fibers in the same layer do not elongate in the same manner. The fiber cells contacting the 
middles of each branch in the Y-shaped sutures in mice lenses possess S-shaped curvatures. 
Indeed, sporadic instead of uniform perturbations in lens fibers packing in Tmod1 null mice 
lenses have been potentially attributed to these differences in fiber cells morphology; even 
though Tmod1 is a structural protein in the membrane skeleton of lens fibers regardless of 
their shape or location (Nowak et al. 2009). This evidences that in mice lenses (and probably 
other mammals) a disruption in the expression of a lens fiber protein does not affect all fibers 
equally due to differences in their shape, even if they are in the same layer.  
Cugbp1 function in primary and the first secondary lens fibers may be critical for the 
overall shape of lenses in zebrafish as the present results show that cugbp1-MOs do not have 
an overall spherical shape by 4dpf (Fig 5.3.4 E, F ) in comparison with normal lenses 
(Greiling and Clark 2009). However, in mice a lack of CUGBP1 in lens early development 
may not affect in the same way all cells in a single layer resulting in a less severe phenotype. 
Nevertheless, as lenses grow throughout life, the defects in early development produced by a 
lack of CUGBP1 activity may become more apparent in maintaining the lens overall shape, 
and transparency. 
DM1 cataracts are probably a result of both a MBNL1 sequestration and CUGBP1 
increased steady state levels. The latter since the present results have evidenced that Cugbp1 
levels and, hence activity are critical for lens development. Moreover, Mbnl1 null adult mice 
possess a cataract phenotype (Kanadia et al. 2003). It would be interesting to study mbnl1 
mRNA and protein expression specifically in the lens to observe if a switch-like expression 
pattern between Cugbp1 and Mbnl1 is observed in lens development as described before in 
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skeletal and heart tissues (Lin et al. 2006; Kalsotra et al. 2008). A change in alternative 
splicing variants may take place at embryonic to larval/postnatal development in 
differentiating lens fibers.  
Moreover, cugbp1 expression during lens early development in zebrafish correlates 
with DMPK protein detection in mice and chicken at embryonic lens development with a 
specific antibody. In the present work, cugbp1 expression is detected in differentiating lens 
fibers. Likewise, DMPK protein, in the lens, was detected specifically at fiber cells and not at 
the epithelium (Harmon 2008). This overlapping gene expression pattern at the lens during 
early development between cugbp1 and Dmpk indicates that in DM1, DMPK mutant mRNAs 
with expanded CUG repeats are probably expressed at embryonic differentiating fiber cells 
that also express CUGBP1. Hence, in DM1, lens fibers probably possess CUGBP1 increased 
steady state levels due to mutant DMPK mRNA expression during early lens development. So, 
CUGBP1 disrupted activity may affect embryonic lens fibers differentiation in DM1, even 
though a cataract obvious phenotype is not apparent at early development. In cugbp1-MO 
embryos, Cugbp1 activity is also disturbed at lens embryonic development leading also to 
flawed lens fibers differentiation.  
In addition, zebrafish embryos and larvae where Cugbp1 protein was down regulated 
also exhibited smaller eyes. As mentioned before, Cugbp1 protein has been shown to be 
expressed ubiquitously at early embryonic development in zebrafish (Hashimoto et al. 2006) 
and other vertebrates (Gautier-Courteille et al. 2004; Kress et al. 2007). Hence, it may play a 
function in the development of other regions of the eye. In addition, microphthalmia, short 
axial length (distance between the anterior and posterior poles of the eye) and other eye 
problems have been reported in DM1 patients. However, ophthalmological flawed features in 
DM1 need further investigation (Ekström 2009).         
 
6.2.3 Cell proliferation and differentiation analysis in the lens of cugbp1 knock 
down zebrafish embryos 
 
According to the expression results from this study, at 2 and 3dpf cugbp1 seemed to be 
expressed at the transition zone of  the lens (Fig 5.1.2b C-F), place where epithelial cells stop 
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being proliferative by exiting the cell cycle and start differentiating to become lens fibers 
(Soules and Link 2005; Griep 2006; Dahm et al. 2007; Greiling and Clark 2009).  
CUGBP1 has been implicated as a key regulator in myogenesis, especially during the 
transition from myoblasts to the differentiation of myotubes. CUGBP1 activity is regulated by 
phosphorylation at specific amino acids by different kinases depending on the cell stage. In 
proliferating myoblasts, CUGBP1 is phosphorylated by Akt kinase in the position 28 (Ser28). 
Ph-S28-CUGBP1 has high affinity towards cyclin D1 mRNA increasing its translation. Since 
D1 is a strong promoter of cell proliferation ph-S28-CUGBP1 increases cell proliferation in 
myoblasts. Unlike cyclins D1 and D2 that promote cell proliferation, cyclin D3 supports cell 
growth arrest and differentiation. At differentiating myoblasts (to become myotubes) cyclin 
D3 levels are increased and Cyclin D3/cdk4 phosphorylates CUGBP1 at Ser302. Ph-S302-
CUGBP1 binds strongly to cdk inhibitor p21 mRNA increasing its translation; thus promoting 
cell cycle arrest which is required for cell differentiation (Salisbury et al. 2008; Schoser and 
Timchenko 2010).  
As mentioned before CUGBP1 has a critical function in myoblasts proliferation and is 
also involved in inducing myoblasts differentiation to myotubes by promoting p21 translation 
(Salisbury et al. 2008). So, a cell proliferation assay in cugbp1-MO and MM embryos was 
performed to observe if Cugbp1 protein has a similar role in lens epithelial cell cycle arrest to 
induce fiber cell differentiation, specifically at the transition zone of the lens. However, BrdU 
incorporation assay did not show any differences between morphant and control lenses at 2dpf 
nor at 3dpf (Fig 5.3.3). Morphants did not exhibit any significant difference in the total 
number of proliferating cells. So, it is not likely that epithelial cells that should be 
differentiating to become lens fibers remain proliferative at the transition zones due to failure 
to translate enough levels of p21. In addition, proliferation was observed at the lateral 
epithelium of morphant lenses. So, it is not probable that cells in this region fail to translate 
appropriate levels of cyclin D1. 
Since cugbp1-MO embryos display smaller lenses, it is possible that a count of the 
percentage of BrdU+ cells (instead of the total number) between cugbp1-MO vs. cugbp1-MM 
embryos would show that morphant lenses have a higher percentage in BrdU+ cells, but this 
might be because morphant fiber cells fail to degrade their nuclei as shown in Fig 5.3.6 and 
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discussed below. So, there might be BrdU positive signals in lens fibers from morphant lenses 
while their BrdU positive counterparts in control lenses are not present when counting. This 
would be due to DNA degradation as a normal process in control lens fiber cells 
differentiation (Counis et al. 1998; Bassnet 2009). 
 Then, the ability of cugbp1-MO embryos to start their differentiation process from 
lens epithelial cells to lens fibers was tested, by analyzing the expression of Aquaporin0 
(Aqp0) as a lens fiber marker (Fig 5.3.4). Varadaraj et al. (2007) have shown that AQP0 is a 
plasma membrane protein expressed in newly formed and still differentiating mice primary 
and secondary lens fibers, but not in lens epithelial cells. Immunohistochemistry results 
demonstrated that morphants as well as control embryos expressed Aqp0 in their lens 
evidencing that Cugbp1 is not required for the initiation of fiber cell differentiation. In 
addition, these results demonstrated that Cugbp1 protein is not needed for Aqp0 protein 
synthesis pathway.  
Furthermore, it was interesting to observe that Aqp0 could be detected at the center 
and most inner part of the lens in morphant embryos at 2 and 3dpf. In contrast, this was not 
possible in controls. This could have happened because morphant lens fibers fail to arrange in 
a compact manner at the same rate as in controls. So, anti-Aqp0 antibody can reach the inner-
most primary fiber cells at the center of the lens. In contrast, control embryos displayed an 
organized arrangement in which fiber cells elongate to form a new layer covering the previous 
formed fiber layers in a compact manner (Varadaraj et al. 2007; Greiling and Clark 2009; 
Chepelinsky 2009) otherwise controls would have displayed an abnormal lens phenotype.  
The visualization of Aqp0 expression allowed the observation of lens fiber membranes 
since Aqp0 constitutes more than 50% of the membrane protein in lens fibers (Varadaraj et al. 
2007). The latter permitted the examination of the lens mass shape arrangements during early 
development in cugbp1 knock down embryos. Indeed, morphant embryos have a defective 
lens mass shape that does not correlate with the shape seen in control and other wild type 
zebrafish lenses (Greiling and Clark 2009). The latter could be due to an impaired lens fiber 
morphogenesis. If lens fibers fail to elongate properly and/or do not have the right overall 
thickness and/or form then they are not going to compact in a correct manner. This would lead 
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to an impaired overall structure of the lens mass as how it was observed in cugbp1-MO 
embryos.  
This defective lens mass shape, the faulty lens fiber arrangement phenotype and 
cugbp1 expression pattern might suggest that Cugbp1 protein is required for proper lens mass 
overall architecture by having an effect at least in lens fibers organization. Morphants lens 
mass seems to have a defective structure and not compact fibers in the lens nucleus during 
early zebrafish development. In addition, epithelial to fiber cell fate does not seem to be 
compromised. 
 
6.2.4 F-actin organization in the lens of cugbp1-MO zebrafish embryos  
 
Aqp0 immunodetection experiment revealed that knocking down cugbp1 expression 
did not alter the epithelial to fiber cell differentiation pathway. Rather, lens mass overall 
structure and lens fibers compaction seems to be affected. Then, an F-actin staining assay on 
the lens was performed (Fig 5.3.5) to further observe if a possible flawed fiber cell shape was 
identified.  
It is known that the actin cytoskeleton has an essential role in lens fiber cell elongation 
and differentiation. Epithelial cell morphology changes are accompanied with membrane 
cytoskeleton remodeling and actin filament reassembly. Lens epithelial cell differentiation is 
coincident with the disassembly of actin stress fibers and the reorganization of F-actin as 
cortical actin during fibergenesis (Rao and Maddala 2006; Lee et al. 2000; Weber and Menko 
2006a). 
The F-actin concentric staining appearance seemed to coincide with an enrichment of 
cortical F-actin (membrane bound) along the length (lateral surfaces) of normal lens fibers 
(Weber and Menko 2006a). Such pattern was apparent at MM lenses. The medium flawed 
phenotype also exhibited an organized concentric F-actin pattern in lens fibers. Nevertheless, 
lenses were smaller and had less compact lens fibers. The latter was evidenced by F-actin 
staining in inner concentric fiber membranes compared to control lenses.  
A severe phenotype showed a highly disorganized F-actin pattern. However, F-actin 
still appeared to be present along lens fibers as in controls and medium flawed phenotype 
lenses. Depolymerization of F-actin has been associated with disordered lens fiber cell 
 106 
packing (Nowak et al. 2009) and blebbing of the plasma membrane (Weber and Menko 
2006a). In the severe phenotype, an abnormal wave/blebbing-like morphology (but still 
concentric) instead of an appearance of concentric rings was obvious, but F-actin still appears 
to be enriched in lens fibers cortical cytoskeleton.  
The fact that there were two flawed phenotypes: one less severe that appeared to have 
an organized F-actin pattern and another with a wave-like F-actin overall arrangement might 
indicate that F-actin disorganization is not a direct effect of cugbp1 down regulation. Rather, it 
is probably a consequence of another important disrupted pathway that is crucial for lens fiber 
proper morphogenesis. In addition, Cugbp1 protein does not seem to be important for the 
maintenance of cortical F-actin in lens cortical fibers. 
 Additionally, it is important to remember that the zebrafish lens TZ is located posterior 
to the equator. So, the anterior elongation of secondary fibers is greater than the posterior 
elongation in respect to the TZ and this difference makes the appearance of the posterior 
suture to happen before the anterior suture (Greiling and Clark 2009). This is most probably 
the reason why an evident posterior lens suture was observed in 4dpf cugbp1-MM embryos, 
while the anterior suture was still not apparent after F-actin staining (Fig 5.3.5 A).  
 
6.2.5 Nuclei degradation in cugbp1-MM embryos vs. cugbp1-MO embryos 
 
It has been demonstrated that lens fibers terminal differentiation includes losing their 
organelles including their nucleus (Appleby and Modak 1977; Counis et al. 1998; Bassnett 
2009). SytoxGreen staining was performed in morphant lenses to test if Cugbp1 might be 
involved in DNA degradation as a normal part of lens fiber differentiation. 
Nuclei staining results on morphant lenses further evidenced an impaired lens fiber 
phenotype due to Cugbp1 down regulation (Fig 5.3.6). 4 and 5dpf morphants still retain nuclei 
in their inner-most fibers; moment at which normal primary fiber cell maturation and 
organelle break-down in the core of the lens should have already occurred. This DNA 
presence scatters incident light and does not allow appropriate focusing on the retina resulting 
in a cataract phenotype (Greiling and Clark 2008; Bassnett 2009).  
In contrast, control embryos exhibited DNA only in the posterior-lateral and posterior 
borders of the lens. Both regions correlate with the places at which newly secondary lens 
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fibers are still differentiating, so it is expected to still observe nuclei in these positions 
(Bassnett 2009).   
It was evident that at 5dpf cugbp1-MO embryos had less amounts of DNA in their lens 
body compared with morphants at 4dpf. This probably happened because at 5dpf the 
morpholino had already dissipated too much, so its effectiveness is being reduced. However, it 
could also have happened just due to delayed nuclei disintegration. 
De María and Arruti (2004) have observed that lens fibers nuclei undergo 
characteristic morphological changes according to the lens fibers differentiation stage. First, 
nuclei are large, round shape and with uncondensed chromatin. Lens from morphants seem to 
retain their nuclei appearance in this stage even at the core region of the lens. Then, as lens 
fibers normally mature, they elongate and nuclei also becomes elongated (De María and Arruti 
2004). Control lenses exhibit this nuclei shape in differentiating cortical fibers. The elongation 
of nuclei is a process that seems to correlate with the development of an elongated form in 
lens fibers. If nuclei do not start elongating and becoming thinner; then fibers are going to 
have a big round structure that is not going to let them elongate properly. And this would lead 
to a disorganized packaging of the fibers and less compact fibers correlating with the lens 
defective phenotype from this study. 
 Finally, as the nuclei disintegrate it is viewed as small rounded bodies (De María and 
Arruti 2004). This conformation is not apparent in the control (MM) neither the morphant 
lenses, most likely because in this last conformation the rounded bodies are too small. They 
probably form as a separation of the elongated shaped nuclei and the small rounded parts are 
so close that at the magnification utilized the separations are not visible and just look as a 
curved thin line.     
It can be speculated that the observation that morphant lenses had not compacted lens 
fibers at the center of the lens (evidenced by Aqp0 expression detection; Fig 5.3.4) could be 
due to a lack of organelle degradation, at least in part. If nuclei and/or other organelles are not 
eliminated from lens fibers then, it is reasonable to think that fibers are not going to be able to 
elongate and stretch properly to become long and relatively thin cells which are organized as 
concentric layers. This could also explain the general flawed lens mass shape observed in 
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morphants, if fibers do not arrange in a highly compacted way then the lens mass is not going 
to be able to have a spherical form. 
An abnormal persistence of nuclei in the center of the lens mass was evident. And this 
happened due to cugbp1 knock down. Nevertheless, most mutations that lead to cataracts 
affect organelle breakdown to some extent. It is possible that a certain mutation can impact the 
organelle disintegration process directly. However, organelle breakdown involves a complex 
series of interdependent steps. So, any mutation that affects lens homeostasis can indirectly 
affect organelle breakdown (Bassnett 2009).    
 
In general, it was interesting to observe that knocking down cugbp1 expression in 
morpholino injected zebrafish embryos led to defective features that resemble those observed 
in DM1 patients. And that this happened even though cugbp1 is up regulated in this disease. 
Hence, CUGBP1 protein levels have to be tightly regulated for proper development and 
overall morphology in vertebrates.     
 Cugbp1 is a very versatile protein present in both nucleus and cytoplasm and known 
to regulate the expression of other proteins by binding to pre and mature mRNAs (Philips et 
al. 1998; Vlasova et al. 2008; Kalsotra et al. 2008; Rattenbacher et al. 2010). So it seems 
obvious that the next step to try to unravel the molecular mechanism/s regulated by this 
protein in the lens will be aimed to identify the targets of cugbp1 in this region of the eye.  
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Chapter 7. Recommendations and Future Directions 
 
7.1 Identification of Cugbp1 RNA targets at the developing zebrafish lens 
 
Since this study has demonstrated that Cugbp1 has a role in lens early formation, the 
next step should be directed to identify what molecules are bound and thus regulated by 
Cugbp1 protein during zebrafish early lens development. In order to do so, the creation of a 
transgenic line with an expression construct that drives Cugbp1 protein expression specifically 
at the lens during early development and where this transgenic protein can easily be isolated 
with its bound targets seems a viable approach. 
  First, an expression construct should be synthesized. This study showed that the 1.2kb 
cugbp1 promoter element identified has high lens specificity during the time points monitored. 
Hence, this DNA sequence could be used as a 5ʹ element in the creation of a new expression 
construct using Tol2kit technology (Kwan et al. 2007). A full-length zebrafish cugbp1 cDNA 
sequence should be used as a middle element. Thermo Fisher Scientific has a vector with a 
complete cugbp1 cDNA insert (Vector pME18S-FL3; Clone ID 5776879). This cDNA should 
include the cap sequence, translation initiation site and all the exons for proper in vivo 
translation. Clone 5776879 could be aligned with Suzuki et al. (2000; Ensembl, ID 
ENSDARP00000026582) complete cugbp1 cDNA sequence and the sequence of the cDNA 
used to make probe (for in situ hybridization assay; 5.1.1 Section; Annex 3; Fig 5.1.1). This 
alignment is important to identify if there are any significant differences between sequences 
that could alter the function of the synthesized protein in the lens. 
A C-terminal fusion protein tag can be added to cugbp1 transgenic protein for easier 
isolation of the RNA-protein complex. The Tol2kit has a 3ʹ entry clone with a c-myc-tag and a 
SV40 late polyA signal (p3E-MTpA, Kwan et al. 2007). The stop codon of the middle element 
(cugbp1 cDNA) has to be removed for the tag to be in-frame with the protein sequence. Then, 
when the transgenic protein is expressed, it will possess the c-myc polypeptide sequence in its 
C-terminal region. This will allow immune precipitation of transgenic Cugbp1 by using a c-
myc-tag antibody. The myc-tag is a polypeptide with 11aa (Terpe 2003). Since it is a small 
peptide, it is unlikely that it will interfere with the biochemical properties of Cugbp1 
transgenic protein.      
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In the multisite gateway LR recombination reaction, the use of destination vector 
pDestTol2CG2 will be helpful to visualize animals that have incorporated the expression 
construct. The latter since this destination vector includes an extra cmlc:EGFP-pA expression 
cassette as a marker for transgenesis. In this cassette, the cmlc 3ʹ element corresponds to a 
promoter from the cardiac myosin light chain gene. This promoter is used to drive cytoplasmic 
EGFP expression specifically in the developing heart (Kwan et al. 2007).  
Then, a transgenic line can be created with the injection of transposase mRNA and the 
created plasmid. The new DNA that should be incorporated in the zebrafish genome has the 
expression construct cugbp1:Cugbp1:MTpA and the transgenesis marker construct. Injections 
have to be performed into one cell-stage zebrafish embryos as described in 4.2.5 Section. The 
embryos that have incorporated the foreign DNA are identified by observing EGFP expression 
in their developing hearts. F0 embryos can be grown up to develop a transgenic line for further 
investigation. 
Alternatively, a transgenic line could be created with a different construct from the one 
mentioned above. A bicistronic construct in which Cugbp1 protein with the myc-tag is 
encoded by the first cistron and GFP is encoded by a second cistron on the same mRNA can 
be created. This can be done when expression of the second cistron is driven by an IRES 
(internal ribosome entry site). An IRES is a sequence that induces translation initiation without 
5ʹ cap recognition (Hellen and Sarnow 2001). This construct would have the 1.2kb cugbp1 
promoter. The major advantage that this construct would have, over the one previously 
mentioned, is that the temporal and spatial expression of both proteins Cugbp1 and GFP 
would be directed by the same promoter. Thus, every cell that expresses GFP would also 
express Cugbp1. This is useful because it marks with fluorescence the cells that are expressing 
the gene of interest (cugbp1), in addition to just being a general transgenesis marker. Plasmid 
pCMV6-AC-IRES-GFP (No. PS100027) from ORIGENE has myc-tag, IRES and GFP 
sequences in tandem and downstream from a multiple cloning site (MCS). cugbp1 cDNA 
sequence could be cloned into this MCS and this new plasmid could be used to develop a new 
DNA cassette with expression of Cugbp1 and GFP driven by the 1.2kb cugbp1 promoter at the 
same time. Monitoring the regions where Cugbp1-myc is present is needed since the 1.2kb 
promoter exhibited activity in other parts of the zebrafish embryo body. Although this activity 
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was rare, this cellular expression marker is useful to discard embryos (or their body parts) that 
express Cugbp1 in other regions besides the lens.     
The next step of this assay is to coimmunoprecipitate (Co-IP) transgenic Cugbp1 with 
its RNA targets. To identify the early role of Cugbp1 in lens development, it will be preferable 
to use 1dpf and 2dpf embryos, since at these days cugbp1 expression was more intense in the 
lens (Fig 5.1.2b). There are several commercially available Kits to Co-IP transgenic proteins 
with a c-myc epitope tag. The ProFoundTM c-Myc Tag IP/Co-IP Kit (Thermo Scientific 
Pierce) is one of them. In this kit, the sample lysate interacts with a high affinity anti-c-Myc 
antibody-coupled agarose resin in a spin column allowing coimmunoprecipitation of c-Myc-
tagged proteins. After the spin column is washed to eliminate cellular components that did not 
IP, the c-myc-tagged protein and its bound targets are eluted from the column. The mRNAs 
that are bound with the transgenic protein can then be separated by phenol/chloroform 
extraction and isopropanol precipitation. 
Afterwards, RNAs can be amplified by Reverse Transcriptase PCR. Then, the samples 
may be amino-allyl labeled with a fluorescent dye. This latter technique consists in 
incorporating a nucleotide analog that has a chemically reactive group to which a fluorescent 
dye can be attached. This can be done while performing PCR. Then, the analog group can be 
linked to an N-hydroxysuccinimidyl ester group attached to a dye. The labeled samples can 
then be probed to a cDNA microarray and the data obtained (positive signals) analyzed 
(Shepard et al. 2003). In this case, a zebrafish cDNA microarray should be used (Lo et al. 
2003). These last mentioned steps are usually performed with a collaboration of a 
Bioinformatics laboratory.       
Usually a bioinformatics laboratory sends a list with the targets identified. Then, first 
candidates are selected for posterior studies. These studies can include expression assays and 
MO knock downs to observe if a defective phenotype overlaps with the one observed with the 
morpholino against cugbp1. The aim is to identify proteins that are post-transcriptionally 
regulated by Cugbp1 protein at the developing zebrafish lens.    
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7.2 Reversal of cugbp1 morpholino phenotype by RNA rescue  
  
 A common strategy to further test morpholino specificity is to reverse its effects by an 
assay referred as RNA rescue (Bill et al. 2009). The cugbp1-MO injected in this study is a 
splice-altering morpholino that targets pre-mRNA by binding to the splice junction of 
exon5/intron5. Hence, the MO does not recognize mature mRNA because the latter does not 
possess the intron5 sequence. So, the complete cDNA sequence of cugbp1 gene (Clone ID 
5776879; Thermo Fisher Scientific) can be used to produce mature mRNA that is capable of 
being translated in zebrafish embryos. At this type of assay, mature mRNAs are normally 
generated in vitro and they can be produced by the same general mechanism as transposase 
mRNA was synthetized in 4.2.4 Section. 
 Then, an assay in which cugbp1 mRNA and cugbp1-MO are injected at the same time 
at the yolk of 1-4 cell-stage embryos should be done. In this test, the protein synthesized from 
the injected mRNA is intended to reverse the effects of the MO. This principal is the purpose 
of a RNA rescue experiment. First, the MO with the concentration previously established 
(2.2ng/embryo; 4.3.1 Section) is injected with different concentrations of mRNA to identify 
the appropriate concentration of mRNA that can eliminate the flawed phenotype of the MO, 
but is not toxic to the embryo.  
 Then, embryos of the same batch should be divided into several groups (Bill et al. 
2009). As a control, one group of embryos is injected with the targeting MO and with a 
control mRNA. This control mRNA can be GFP-encoding, so its expression can be verified 
under a fluorescence microscope (Leica Microscope MZ 16F). These embryos should have the 
same defects as cugbp1-MO injected embryos (5.3.2 Section). Another group is the one 
injected with cugbp1-MO and the appropriate concentration of cugbp1 mRNA that exhibits 
the rescued phenotype. In addition, groups injected only with the cugbp1 mRNA, the GFP 
mRNA or just the MO should be maintained. 
 In particular, embryos injected with different concentrations of just the cugbp1 mRNA 
should be carefully monitored. Since it has been previously discussed (6.2.2 Section), that 
overexpression of CUGBP1 in transgenic mice and DM1 models and tissues produces 
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defective features, some of which are similar to the ones observed in cugbp1-MO injected 
embryos.          
  
7.3 Other experiments 
 
cugbp1-MO embryos seem to mimic characteristics observed in DM1 disease and 
transgenic mice overexpressing CUGBP1 in heart and skeletal muscles. Therefore, it will be 
interesting to realize histological analyses in cugbp1-MO heart and skeletal muscle tissues. A 
comparison of the histopathological abnormalities seen in DM1 tissues, DM1 mice models 
and transgenic mice induced to overexpress CUGBP1 should be addressed.   
 
In addition, a characterization of the differences in lens sections from cugbp1-MO and 
cugbp1-MM embryos should be performed by using light microscopy. Transmission electron 
microscopy imaging can be realized, especially on the regions of the lens that exhibit any 
abnormalities seen during light microscopy observations. 
 
It will also be interesting to study if CUGBP1 expressed in early lens development is 
hyperphosphorylated. The latter since Kuyumcu-Martinez et al. (2007) have shown that 
CUGBP1 is hyperphosphorylated at early development in mice heart and skeletal muscle, but 
not at the adult stage. These studies would be easier to perform in mice embryos because 
zebrafish lenses in early development are too small. Lens tissue could be separated from mice 
embryos during E12.0-12-5 since at this time lapse primary lens fibers are elongating. 2D-gel 
electrophoresis and Western Blot could be used to observe the isoelectric point of CUGBP1. 
Alkaline phosphatase treatment (CIAP) would be done to identify if an acidic shift is observed 
due to phosphorylation. These techniques can be performed essentially as described by 
Kuyumcu-Martinez et al. (2007). This assay could also be tried out in zebrafish Cugbp1-myc 
transgenic protein from 7.1 Section.  
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Annex 1. Signed accreditation 
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Annex 2. CS10R plasmid 
 
 
 
 
 
 
 
 
 
 
*CS10R plasmid figure was provided by Dr. Chanjae Lee, Postdoc. 
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Relevant difference between sequences 
Probe sequence lacks 12bp 
Start codon 
Annex 3. Sequence alignment of cugbp1 cDNA used for probe synthesis 
 
                      
                              
 
Probe           ATGAATGGGTCTCTGGACCACCCAGACCAGCCCGACATTGATTCTATAAAGATGTTTGTG 60          
DDBJ            ATGAATGGGTCTCTGGACCACCCAGACCAGCCCGACATTGATTCTATAAAGATGTTTGTG 60 
                ************************************************************ 
 
Probe           GGTCAGATCCCTCGGACGTGGTCAGAGGATCAGCTGCGTGAGCTGTTTGAGCCCTATGGT 120 
DDBJ            GGTCAGATCCCTCGGACGTGGTCAGAGGATCAGCTGCGTGAGCTGTTTGAGCCCTATGGT 120 
                ************************************************************ 
 
Probe           GCAGTTTATGAAATCAATGTTCTTCGTGACAGGAGTCAAAACCCCCCACAGAGTAAAGGT 180 
DDBJ            GCAGTTTATGAAATCAATGTTCTTCGTGACAGGAGTCAGAACCCCCCACAGAGTAAAGGT 180 
                ************************************** ********************* 
 
Probe           TGTTGTTTTGTCACATATTACACCCGTAAGTCTGCATTAGAAGCACAAAATGCCCTTCAC 240 
DDBJ            TGTTGTTTTGTCACATATTACACCCGTAAGTCTGCATTAGAAGCACAAAATGCCCTTCAC 240 
                ************************************************************ 
 
Probe           AACATGAAGATTCTTCCAGGGATGCATCATCCCATACAAATGAAACCTGCAGACAGTGAG 300 
DDBJ            AACATGAAGATTCTTCCAGGGATGCATCATCCCATACAAATGAAACCTGCAGACAGTGAG 300 
                ************************************************************ 
 
Probe           AAAAACAATGCGGTAGAAGATAGAAAGCTGTTTGTTGGAATGATTTCAAAGAAGTGCAAT 360 
DDBJ            AAAAACAATGCGGTAGAAGATAGAAAGCTGTTTGTTGGAATGATTTCAAAGAAGTGCAAT 360 
                ************************************************************ 
 
Probe           GAGAACGACATCAGACTCATGTTTTCTCCATATGGTCAAATCGAGGAGTGCCGCATATTG 420 
DDBJ            GAGAACGACATCAGACTCATGTTTTCTCCATATGGTCAAATCGAGGAGTGCCGCATATTG 420 
                ************************************************************ 
 
Probe           AGAGGTCCAGACGGACTAAGCCGTGGCTGTGCCTTCGTCACATTCACAGCGAGACAGATG 480 
DDBJ            AGAGGTCCAGACGGACTAAGCCGTGGCTGTGCCTTCGTCACATTCACAGCGAGACAGATG 480 
                ************************************************************ 
 
Probe           GCCCAGTCTGCCATCAAATCCATGCACCAGTCACAGACTATGGAGGGCTGTTCTTCTCCC 540 
DDBJ            GCCCAGTCTGCCATCAAATCCATGCACCAGTCACAGACTATGGAGGGCTGTTCTTCTCCC 540 
                ************************************************************ 
 
Probe           ATCGTGGTGAAGTTTGCAGACACACAGAAGGATAAAGAACAGAAACGCATCGCCCAGCAG 600 
DDBJ            ATCGTGGTGAAGTTTGCAGACACACAGAAGGATAAAGAACAGAAACGCATCGCCCAGCAG 600 
                ************************************************************ 
 
Probe           CTGCAGCAACAGATGCAACAGCTCAATGCTGCCTCCATGTGGGGAAACCTTACAGGGCTG 660 
DDBJ            CTGCAGCAACAGATGCAACAGCTCAATGCTGCCTCCATGTGGGGAAACCTTACAGGGCTG 660 
                ************************************************************ 
 
 
Probe           AACTCACTGGGCCCACAGTACCTTGCACTT------------CTACAGCAGTCTGCTTCC 708 
DDBJ            AACTCACTGGGCCCACAGTACCTTGCACTTTATTTGCAGCTTCTACAGCAGTCTGCTTCC 720 
                ******************************            ****************** 
 
                                                                  
                                                          
 
                                                                          
Probe           TCTGGAAATGCGCTCAACAATCTCCATCCAATGTCAGGTCTGAATGCCATGCAAAATCTG 768 
DDBJ            TCTGGAAATGCGCTCAACAATCTCCATCCAATGTCAGGTCTGAATGCCATGCAAAATCTG 780 
                ************************************************************ 
 
Probe           GCTGCATTAGCAGCAGCAGCGAGTGCTACACAGGCCACACCTACAGGTAGCAGTGCGCTG 828 
DDBJ            GCTGCATTAGCAGCAGCAGCGAGTGCTACACAGGCCACACCTACAGGTAGCAGTGCGCTG 840 
                ************************************************************ 
 
Probe           ACCACCTCCAGCTCCCCTCTCAGCGTCCTCACCAGCTCAGGTACGCCCTCCGGACAGCCT 888 
DDBJ            ACCACCTCCAGCTCCCCTCTCAGCGTCCTCACCAGCTCAGGTACGCCCTCCGGACAGCCT 900 
                ************************************************************ 
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Length of Probe sequence (bp)    
Probe           GCTCAATCTGCCTGGGATGCCTACAAGGCAGGTTCCTCTCCCACCTCCAGTACTAGTTCT 948 
DDBJ            GCTCAATCTGCCTGGGATGCCTACAAGGCAGGTTCCTCTCCCACCTCCAGTACTAGTTCT 960 
                ************************************************************ 
 
Probe           TCTGTGAACCCCATGGCATCTTTAGGTGCTCTTCAGTCTCTTGCTGCGGGCGCTGGAGCA 1008 
DDBJ            TCTGTGAACCCCATGGCATCTTTAGGTGCTCTTCAGTCTCTTGCTGCGGGCGCTGGAGCA 1020 
                ************************************************************ 
 
Probe           GGTCTCAACATGAGTTCCCTAGCAAGCATGGCTGCTCTAAATGGTGGTCTGGGCAGCGGA 1068 
DDBJ            GGTCTCAACATGAGTTCCCTAGCAAGCATGGCTGCTCTAAATGGTGGTCTGGGCAGCGGA 1080 
                ************************************************************ 
 
Probe           GGTCTCTCCAACGGCTCTGGAAGCACTATGGAGGCTCTGACTCAGGCGGCCTATTCTGGG 1128 
DDBJ            GGTCTCTCCAACGGCTCTGGAAGCACTATGGAGGCTCTGACTCAGGCGGCCTATTCTGGG 1140 
                ************************************************************ 
 
Probe           ATCCAGCAGTATGCAGCTGCCGCTCTGCCAAGCCTCTACAGTCAGAGTTTACTGTCCCAG 1188 
DDBJ            ATCCAGCAGTATGCAGCTGCCGCTCTGCCAAGCCTCTACAGTCAGAGTTTACTGTCCCAG 1200 
                ************************************************************ 
 
Probe           CAGAACGTTAGCGCTGCTGGCAGCCAAAAAGAAGGCCCTGAAGGAGCAAACCTGTTCATC 1248 
DDBJ            CAGAACGTTAGCGCTGCTGGCAGCCAAAAAGAAGGCCCTGAAGGAGCAAACCTGTTCATC 1260 
                ************************************************************ 
 
Probe           TACCATCTGCCACAGGAGTTTGGTGATCAGGATTTGTTGCAGATGTTTATGCCTTTCGGC 1308 
DDBJ            TACCATCTGCCACAGGAGTTTGGTGATCAGGATTTGTTGCAGATGTTTATGCCTTTCGGC 1320 
                ************************************************************ 
 
Probe           AACGTCATCTCTGCCAAGGTCTTTATTGACAAACAGACCAACCTTAGCAAGTGTTTTGGC 1368 
DDBJ            AACGTCATCTCTGCCAAGGTCTTTATTGACAAACAGACCAACCTTAGCAAGTGTTTTGGC 1380 
                ************************************************************ 
 
Probe           TTTGTAAGTTACGACAATCCAGTTTCGTCCCAGGCAGCCATTCAGTCAATGAACGGTTTT 1428 
DDBJ            TTTGTAAGTTACGACAATCCAGTTTCGTCCCAGGCAGCCATTCAGTCAATGAACGGTTTT 1440 
                ************************************************************ 
 
Probe           CAGATTGGAATGAAGCGGCTGAAGGTGCAACTTAAACGATCTAAAAATGACAGCAAGCCA 1488 
DDBJ            CAGATTGGAATGAAACGGCTGAAAGTGCAACTTAAACGATCTAAAAATGACAGCAAGCCA 1500 
                ************** ******** ************************************ 
           
                                
    
Probe           TACTGA 1494       
DDBJ            TACTGA 1506 
                ****** 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            
*DDBJ corresponds to previously reported cugbp1 cDNA sequence by Suzuki et al. (2000), 
Accession number AB032726. Probe refers to the sequence of cugbp1 cDNA used to make 
antisense and sense probes for the in situ hybridization assay.  
Stop codon                 
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Annex 4. Amino acid sequence from cugbp1 cDNA used for probe synthesis  
 
 
 
 
 
 
*RED refers to amino acids, BLUE refers to nucleotides. 
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Annex 5. Protocol for cugbp1 probe synthesis  
 
 
DIG-labeled, single stranded RNA antisense and sense probes were generated according 
to: DIG RNA Labeling Mix, 10 x conc. Cat No. 11 277 073 910 (Roche Applied Science).                   
 
https://e-labdoc.roche.com/LFR_PublicDocs/ras/11277073910_en_21.pdf 
 
Reagents: 
 
 
1. DIG RNA Labeling Mix, 10X conc. 10mM ATP, 10mM CTP, 10mM GTP, 6.5mM 
UTP, 3.5mM DIG-11-UTP, pH 7.5 (20˚C). 
2. Transcription buffer, 10X conc. 400mM Tris-HCl, pH 8.0 (20˚C); 60mM MgCl2, 
100mM dithiotreitol (DTT), 20mM spermidin. 
3. RNase inhibitor 20U/µl 
4. DNase I. 10U/µl 
 
 
Methods: 
 
Note: Make sure to work under RNase-free conditions.  
 
1. Add the following to a microfuge tube on ice:   
 
2µl (1µg) linearized plasmid DNA. 
2µl DIG RNA labeling mix, 10X 
2µl Transcription buffer, 10X.  
1µl RNase inhibitor (adding this reagent is not mentioned in the original protocol). 
2µl (20U/µl) RNA polymerase T7 or SP6 for antisense or sense probes, respectively. 
11µl sterile RNase free double distilled water to a final volume of 20µl.  
 
2. Mix and centrifuge briefly. 
3. Incubate for 2 hours at 37˚C. 
4. Add 2µl DNase I, RNase-free to remove template DNA. 
5. Incubate for 15 minutes at 37˚C. 
6. Add 2µl 0.2M EDTA (pH 8.0) to stop the reaction. 
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Annex 6. Whole mount RNA in situ hybridization protocol 
 
 
A. Fixation and permeabilization 
 
Fixation 
Dechorionate embryos prior to fixing 
Fix embryos in 4% PFA, overnight at 4˚C 
Wash 3X with PSB 5 min at RT 
Add 100% MEOH, sit RT 5 min  and then aliquot embryos (12-15) into tubes with fresh 100% 
MEOH. Store at -20 for at least 30 min. 
 
Rehydration (all at RT) 
5 min 50% MEOH/PBST 
5 min 30% MeOH/PBST 
2X 5 min PBST 
Collagenase  (1mg/ml PBST) (in Tupperware at bottom of -20 5.5hrs  b/f PK)  
2 DAY   1 HOUR 
3 DAY   2 HOUR 
 
PK Treatment 
PK stocks 2 mg/mL (add 5 µL/ml PBST for 10 µg/mL) 
Digest with PK (10µ g/mL PBST) at RT 
 
Developmental period Digestion time  
 
> 10HRS    7 min 
1 somite  10 min 
24 hpf  12 min 
33 hpf  14 min 
36 hpf 15 min 
48-50 hpf  20 min 
60 hpf  27 min 
72 hpf  30 min 
 
Rinse 2X  5 min PBST at RT 
Refix in PFA 25 min at RT 
Wash 2X 5 min PBST at RT  
 
B. Hybridization  
 
Prehyb in Hyb solution at 55˚C for 3-5 hours  
 
Hybridization 
Remove prehyb and add Hyb with probe 
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Heat Hyb+probe solution 10 min at 68˚C before adding. (10 µl of synthesized probe in 1ml of 
Hyb buffer = Hyb+probe solution). 500 µl per tube is recommended.   
Incubate overnight at 55 ˚C 
 
Washes 
Make solutions for washes before starting: 
 
Solution 1: 
2X SSCT from stock 20X SSC  (1:10) 
V1C1  = V2 C2 
Add 50µl Tween 
 
 
Solution 2: 
0,2X SSCT    (1:100) 
V1C1  = V2 C2 
V120X  = 50ml*0,2X  
V1  = 0,5ml   =500µl  
Add 50µl Tween
 
 
Solution 3: 
50% formamide /2X SSCT 
25ml formamide + 25ml 2X SSCT 
 
Heat every solution before using in the following indicated temperatures     
Remove Probe and save at -20˚C (can reuse 3-4 times) 
Wash 20 min at 55˚C in 50% formamide/2XSSCT 
Wash 3X 10 min at 37˚C in 2X SSCT 
Wash 2X  15 min at 55˚C in 0,2X SSCT 
Wash 5 min at 37˚C in PBST 
Wash 5 min at RT in PBST 
 
C. Anti-digoxigenin alkaline phosphatase (AP) labeling  
 
Detection 
Block 1 (or more) at RT in Block 
Remove block and add primary Ab/block (preincubated)  
Leave for 4 hours at room temperature or overnight at 4˚C 
 
D. Colorization 
 
Washes 
4X 20 min at RT with PBST 
If Ab added for 4 hours at RT, can leave in last PBST overnight at 4˚C 
3X 5 min RT in Staining buffer 
5ml 1M Tris 9,5 
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2,5ml 1M MgCl2 
5ml 1M NaCl 
50µl T-20  + to 50ml with H2O 
Incubate in NBT/BCIP stain (500µl) at RT in dark. Check embryos every 30 min 
Wash 3X after desired staining level in PBS, RT.  
Fix in PFA at 4˚C to preserve 
 
E. Solutions  
 
4% PFA: 2g PFA in 50ml PBS. Cover with foil, stir and heat to dissolve. Takes about 10-
15min, cool on ice. Store at 4˚C for 7days. 
PBST: 1X PBS with 0.1% Tween20. 
SSCT: SSC with 0.1% Tween20, 20X Stock. 
HYB: 50ml: 50% formamide 25ml, 5X SSC (12.5ml of 20X), 0.1% Tween20 50µl, 5mg/ml 
yeast tRNA, 50µg/ml heparin. Can store at -20˚C for years. 
Block: 500µl NGS into 10ml of 1X PBTD.   
Other: 2g BSA, 2ml DMSO, 600µl Triton X-100, 500µl Tween20, 4ml NGS, 1X PBS.   
Staining Buffer:  50ml, store at 4˚C for 2 weeks. 100mM, Tris 9.5 (5ml, 1M), 50mM MgCl2 
(2.5ml 1M), 100mM NaCl (5ml 1M). 0.1% Tween20 (50µl), H2O to 50ml.   
NBT/BCIP:  1 tablet /10ml H2O plus 10 µl Tween20. Freeze in 1ml aliquots at -20 ˚C in 
dark. 
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Annex 7. Immunohistochemistry protocol  
 
From Uribe and Gross (2007). 
 
Materials: 
 
• Reagents 
 
1. DMSO (Dimethylsulfoxide may be harmful if absorbed through the skin or if its fumes 
inhaled). Safety directions: wear appropriate gloves and safety glasses. Use in a 
chemical fume hood to prevent inhalation. Store in a tightly closed container, DMSO is 
combustible. Keep away from heat, sparks, and open flame. 
2. Normal Goat Serum (NGS) 
3. Paraformaldehyde, 4% dissolved in 1X PBS 
4. Phosphate Buffered Solution (PBS), 1X 
5. Primary Antibody 
6. Secondary Antibody 
7. Sucrose, 25% and 35% both dissolved in 1X PBS 
8. Tween-20 
9. Vectashield Mounting Medium (Vector Labs) 
 
• Equipment 
 
1. Coverslips, No. 1 thickness 
2. Cryostat 
3. Cryomolds (Tissue Tek) 
4. Eppendorf Tubes, 1.5 ml 
5. Humid Chamber: A Tupperware container with air-sealed lock and wet paper towels or 
kimwipes inside to provide moisture 
6. Microslides, 1.0 mm thick, pre-cleaned and gelatin-coated 
7. PAP pen (Sigma) 
8. Razor Blade 
9. Slide jar or Coplin jar 
10. Tissue Freezing Medium (Triangle Biomedical Sciences (TBS)) 
 
Methods: 
 
• Fixation 
 
1. Collect and fix whole zebrafish embryos or surgically removed adult eyes in 4% 
Paraformaldehyde (PFA) at 4°C overnight (or for more time) or at room temperature 
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for 4-6 hours in eppendorf tubes. If collecting embryos before 48hpf, make sure to 
remove the chorion with forceps prior fixation.  
2. Remove 4% PFA by using a pipette to gently remove solution. Rinse in 1x PBS 3 
times, 5 minutes each for total time of 15 minutes. 
3. Soak specimen in 25% Sucrose dissolved in 1x PBS at room temperature until 
embryos or eyes sink to the bottom of the tube (time varies, but may take up to 2.5 
hours). 
4. Remove 25% sucrose and add 35% sucrose dissolved in 1x PBS. Soak at room 
temperature until embryos or eyes sink to the bottom of the tube (again, time varies). 
Pause point: may leave in 35% sucrose at 4 °C for up to a week. 
 
• Cryosectioning 
 
5. To line fish up in cryomolds: 
 
a. Prepare desired amount of cryomolds by filling cryomolds with Tissue Freezing 
Medium (TFM) at room temperature. Take care not to get any bubbles in the 
molds. 
b. Using one TFM-filled mold as a transfer dish, remove specimen(s) from Eppendorf 
tube and stir gently around in TFM-filled mold to wash out 35% Sucrose. 
c. Transfer specimen(s) to a new TFM-filled cryomold. With a blunt needle, 
submerge embryos in the TFM and move embryos into a row that faces one side of 
the mold: line up fish head first such that their tails are facing center of mold and 
their heads are against the wall. Keep embryos as close to one another as possible 
and in a straight line. For adult eye, orient in mold with lens facing outward. If not 
interested in lens tissue, one may remove the lens during this step for easier 
cryosectioning. 
d. Carefully transfer to -80 °C to freeze. Pause point: may store at -80°C indefinitely. 
 
6. To prepare for cryosectioning: 
 
a. Set Cryostat to -20 °C. Remove specimen block from cryomold inside the cryostat. 
Using a razor blade, carefully trim away all excess frozen medium around 
specimen. 
b. Place TFM on center of chilled cryostage to which your sample will be placed. 
Carefully place trimmed specimen onto this TFM with side to be sectioned facing 
up. Ensure that specimen block is as straight as possible. Add more TFM around 
periphery of sample on stage. Freeze for 1-2 minutes prior to sectioning. 
c. Transfer cryostage to cryostage holder. 
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7. Using the trim function on the cryostat set to between 30-60 microns, trim through 
block until a uniform section is made in the appropriate part of the sample. Quickly 
transfer section to room temperature gelatin-coated slide by allowing cryosection to 
gently melt onto slide. Be careful not to section past the area of interest by checking 
sections using a basic light microscope. 
8. Continue to section at 8-12 micron thickness. Gently transfer each section to room 
temperature gelatin-coated slide by allowing section to melt onto slide. 
9. Allow sections to adhere to slide at room temperature for at least 2 hours prior to 
immunostaining. Pause point: slides may be stored at -20 °C for up to a month. In this 
case, slides should be brought to room temperature prior to beginning immunostaining. 
 
• Immunostaining 
 
10. Circle area of interest on slides with hydrophobic PAP pen. This will form a well to 
hold block and antibody solutions. Be careful not to touch sections. Rehydrate slides in 
PBTD, [0.1% Tween-20, 1% DMSO in 1 X PBS] at room temperature for 2-3 min in 
Coplin Jar. 
11. Remove slides from PBTD, drain excess off slide and place slides in humid chamber. 
From this point forward, it is critical to not let the slides dry. 
12. Gently pipette ~200-300 microliters of Block [5% NGS in PBTD] onto slides (Note: 
solution volume depends on how large area of interest). 
13. Incubate at room temperature for 1-2 hours. 
14. Remove Block from slides by draining off excess onto kimwipes 
15.  Add ~200-300 microliters of primary antibody diluted in block. 
16. Incubate in humid chamber overnight at 4 °C. 
17.  Remove primary antibody by rinsing slides in PBTD 3 times at room temperature for 
10 minutes each. 
18. Drain excess PBTD, return slides to humid chamber and place 200-300 microliters of 
appropriate concentration of secondary antibody diluted in block. 
19. Incubate at room temperature for 1-2 hours. 
20. Remove secondary antibody by rinsing slides in PBTD 3 times at room temperature for 
10 minutes each. 
21. Drain as much PBTD from slide as possible. Add one drop of Vectashield mounting 
medium directly onto sections. 
22. Carefully place no. 1 thickness coverslip on slide. Allow Vectashield to harden at room 
temperature for at least 3 hours before imaging. Pause point; may place slides in 4°C 
for up to 1 week until ready to image. 
23. Image on confocal or fluorescent microscope. 
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Annex 8. cugbp1 promoter sequence and location  
 
 
Gene ID: ENSDARG00000005315  
Transcript ID: ENSDART00000018448 
 
Exon3      CATTTGACAAAGGCACTGGATGGATAGTATCGAAGCTGAAGCCCTGTACCTGACCACAGC        
       GCAGCACGGGCAACCTCAATGCGA GCTTTCTCTTCCTGCTGTGGAAGTACCTGCCCTTG        
       GCGG   
Intron3    GTAAGCACACATTCACTTTGTTTTTTATTACCTCAGGGGTGCGAGGATGCCCTCCATCTA        
       CAGGTTTTCCCTATTTCAAACAGCTTCTCTTTGAAGCAGGAACAAGAAGAAACATATAGC        
       TTTCTTTTATAGAAAAGAAATATGCATGTATGCCATGAGCAGCCCACCAGATGTCACTGC        
       GTGGCAGGCAATGATGTCATGGCTGTTTGAATGTATAATTAGGGAAGCAATAGAATGATT        
       ACACTTATTAATTACGGAACTATCTGTGTTAGAATATTTTTGTGTACAATTTGAACTTTT        
       GTTTCTGAATGTATTACAGCTTTATAGTTTATGCATTTATTTTTTCCAGTAGCGAAAAGC        
       GTTGTAATGCTTTATTTTTAATGTACTTTATTATAGGTTTTTTGATGTTATGTTGAACAA        
       GACCAATTAATAGACCTTTGCTTGCCTGCGGCTTGTTTTGTTTGTCACCATTGACTGAAG        
       GCTTATAACACAACCCTTGTCGCATGACCCCGAGCAGCTTGTTGCTCCCTCCCTTCCGTC        
       ACCCCTCCATGCTGGAATGGTGCACGATCCGTGGCCCGTTGCCGGAACCTGATTGTGTCC        
       TGGGGGCGCTTCAGCTCAGGGATTACCAGAGAGCTGCCTGTCCCCATTCATTCCTGCCGT       
       TCACTCACGCTTATCAGCATCGATCTGACACTTTATTTATCTGACACTGCACTCAGTTCT        
       GCTTTGCTAAGAGAAAAACTCACAAAAAAGTCCCCCTCCATCAGCACTTTCTTTTGTGGG        
       ATCAGGGGTGCAGCTTTTAGTGGCCAGTCGGGTCCATCCTAATCCTCAGGCCCAACCCAG        
       TGACCAGTGCTAGGGCCTGTGTTTGTCATCCAGCTTCGTCGTTGTCTCTCTTTGCTCCAT        
       GTGGATTTGCGTTTTGTGGGGCCTCCTCAGCCTCCATGAGGTGCACACTTCCCCGTTCTC        
       TCCCAGCTGTTCCCATGTCACTTATCACGACTTGTGAACTTTGAGAGACATTGTACTTAA        
       CGGATAGTTGCTGTTGAAGTGTGAGCCGGTCTGCTGTTTTTGTGTATTGTCACCGTTCAT        
       TTGAGACTTGCTAATTGCTGAAGGCCTGAAGAA AATGGCTTCCTTT.......CTGTAG        
  
 
Primers used to amplify the 1152bp cugbp1 promoter 
                                   
Primer 1: 5'-gtacaggtaccgctttctcttcctgc 
 
 
 
                                                
5-gtacaggtaccgctttctcttcctgc-> 
     ||      ||||||||||||||| 
ttggagttacgctcgaaagagaaggacgacac 
 
 
 
 
Primer 2: 5'-gtagacactagtttcttcaggccttc 
 
 
 
 
<-cttccggacttctttgatcacagatg-5 
  ||||||||||||||| | |  ||    
Ctgaaggcctgaagaaaatggcttcctttaag  
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Annex 9. RT-PCR Morpholino Activity 
 
A. Morpholino disrupted splicing by removing exon4 
 
Exon 4 (188bp) 
 
AAGCAAGAAGATGAATGGGTCTCTGGACCACCCAGACCAGCCCGACATTGATTCTATAAA 
GATGTTTGTGGGTCAGATCCCTCGGACGTGGTCAGAGGATCAGCTGCGTGAGCTGTTTGA 
GCCCTATGGTGCAGTTTATGAAATCAATGTTCTTCGTGACAGGAGTCAGAACCCCCCACA 
GAGTAAAG 
 
Intron 4 (289bp) 
 
gtactttacagatggctttcaacttaatacagtttgttccaaatcccagtgagcacattg 
catatgcatacacaattgtgcagttataaaactatgcttaaaaaaagttgtcttgggatg 
caggatacttcagttgcctcctttttggaacagtccccatagtgggaatgtgccaatgat 
ttctcgtagagatgctcactggtgtttggaaactgtgttctagagagtggtctctgtgga 
aatgttgtcatcttggacgtgattcatagaccatttattgcatttgcag 
 
Exon 5 (83bp) 
 
GTTGTTGTTTTGTCACATATTACACCCGTAAGTCTGCATTAGAAGCACAAAATGCCCTTC 
ACAACATGAAGATTCTTCCAGGG 
 
Intron 5 (240bp) 
 
gtgagaaaatgtttttattttattatatcaataatccattaattctcctgtgtgtcgtca 
aatgacctggcattctaccaatttattgcttttaaaaatacatcatatataagcacatat 
tgagataatttcataatagcattttcagtacacccaaaggagctgtggaagatgttcaga 
tttctcatgagggctgggaaatgtcagcattaagtcacataattttatttttttcttcag 
 
Exon 6 (49)  
 
ATGCATCATCCCATACAAATGAAACCTGCAGACAGTGAGAAAAACAATG 
 
 
 
In silico PCR Primer(s) search for: 2  
 
1 5'-atgaatgggtctctggaccac 
 
Position: 11->31 21bp 100%    
 
5-atgaatgggtctctggaccac-> 
  ||||||||||||||||||||| 
tctacttacccagagacctggtgggtc 
 
2 5'-cattgtttttctcactgtctgcagg 
 
Position: 213<-237 25bp 100%    
 
<-ggacgtctgtcactctttttgttac-5 
  ||||||||||||||||||||||||| 
aacctgcagacagtgagaaaaacaatg 
 
 
1 5'-atgaatgggtctctggaccac 
2 5'-cattgtttttctcactgtctgcagg 
  
PCR product size: 227bp 
 
*Blue Outlines: regions amplified by RT-PCR. 
 Cross out: regions deleted by splicing. 
Region recognized by  
 
primer for RT-PCR 
Region recognized by 
 
primer for RT-PCR 
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Regions recognized 
 
by MO, but not by MM 
 
Annex 9. RT-PCR Morpholino Activity 
 
B. Mismatch morpholino did not disrupt splicing 
 
Exon 4 (188bp)  
 
AAGCAAGAAGATGAATGGGTCTCTGGACCACCCAGACCAGCCCGACATTGATTCTATAAA 
GATGTTTGTGGGTCAGATCCCTCGGACGTGGTCAGAGGATCAGCTGCGTGAGCTGTTTGA 
GCCCTATGGTGCAGTTTATGAAATCAATGTTCTTCGTGACAGGAGTCAGAACCCCCCACA 
GAGTAAAG 
 
Intron 4 (289bp) 
 
gtactttacagatggctttcaacttaatacagtttgttccaaatcccagtgagcacattg 
catatgcatacacaattgtgcagttataaaactatgcttaaaaaaagttgtcttgggatg 
caggatacttcagttgcctcctttttggaacagtccccatagtgggaatgtgccaatgat 
ttctcgtagagatgctcactggtgtttggaaactgtgttctagagagtggtctctgtgga 
aatgttgtcatcttggacgtgattcatagaccatttattgcatttgcag 
 
Exon 5 (83bp) 
 
GTTGTTGTTTTGTCACATATTACACCCGTAAGTCTGCATTAGAAGCACAAAATGCCCTTC 
ACAACATGAAGATTCTTCCAGGG 
 
Intron 5 (240bp)  
 
gtgagaaaatgtttttattttattatatcaataatccattaattctcctgtgtgtcgtca 
aatgacctggcattctaccaatttattgcttttaaaaatacatcatatataagcacatat 
tgagataatttcataatagcattttcagtacacccaaaggagctgtggaagatgttcaga 
tttctcatgagggctgggaaatgtcagcattaagtcacataattttatttttttcttcag 
 
Exon 6 (49bp)  
ATGCATCATCCCATACAAATGAAACCTGCAGACAGTGAGAAAAACAATG 
 
 
 
In silico PCR Primer(s) search for: 1  
 
1 5'-atgaatgggtctctggaccac 
 
Position: 11->31 21bp 100%    
 
5-atgaatgggtctctggaccac-> 
  ||||||||||||||||||||| 
tctacttacccagagacctggtgggtc 
 
2 5'-cattgtttttctcactgtctgcagg 
 
Position: 296<-320 25bp 100%    
 
<-ggacgtctgtcactctttttgttac-5 
  ||||||||||||||||||||||||| 
aacctgcagacagtgagaaaaacaatg 
 
 
1 5'-atgaatgggtctctggaccac 
2 5'-cattgtttttctcactgtctgcagg 
  
PCR product size: 310bp 
 
 
 
*Blue Outlines: amplified regions by RT-PCR. 
 Cross out: regions deleted by splicing. 
Region recognized by  
 
primer for RT-PCR 
Region recognized by 
 
primer for RT-PCR 
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Annex 10. BrdU+ cell counts  
 
 
 
 
 
 
Eye Section 
n = 27 
24 to 26hpf 
Number of BrdU+ cells 
72 to 74hpf 
Number of BrdU+ cells 
cugbp1-MM cugbp1-MO cugbp1-MM cugbp1-MO 
 
1 
1 9 5 14 6 
2 7 5 13 7 
3 6 5 10 7 
 
2 
1 8 7 13 7 
2 8 9 12 8 
3 6 6 10 7 
 
3 
1 8 9 10 7 
2 8 7 3 7 
3 4 6 9 9 
 
4 
1 7 8 8 7 
2 9 10 8 7 
3 7 7 7 8 
 
5 
1 7 7 8 8 
2 8 9 9 9 
3 7 7 9 12 
 
6 
1 8 8 15 8 
2 8 9 13 12 
3 2 9 15 14 
 
7 
1 8 11 5 8 
2 7 13 7 8 
3 5 10 5 10 
 
8 
1 13 9 7 7 
2 14 6 8 6 
3 7 4 5 6 
 
9 
1 12 9 8 7 
2 13 11 9 8 
3 11 9 9 9 
Mean ± SEM 8.037 ± 0.5188 7.963 ± 0.4117 9.222 ± 0.6047 8.111 ± 0.3711 
 
 
 
 
 
